data_2bw2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bw2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 57' ' ' LEU . 29.8 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.455 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.606 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 18.9 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.452 HD21 ' N ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.584 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.419 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.599 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.698 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CD2' HG12 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.654 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.698 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.446 ' OD1' ' HA3' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.412 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.748 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.504 ' HB3' HE21 ' A' ' 102' ' ' GLN . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.446 ' HA3' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.442 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 80' ' ' ASN . 32.0 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.496 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.428 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.575 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.418 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 57' ' ' LEU . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.461 HG21 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HB2' HG12 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.599 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.751 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.44 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.42 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.751 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.457 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.557 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.609 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.536 ' CE2' HD12 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' ' CD2' ' A' ' 28' ' ' HIS . 23.0 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 HD23 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CD2' ' HG3' ' A' ' 14' ' ' GLN . 33.1 m170 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CZ3' HD23 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.478 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD21 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.623 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 65' ' ' ILE . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.4 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.556 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.542 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG21 ' A' ' 83' ' ' ILE . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG13 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 13.6 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.543 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.629 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 113' ' ' GLN . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.436 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.53 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.419 ' H ' HG23 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.5 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' H ' HG23 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.713 0.292 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.417 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.463 ' HB2' HG22 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.535 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.626 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 125' ' ' LYS . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.416 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.413 ' CB ' ' HA2' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.673 HD12 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.557 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.673 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.444 ' HA ' HG23 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' MET . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.603 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD22 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' CG ' ' HZ2' ' A' ' 70' ' ' LYS . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' HA ' HG21 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' HG13 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.437 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 21.1 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.561 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 112' ' ' MET . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 69' ' ' SER . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.443 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 137' ' ' THR . 2.5 t60 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.42 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.414 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.9 OUTLIER -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' HG21 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.419 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.52 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.577 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.557 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.627 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 112' ' ' MET . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.605 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.483 ' CD2' ' HE1' ' A' ' 112' ' ' MET . 25.5 t60 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.534 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.485 HD23 HE21 ' A' ' 51' ' ' GLN . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.485 HE21 HD23 ' A' ' 48' ' ' LEU . 10.3 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.67 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.498 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.6 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.56 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.568 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.594 ' HE1' ' CD2' ' A' ' 134' ' ' HIS . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 112' ' ' MET . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 120' ' ' ILE . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' HE1' ' A' ' 112' ' ' MET . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 135' ' ' MET . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.507 ' CG ' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.547 ' CE2' HD12 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD1' HG12 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.498 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.411 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.642 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.461 ' HH ' ' HB2' ' A' ' 57' ' ' LEU . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.642 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.525 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.465 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.487 ' O ' HG11 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.491 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.547 HE21 HD12 ' A' ' 57' ' ' LEU . 3.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CD2' HG12 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HE2' ' CG ' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.43 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.824 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.643 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.448 ' HA ' HG21 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 10.9 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.643 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 112' ' ' MET . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.824 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.556 ' NH1' ' HB ' ' A' ' 131' ' ' VAL . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.556 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 137' ' ' THR . 2.4 t60 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 . . . . . 0 N--CA 1.422 -1.834 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.521 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.601 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' HD22 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.471 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 70' ' ' LYS . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' HA ' HG21 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.56 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.408 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.452 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 34.3 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.702 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.458 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 112' ' ' MET . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.545 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.545 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 126' ' ' ALA . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.58 ' CE2' HD12 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 138' ' ' TYR . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.694 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.463 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.694 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.469 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.5 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.451 ' HB2' HG21 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 83' ' ' ILE . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 82' ' ' VAL . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.401 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.2 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.589 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.58 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.477 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.58 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.47 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.404 HE21 HD12 ' A' ' 57' ' ' LEU . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.565 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.619 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.465 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 70' ' ' LYS . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 64' ' ' ASP . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.418 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.423 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.423 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 19.8 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.611 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 112' ' ' MET . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.534 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' HG21 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' HG23 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.566 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HG2' HD21 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.566 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.482 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.57 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.416 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.512 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 22.5 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.61 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 113' ' ' GLN . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.595 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 112' ' ' MET . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.496 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.538 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 35' ' ' SER . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.462 ' H ' HG11 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.449 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB2' HG13 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.431 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.538 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HA ' HD11 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.483 ' HA ' HG21 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 28.6 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HD22 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.647 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 113' ' ' GLN . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.527 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.6 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.636 ' O ' HG21 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.491 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.548 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.402 ' CD2' HG12 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.664 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.583 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.484 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.541 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.469 ' H ' HG23 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 127' ' ' GLU . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 137' ' ' THR . 17.1 t60 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' HD12 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.417 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.497 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.629 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.456 ' HE1' ' CD2' ' A' ' 134' ' ' HIS . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 112' ' ' MET . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 120' ' ' ILE . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.488 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' HD12 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.543 ' HA ' HG21 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.533 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.436 ' HB2' HG22 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.595 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.667 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.515 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.404 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.405 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.661 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.564 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.575 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.422 HG21 ' H ' ' A' ' 125' ' ' LYS . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.422 ' H ' HG21 ' A' ' 124' ' ' THR . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' O ' HG11 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.433 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.502 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.564 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.629 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD21 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.491 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.468 ' HA ' HG21 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG13 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 14.3 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.65 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.582 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.469 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 112' ' ' MET . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.559 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.455 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.47 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CE2' HD12 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.418 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 C--O 1.243 0.737 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.4 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.454 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.632 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.501 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG21 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.731 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.415 HG21 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.404 ' CB ' ' HA2' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.426 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.731 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.611 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 113' ' ' GLN . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.464 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.611 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 112' ' ' MET . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.461 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.4 HG13 ' CZ ' ' A' ' 39' ' ' PHE . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.439 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.404 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.769 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 83' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.414 HG21 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.445 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.474 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.769 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.539 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 110' ' ' SER . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.494 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.539 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.491 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 137' ' ' THR . 2.2 t60 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.4 ' CA ' HG23 ' A' ' 103' ' ' ILE . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB2' HG23 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.619 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB2' HG22 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.522 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.458 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.618 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.618 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.458 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.543 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.44 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HA ' HG21 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.448 ' OG ' HG13 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.7 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.614 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 112' ' ' MET . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' ' HZ3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.619 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.424 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.483 ' CA ' HG23 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.402 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.49 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.631 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.44 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.529 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.529 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.663 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.451 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 113' ' ' GLN . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 112' ' ' MET . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.439 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG22 ' OE1' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.476 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.609 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.451 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.825 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.575 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.424 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.401 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.401 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.578 HD21 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.641 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.401 HG22 ' OE1' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.445 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CZ3' HD21 ' A' ' 15' ' ' LEU . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.433 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.524 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.415 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.803 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.719 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.405 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.719 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.474 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 112' ' ' MET . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.537 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.533 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HA ' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.533 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.404 ' HA ' HG21 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.436 0.636 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.51 146.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 124.767 1.227 . . . . 0.0 109.315 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 4' ' ' GLU . 2.7 t -113.63 169.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.825 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.418 ' H ' HG13 ' A' ' 3' ' ' VAL . 8.2 mm-40 -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -126.17 -175.72 3.45 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.813 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -114.55 -32.87 5.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -82.16 131.68 55.63 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 171.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.456 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.486 HE21 HD12 ' A' ' 57' ' ' LEU . 29.8 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.403 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.481 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.455 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.606 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.606 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 HD13 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.422 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.536 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 18.9 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.452 HD21 ' N ' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.584 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.583 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.419 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.419 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.599 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.435 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.42 153.72 29.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.59 169.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-O 121.134 0.492 . . . . 0.0 111.245 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.88 129.04 38.45 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.2 167.46 19.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.829 0.823 . . . . 0.0 112.428 -169.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -66.69 -34.66 78.35 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.679 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.13 157.29 45.64 Favored Pre-proline 0 N--CA 1.427 -1.615 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.342 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.698 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.497 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CD2' HG12 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.522 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.654 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.654 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.698 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.434 ' HA ' ' HA2' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.446 ' OD1' ' HA3' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.412 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.748 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.504 ' HB3' HE21 ' A' ' 102' ' ' GLN . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.748 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.446 ' HA3' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.449 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.442 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.504 HE21 ' HB3' ' A' ' 80' ' ' ASN . 32.0 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.496 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.428 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.617 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.575 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.417 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.441 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.418 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -136.27 114.0 11.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.603 0.761 . . . . 0.0 108.959 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.05 -175.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.131 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.2 98.91 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.957 0.786 . . . . 0.0 111.795 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -106.04 -164.03 0.98 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.71 -46.25 89.01 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.678 0.751 . . . . 0.0 109.49 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.78 149.38 39.43 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.683 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' NE2' HD12 ' A' ' 57' ' ' LEU . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.42 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.461 HG21 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.506 ' HB2' HG12 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.599 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.405 ' HD2' ' HA ' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.553 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.735 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.751 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.44 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.42 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.751 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.457 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.567 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.557 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.431 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.609 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.536 ' CE2' HD12 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.98 151.83 37.48 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.32 -177.36 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.11 108.57 14.88 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -81.35 -179.42 7.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.086 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.38 -12.72 34.04 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.621 0.724 . . . . 0.0 109.306 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -72.82 142.71 83.59 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.555 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.412 ' HG3' ' CD2' ' A' ' 28' ' ' HIS . 23.0 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 HD23 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CD2' ' HG3' ' A' ' 14' ' ' GLN . 33.1 m170 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.569 ' CZ3' HD23 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.478 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD21 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.623 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.449 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 65' ' ' ILE . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.4 ' H ' ' CG ' ' A' ' 64' ' ' ASP . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.556 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.412 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.542 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.755 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.755 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.449 ' O ' HG21 ' A' ' 83' ' ' ILE . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG13 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.412 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.414 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.4 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 13.6 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.543 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.629 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' A' ' 113' ' ' GLN . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.436 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.53 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.452 HD11 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.419 ' H ' HG23 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.556 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.5 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' H ' HG23 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.5 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.472 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.502 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.66 161.12 42.99 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.5 m -83.99 168.89 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.454 0.471 . . . . 0.0 110.744 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.35 124.05 44.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 m170 68.99 -163.39 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.51 1.131 . . . . 0.0 109.672 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.54 -13.39 49.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.415 0.626 . . . . 0.0 109.316 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.0 157.12 43.71 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.217 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.436 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.417 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.463 ' HB2' HG22 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.535 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.626 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' HZ3' ' HB2' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.626 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.535 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.468 ' CG ' ' HZ1' ' A' ' 125' ' ' LYS . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.613 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.48 HG23 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.416 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.413 ' CB ' ' HA2' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.428 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.552 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.673 HD12 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.563 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.557 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.549 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.468 ' HZ1' ' CG ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.435 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.673 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.444 ' HA ' HG23 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.542 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -102.35 159.12 15.69 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.48 171.26 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 121.75 0.786 . . . . 0.0 111.809 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.04 127.13 39.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -104.29 -178.11 3.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -74.23 -39.91 62.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.86 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.74 135.79 59.48 Favored Pre-proline 0 N--CA 1.428 -1.568 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.642 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.642 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' HB2' HG21 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 36' ' ' MET . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.603 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD22 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.603 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' CG ' ' HZ2' ' A' ' 70' ' ' LYS . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.524 ' O ' HG12 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' HA ' HG21 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.468 ' OG ' HG13 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.427 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.437 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 21.1 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD11 ' CB ' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.434 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.561 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 112' ' ' MET . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 69' ' ' SER . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.443 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.575 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 137' ' ' THR . 2.5 t60 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.426 ' HA ' HG21 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.739 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.24 131.01 50.62 Favored 'General case' 0 CA--C 1.487 -1.454 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.737 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 5' ' ' HIS . 25.1 m -90.25 168.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.56 110.24 22.38 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.404 ' O ' HG22 ' A' ' 3' ' ' VAL . 81.2 m-70 76.28 -171.12 0.09 Allowed 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 125.385 1.678 . . . . 0.0 108.639 -166.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -106.61 -20.8 13.25 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -118.85 156.67 51.66 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD21 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.42 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.63 HG21 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.404 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.9 OUTLIER -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' HG21 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.419 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.52 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.558 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.577 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.557 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.627 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.413 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 112' ' ' MET . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.453 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.445 ' H ' HG23 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.453 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.605 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.483 ' CD2' ' HE1' ' A' ' 112' ' ' MET . 25.5 t60 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.441 ' CE2' HD11 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG21 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.378 0.609 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.54 170.54 15.87 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.36 151.13 10.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.019 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.89 121.21 31.02 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.28 168.42 12.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -82.67 -12.72 57.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.371 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -80.22 110.64 17.23 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.224 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.43 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.534 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.485 HD23 HE21 ' A' ' 51' ' ' GLN . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.455 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.485 HE21 HD23 ' A' ' 48' ' ' LEU . 10.3 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.525 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.688 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.764 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.67 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.764 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.455 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.498 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.6 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.56 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.568 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.594 ' HE1' ' CD2' ' A' ' 134' ' ' HIS . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 112' ' ' MET . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.566 ' H ' ' C ' ' A' ' 120' ' ' ILE . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' CG ' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.594 ' CD2' ' HE1' ' A' ' 112' ' ' MET . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.4 ' HA ' ' HE3' ' A' ' 135' ' ' MET . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.507 ' CG ' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.547 ' CE2' HD12 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.686 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -113.63 144.87 42.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 4' ' ' GLU . 6.2 t 61.93 -175.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 108.985 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.499 ' H ' HG13 ' A' ' 3' ' ' VAL . 12.1 pt-20 -101.59 126.6 48.44 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -126.21 159.62 32.49 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.237 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -89.55 -19.19 25.3 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.771 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -68.21 124.28 89.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.203 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.537 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.5 ' CD1' HG12 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.498 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.411 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.642 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.421 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.461 ' HH ' ' HB2' ' A' ' 57' ' ' LEU . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.642 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.472 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.561 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.458 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.494 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.739 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.416 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.462 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.525 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.404 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.465 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.407 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.475 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.487 ' O ' HG11 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.491 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.494 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.02 -175.79 2.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.3 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.05 169.77 17.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -77.17 110.23 11.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -95.42 168.06 10.94 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.882 0.849 . . . . 0.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.99 -30.8 7.36 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.191 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -96.82 127.92 37.54 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.537 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.547 HE21 HD12 ' A' ' 57' ' ' LEU . 3.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.493 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.418 ' CD2' HG12 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.604 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.604 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' HE2' ' CG ' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.43 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.54 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.824 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.643 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.448 ' HA ' HG21 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.452 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.567 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 10.9 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.643 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.46 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 112' ' ' MET . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.824 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.556 ' NH1' ' HB ' ' A' ' 131' ' ' VAL . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.556 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 137' ' ' THR . 2.4 t60 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.53 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.453 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.413 ' CD ' ' HZ1' ' A' ' 53' ' ' LYS . 33.6 tt0 -81.4 131.91 35.3 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 m -133.22 176.32 9.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.019 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -81.28 138.4 35.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.42 -171.88 2.22 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.711 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -78.03 -33.7 50.93 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.606 0.717 . . . . 0.0 109.611 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -84.07 135.46 42.11 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.947 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG22 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.521 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.601 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HG2' HD22 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HZ1' ' CD ' ' A' ' 2' ' ' GLU . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.601 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.521 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.471 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.474 ' CG ' ' HZ2' ' A' ' 70' ' ' LYS . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' HG12 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.795 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.702 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.795 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' HA ' HG21 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.56 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.408 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.452 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.452 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 34.3 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.702 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.524 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.458 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 112' ' ' MET . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.56 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.527 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.545 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.545 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 126' ' ' ALA . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.493 ' O ' HG23 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.511 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.485 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.58 ' CE2' HD12 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 138' ' ' TYR . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.399 0.619 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.1 pm0 -90.6 160.86 15.7 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.209 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -99.51 178.96 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.155 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -75.59 137.44 40.79 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -98.33 174.42 6.49 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.358 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -80.23 -54.06 6.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.713 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -87.25 148.74 45.51 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.521 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.463 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.694 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.469 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.521 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.694 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.516 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.602 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.469 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.622 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.5 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.451 ' HB2' HG21 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.647 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.768 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 83' ' ' ILE . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' HG22 ' A' ' 82' ' ' VAL . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.504 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.504 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.401 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.2 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.647 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.535 ' HA ' HD22 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 114' ' ' LYS . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.421 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.589 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.58 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.43 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.477 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.58 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.43 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.47 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -156.7 169.26 25.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.25 173.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -71.83 122.25 20.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -76.37 171.42 14.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.589 0.709 . . . . 0.0 109.669 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 9.4 m-85 -102.82 -34.17 9.09 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.03 112.41 62.94 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.404 HE21 HD12 ' A' ' 57' ' ' LEU . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.71 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.416 ' HB2' HG22 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.565 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.619 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD22 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.465 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 70' ' ' LYS . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.583 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 64' ' ' ASP . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.583 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.592 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.418 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.453 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.611 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.431 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.424 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.444 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.423 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.423 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.431 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 19.8 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.611 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.564 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 112' ' ' MET . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.592 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.534 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.46 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.71 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.491 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.45 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CE2' HD12 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HA ' HG21 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.725 0.298 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.67 -172.41 0.18 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.54 176.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.838 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.71 137.84 31.96 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -113.28 176.73 4.9 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.247 0.546 . . . . 0.0 110.156 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -94.12 -37.26 11.69 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.79 164.28 24.57 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.804 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.647 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.521 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' HG23 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.566 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.449 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HG2' HD21 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.594 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.566 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.482 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.57 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.416 ' O ' ' HA2' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.512 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' OG ' HG13 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.438 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.606 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.411 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.661 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 22.5 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.61 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.492 HD11 ' CB ' ' A' ' 113' ' ' GLN . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.595 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.414 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 112' ' ' MET . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.606 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HA ' HG21 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.489 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.496 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.476 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 66.4 162.33 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.179 0.991 . . . . 0.0 111.601 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.15 163.36 7.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.98 110.02 22.25 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.164 0.507 . . . . 0.0 110.589 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.341 9.5 p80 -107.49 138.38 43.82 Favored 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.293 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -92.25 -17.42 24.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.392 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.51 117.34 67.58 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.411 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.538 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' H ' ' A' ' 35' ' ' SER . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.462 ' H ' HG11 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.449 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB2' HG13 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.449 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.496 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.431 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.637 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.533 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.637 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.431 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.538 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' O ' HG11 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.429 ' HA ' HD11 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.796 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.483 ' HA ' HG21 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.454 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 28.6 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.508 ' HA ' HD22 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.647 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.431 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 113' ' ' GLN . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.507 HG23 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.527 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.6 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.636 ' O ' HG21 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.6 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.491 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.636 HG21 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.548 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.661 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -84.91 153.42 22.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.484 27.9 m 55.36 115.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -78.84 112.25 15.8 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.092 -1.867 . . . . 0.0 112.398 -174.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 m170 68.09 -164.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.31 1.444 . . . . 0.0 111.261 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -91.7 -3.49 56.21 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.846 0.831 . . . . 0.0 109.339 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.76 130.61 86.82 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 113.89 -1.504 . . . . 0.0 107.906 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.501 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.65 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.402 ' CD2' HG12 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.476 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.664 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.494 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.664 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.59 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.482 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.607 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.782 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG23 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.466 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.607 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.641 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.528 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.583 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.583 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.484 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.541 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.469 HG23 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.469 ' H ' HG23 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 127' ' ' GLU . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.65 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 137' ' ' THR . 17.1 t60 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.504 ' CE2' HD12 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.417 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -76.27 139.83 41.29 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.16 172.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.24 150.13 24.59 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -129.97 -169.33 2.11 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -24.2 60.65 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.3 145.06 63.46 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.459 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.604 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.51 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.445 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' HG2' HD22 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.746 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.746 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.497 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.497 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.629 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.56 ' HA ' HD22 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.456 ' HE1' ' CD2' ' A' ' 134' ' ' HIS . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.51 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 112' ' ' MET . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.463 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 120' ' ' ILE . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.51 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.406 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.488 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.565 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.525 ' CE2' HD12 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.543 ' HA ' HG21 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.533 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -142.58 150.25 40.09 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 4' ' ' GLU . 3.8 t -88.83 178.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.488 ' H ' HG13 ' A' ' 3' ' ' VAL . 9.6 pt-20 -70.16 146.69 50.62 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.448 . . . . 0.0 110.126 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -111.32 -177.01 3.09 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -73.26 -42.76 62.14 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.569 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -97.03 137.62 21.27 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.722 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.667 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.436 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.409 ' HB2' ' HA ' ' A' ' 4' ' ' GLU . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.436 ' HB2' HG22 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.586 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.45 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.595 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HG2' HD22 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.595 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.45 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.431 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.667 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.515 ' O ' HG12 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.756 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.435 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.661 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.546 ' O ' ' HB2' ' A' ' 108' ' ' LEU . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.564 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.575 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.444 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.422 HG21 ' H ' ' A' ' 125' ' ' LYS . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.422 ' H ' HG21 ' A' ' 124' ' ' THR . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' O ' HG11 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.427 HG11 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.596 ' O ' HG23 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.596 HG23 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.433 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.82 153.2 31.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.496 HG13 ' H ' ' A' ' 4' ' ' GLU . 12.9 t 69.71 -179.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -173.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.496 ' H ' HG13 ' A' ' 3' ' ' VAL . 8.6 pt-20 -88.5 103.6 16.03 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.3 0.572 . . . . 0.0 110.472 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.8 -174.95 4.96 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.764 0.792 . . . . 0.0 110.534 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -92.91 -8.69 42.57 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.799 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.23 152.12 83.86 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.619 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' PHE . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.468 HG13 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.502 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.456 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.502 HG22 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' HB2' HG12 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.468 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.564 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.629 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' HG2' HD21 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.491 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.4 ' O ' ' HA3' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.785 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.468 ' HA ' HG21 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.428 ' OG ' HG13 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.559 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 14.3 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.65 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.582 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.58 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.469 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 112' ' ' MET . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.559 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.455 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.47 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.47 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.412 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.45 ' CE2' HD12 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.418 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.57 151.33 33.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.97 160.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.788 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.55 98.52 10.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.202 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -114.99 168.99 9.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.425 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -90.5 -11.8 39.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -70.56 158.09 88.6 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.27 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.4 ' H ' HD22 ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.472 ' HB2' HG22 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.454 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.446 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.463 ' HG2' HD22 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.632 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' HA3' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.501 ' CD2' ' HA2' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG21 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.784 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.731 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.784 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.425 HG23 ' O ' ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.415 HG21 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' CB ' ' HA2' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.539 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.426 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.406 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.731 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.602 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.611 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HB2' ' HG2' ' A' ' 113' ' ' GLN . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.464 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.611 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 112' ' ' MET . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.501 ' HA2' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.461 ' CB ' ' HA3' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.467 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.442 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.14 104.39 16.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.559 0.695 . . . . 0.0 110.962 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 178.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.926 178.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.52 118.8 6.96 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.862 0.726 . . . . 0.0 109.209 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.256 4.0 p-80 -90.66 -176.97 4.89 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.83 -24.04 18.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.884 -167.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -82.66 148.44 58.05 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.398 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.4 HG13 ' CZ ' ' A' ' 39' ' ' PHE . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.581 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' HA2' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.439 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HE1' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.4 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.404 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.412 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 HG12 HG21 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.745 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.769 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.745 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 ' O ' HG21 ' A' ' 83' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.414 HG21 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.481 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.445 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.474 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.769 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.539 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.507 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 110' ' ' SER . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.422 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.494 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.539 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.491 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.491 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.581 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.422 ' O ' HG23 ' A' ' 137' ' ' THR . 2.2 t60 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.465 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 134' ' ' HIS . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.4 ' CA ' HG23 ' A' ' 103' ' ' ILE . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.595 0 CA-C-O 120.919 0.39 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -127.99 149.12 50.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.52 171.54 4.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.42 115.84 30.94 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 177.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -74.06 158.22 34.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.007 0.908 . . . . 0.0 111.968 -175.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -105.01 -42.52 5.3 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.486 -170.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -86.99 134.29 37.26 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.681 178.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' HB2' HG23 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.619 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HB2' HG22 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.522 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.458 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.618 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.618 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.458 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.543 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.44 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HA ' HG21 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.448 ' OG ' HG13 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.44 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.7 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.614 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.5 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.48 ' HA ' HD22 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.537 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 112' ' ' MET . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.451 ' HB3' ' HZ3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.619 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.516 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.466 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.532 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.424 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.483 ' CA ' HG23 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.62 177.2 4.78 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.33 167.75 23.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.73 137.27 51.86 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m80 60.2 -167.84 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.105 0.962 . . . . 0.0 111.957 177.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.96 -10.3 39.9 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.99 156.25 88.13 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.917 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.623 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG13 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.402 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.49 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.631 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.44 ' HG2' HD22 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.631 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.529 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.529 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.663 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.76 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.76 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.429 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.429 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.451 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 113' ' ' GLN . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.481 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.576 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 112' ' ' MET . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.663 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.595 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.526 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.476 HG23 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.418 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.623 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.578 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.439 ' CZ ' HD12 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -85.04 133.41 34.24 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -115.35 178.28 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-O 121.416 0.627 . . . . 0.0 112.08 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.21 113.76 26.11 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 173.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -172.05 3.67 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.571 0.701 . . . . 0.0 111.763 -172.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.05 -20.02 29.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -78.52 132.01 66.66 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 170.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.408 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.529 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG22 ' OE1' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.476 ' HE3' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ2' ' HE3' ' A' ' 36' ' ' MET . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.609 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.557 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.526 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.451 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.774 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.825 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.774 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.497 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.654 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.522 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.825 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.729 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.729 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.575 ' HB2' HD11 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.654 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.529 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.509 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.424 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.401 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.39 179.87 7.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.369 15.5 m 59.9 158.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 127.609 2.364 . . . . 0.0 116.679 175.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.57 111.64 21.44 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.383 -177.363 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -100.33 -160.02 0.77 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -83.41 -12.48 56.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -85.87 150.64 53.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.369 -1.741 . . . . 0.0 107.101 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.401 ' OE1' HG22 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.578 HD21 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.641 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG22 ' OE1' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.421 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.445 ' CZ ' HG13 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CZ3' HD21 ' A' ' 15' ' ' LEU . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HG2' HD22 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.627 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.502 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.433 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.524 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.415 ' O ' HG21 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.803 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.719 ' HA2' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.803 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.523 ' CD1' ' HA2' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.44 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.495 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.405 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.54 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.719 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.518 ' HA ' HD22 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.474 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.599 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 112' ' ' MET . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.537 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.533 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HA ' ' CG2' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.533 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.54 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.496 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' MET . . . . . 0.54 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.505 ' CE2' HD12 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.404 ' HA ' HG21 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 65' ' ' ILE . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' HG13 ' A' ' 13' ' ' VAL . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.469 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.63 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.469 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 20' ' ' LEU . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 48.3 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.611 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.598 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CD2' HG11 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.756 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.55 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.709 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG12 HG22 ' A' ' 85' ' ' THR . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' HG22 ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 HG12 ' A' ' 75' ' ' ILE . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.4 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.8 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.429 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.595 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' LEU . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' A' ' 29' ' ' LYS . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HB2' HG21 ' A' ' 33' ' ' VAL . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.663 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' HD2' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.663 HD23 ' HG2' ' A' ' 50' ' ' GLU . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.755 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.755 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.597 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 120' ' ' ILE . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.451 ' HG3' ' CE1' ' A' ' 28' ' ' HIS . 29.9 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 65' ' ' ILE . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' ' HG3' ' A' ' 14' ' ' GLN . 57.3 m-70 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.715 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.579 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.491 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.646 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' HD23 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.402 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 20' ' ' LEU . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 77' ' ' VAL . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 87' ' ' HIS . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.445 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 36.9 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 139' ' ' SER . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HA ' HD23 ' A' ' 108' ' ' LEU . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 122' ' ' PHE . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.475 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' H ' HG22 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' HG22 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.713 0.292 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HE2' ' A' ' 29' ' ' LYS . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 65' ' ' ILE . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.547 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.69 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 20' ' ' LEU . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 85' ' ' THR . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.542 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.631 HG22 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HE1' ' HG ' ' A' ' 84' ' ' SER . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HE22 ' A' ' 98' ' ' GLN . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.609 ' HG2' HG22 ' A' ' 82' ' ' VAL . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.618 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.661 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.565 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.672 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.562 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.597 ' HB2' HG22 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 33' ' ' VAL . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.661 ' HG2' HD23 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 50' ' ' GLU . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.558 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' HH21 ' A' ' 123' ' ' ARG . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 85' ' ' THR . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 75' ' ' ILE . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.523 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 55.7 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.511 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.438 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 77' ' ' VAL . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.478 HH21 ' HA3' ' A' ' 73' ' ' GLY . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 137' ' ' THR . 19.2 t-80 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.583 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' GLN . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 15' ' ' LEU . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.646 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.667 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.535 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.464 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 82' ' ' VAL . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 110' ' ' SER . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.543 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.639 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 113' ' ' GLN . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.438 ' O ' HG22 ' A' ' 137' ' ' THR . 56.8 t-80 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD11 ' HE2' ' A' ' 29' ' ' LYS . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' ILE . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 15' ' ' LEU . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.559 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 20' ' ' LEU . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.674 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' HA ' HD12 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' HA ' HG22 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.514 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.0 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.564 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.588 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HA ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 113' ' ' GLN . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.513 ' CD2' ' HE2' ' A' ' 138' ' ' TYR . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 mm-40 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' GLU . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 26' ' ' ILE . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 27' ' ' GLU . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD12 HE21 ' A' ' 14' ' ' GLN . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD1' HG11 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' HG12 ' A' ' 120' ' ' ILE . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.569 ' HG2' HG22 ' A' ' 82' ' ' VAL . 59.1 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.557 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.641 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.476 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 103' ' ' ILE . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD11 ' HE2' ' A' ' 29' ' ' LYS . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HE2' HD11 ' A' ' 15' ' ' LEU . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.401 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.628 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 50' ' ' GLU . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.818 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.497 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 33.2 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.651 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 113' ' ' GLN . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 117' ' ' LEU . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 113' ' ' GLN . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.564 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 137' ' ' THR . 20.6 t-80 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 . . . . . 0 N--CA 1.422 -1.834 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' A' ' 13' ' ' VAL . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB2' HG21 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.515 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 66' ' ' SER . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 26.2 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.711 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.587 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 113' ' ' GLN . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.572 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 124' ' ' THR . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.492 ' O ' HG22 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE2' HD13 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.452 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.686 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 33' ' ' VAL . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.686 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.637 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 11' ' ' VAL . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD23 ' HG2' ' A' ' 50' ' ' GLU . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.514 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' HE22 ' A' ' 98' ' ' GLN . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.47 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.4 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.656 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.627 ' HA ' HD23 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 116' ' ' LEU . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.584 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.584 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.59 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.426 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.707 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.627 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HG2' HD23 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.645 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 HD12 ' HE ' ' A' ' 123' ' ' ARG . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.5 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.423 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.481 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.439 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.1 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.573 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 113' ' ' GLN . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.707 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.517 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HB2' HG22 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.635 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.502 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HA ' HG22 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' HG12 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' HE22 ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.453 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 59.3 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.618 ' HA ' HD13 ' A' ' 108' ' ' LEU . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.615 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 77' ' ' VAL . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.554 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 9' ' ' LEU . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 39' ' ' PHE . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HB2' HG11 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.444 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.409 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.647 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.58 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 103' ' ' ILE . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.3 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HA ' HD23 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.662 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 77' ' ' VAL . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.642 ' O ' HG22 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HE2' HD21 ' A' ' 15' ' ' LEU . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.745 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.745 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.809 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.537 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.412 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.411 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.612 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.714 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 124' ' ' THR . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 38.7 t-80 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.644 HD11 ' HE2' ' A' ' 29' ' ' LYS . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 97' ' ' ILE . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HE2' HD11 ' A' ' 15' ' ' LEU . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.503 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.448 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.635 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.502 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 23' ' ' ASP . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.553 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.633 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.622 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 109' ' ' GLU 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.537 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.481 ' O ' HG22 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.593 ' HA ' HG22 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.541 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB2' HG21 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HG2' HD23 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.678 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.802 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.667 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.881 HD23 ' HG3' ' A' ' 112' ' ' MET . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.881 ' HG3' HD23 ' A' ' 108' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.796 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.447 ' HA ' HG22 ' A' ' 103' ' ' ILE . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.409 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 29' ' ' LYS . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.515 HG23 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.683 ' HB2' HG13 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.488 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.44 ' OG ' HG12 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 39.4 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.655 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.467 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.558 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 77' ' ' VAL . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.567 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.504 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.421 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 C--O 1.243 0.737 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HE2' HD11 ' A' ' 15' ' ' LEU . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 53' ' ' LYS 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 125' ' ' LYS 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.471 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CD2' ' HA3' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.74 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.417 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.444 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 26.2 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.74 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HA ' HD13 ' A' ' 108' ' ' LEU . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 106' ' ' GLU . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HG2' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.471 ' CB ' ' HA2' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.441 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 9' ' ' LEU . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 15' ' ' LEU . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 39' ' ' PHE . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' A' ' 33' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.62 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 103' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.461 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.778 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.508 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.508 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.8 mm-40 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD11 ' HE2' ' A' ' 29' ' ' LYS . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.671 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.671 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.642 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' ' 20' ' ' LEU . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.555 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.504 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' HG12 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 62.2 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.535 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.581 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 113' ' ' GLN . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' HD11 ' A' ' 15' ' ' LEU . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HB2' HG11 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.558 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.447 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.561 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 139' ' ' SER . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 108' ' ' LEU . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD2' HD12 ' A' ' 117' ' ' LEU . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 113' ' ' GLN . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.699 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 124' ' ' THR . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.572 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 65' ' ' ILE . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.572 HG23 ' NE2' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 20' ' ' LEU . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.428 HD21 ' HA2' ' A' ' 88' ' ' GLY . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.48 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.834 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 113' ' ' GLN . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.57 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 131' ' ' VAL . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.565 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' A' ' 65' ' ' ILE . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.565 HG23 ' NE2' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.652 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 98' ' ' GLN . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.47 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.726 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.556 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 113' ' ' GLN . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.608 ' H ' HG22 ' A' ' 124' ' ' THR . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.436 0.636 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.51 146.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 124.767 1.227 . . . . 0.0 109.315 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 4' ' ' GLU . 2.7 t -113.63 169.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.825 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' H ' HG12 ' A' ' 3' ' ' VAL . 8.2 mm-40 -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -126.17 -175.72 3.45 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.813 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -114.55 -32.87 5.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -82.16 131.68 55.63 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 171.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 65' ' ' ILE . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' HG13 ' A' ' 13' ' ' VAL . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.469 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.63 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.469 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 20' ' ' LEU . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 48.3 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.611 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.598 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.42 153.72 29.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.59 169.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-O 121.134 0.492 . . . . 0.0 111.245 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.88 129.04 38.45 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.2 167.46 19.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.829 0.823 . . . . 0.0 112.428 -169.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -66.69 -34.66 78.35 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.679 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.13 157.29 45.64 Favored Pre-proline 0 N--CA 1.427 -1.615 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.342 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CD2' HG11 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.756 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.55 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.709 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG12 HG22 ' A' ' 85' ' ' THR . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.441 ' O ' HG22 ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 HG12 ' A' ' 75' ' ' ILE . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.4 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.8 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.429 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.595 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -136.27 114.0 11.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.603 0.761 . . . . 0.0 108.959 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.05 -175.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.131 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.2 98.91 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.957 0.786 . . . . 0.0 111.795 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -106.04 -164.03 0.98 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.71 -46.25 89.01 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.678 0.751 . . . . 0.0 109.49 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.78 149.38 39.43 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.683 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' LEU . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' A' ' 29' ' ' LYS . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HB2' HG21 ' A' ' 33' ' ' VAL . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.663 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' HD2' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.663 HD23 ' HG2' ' A' ' 50' ' ' GLU . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.755 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.755 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.597 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 120' ' ' ILE . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.98 151.83 37.48 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.32 -177.36 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.11 108.57 14.88 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -81.35 -179.42 7.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.086 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.38 -12.72 34.04 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.621 0.724 . . . . 0.0 109.306 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -72.82 142.71 83.59 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.451 ' HG3' ' CE1' ' A' ' 28' ' ' HIS . 29.9 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 65' ' ' ILE . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' ' HG3' ' A' ' 14' ' ' GLN . 57.3 m-70 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.715 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.579 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.491 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.646 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' HD23 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.402 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 20' ' ' LEU . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 77' ' ' VAL . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 87' ' ' HIS . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.445 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 36.9 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 139' ' ' SER . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HA ' HD23 ' A' ' 108' ' ' LEU . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 122' ' ' PHE . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.475 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' H ' HG22 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' HG22 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.66 161.12 42.99 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 9' ' ' LEU . 20.5 m -83.99 168.89 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.454 0.471 . . . . 0.0 110.744 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.35 124.05 44.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 m170 68.99 -163.39 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.51 1.131 . . . . 0.0 109.672 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.54 -13.39 49.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.415 0.626 . . . . 0.0 109.316 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.0 157.12 43.71 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.217 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HE2' ' A' ' 29' ' ' LYS . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 65' ' ' ILE . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.547 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.69 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 20' ' ' LEU . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 85' ' ' THR . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.542 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.631 HG22 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HE1' ' HG ' ' A' ' 84' ' ' SER . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HE22 ' A' ' 98' ' ' GLN . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.609 ' HG2' HG22 ' A' ' 82' ' ' VAL . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.618 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.661 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.565 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.672 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.562 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -102.35 159.12 15.69 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.48 171.26 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 121.75 0.786 . . . . 0.0 111.809 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.04 127.13 39.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -104.29 -178.11 3.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -74.23 -39.91 62.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.86 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.74 135.79 59.48 Favored Pre-proline 0 N--CA 1.428 -1.568 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.642 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.597 ' HB2' HG22 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 33' ' ' VAL . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.661 ' HG2' HD23 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 50' ' ' GLU . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.558 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' HH21 ' A' ' 123' ' ' ARG . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 85' ' ' THR . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 75' ' ' ILE . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.523 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 55.7 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.511 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.438 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 77' ' ' VAL . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.478 HH21 ' HA3' ' A' ' 73' ' ' GLY . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 137' ' ' THR . 19.2 t-80 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.583 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.739 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.24 131.01 50.62 Favored 'General case' 0 CA--C 1.487 -1.454 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.737 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 5' ' ' HIS . 25.1 m -90.25 168.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.56 110.24 22.38 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 3' ' ' VAL . 81.2 m-70 76.28 -171.12 0.09 Allowed 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 125.385 1.678 . . . . 0.0 108.639 -166.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -106.61 -20.8 13.25 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -118.85 156.67 51.66 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' GLN . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 15' ' ' LEU . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.646 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.667 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 1.0 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.464 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 82' ' ' VAL . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 110' ' ' SER . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.543 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.639 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 113' ' ' GLN . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.438 ' O ' HG22 ' A' ' 137' ' ' THR . 56.8 t-80 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.378 0.609 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.54 170.54 15.87 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.36 151.13 10.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.019 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.89 121.21 31.02 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -88.28 168.42 12.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -82.67 -12.72 57.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.371 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -80.22 110.64 17.23 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.224 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD11 ' HE2' ' A' ' 29' ' ' LYS . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' ILE . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 15' ' ' LEU . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.559 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 20' ' ' LEU . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.674 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' HA ' HD12 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' HA ' HG22 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.514 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 54.0 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.564 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.575 HD13 ' HB2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.588 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HA ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 113' ' ' GLN . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.513 ' CD2' ' HE2' ' A' ' 138' ' ' TYR . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.686 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -113.63 144.87 42.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 4' ' ' GLU . 6.2 t 61.93 -175.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 108.985 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 3' ' ' VAL . 12.1 pt-20 -101.59 126.6 48.44 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -126.21 159.62 32.49 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.237 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -89.55 -19.19 25.3 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.771 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 mm-40 -68.21 124.28 89.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.203 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' GLU . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 26' ' ' ILE . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 27' ' ' GLU . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD12 HE21 ' A' ' 14' ' ' GLN . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD1' HG11 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' HG12 ' A' ' 120' ' ' ILE . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.429 ' O ' HG22 ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 t60 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.569 ' HG2' HG22 ' A' ' 82' ' ' VAL . 59.1 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.557 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.641 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.476 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 103' ' ' ILE . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.02 -175.79 2.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.3 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.05 169.77 17.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -77.17 110.23 11.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -95.42 168.06 10.94 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.882 0.849 . . . . 0.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.99 -30.8 7.36 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.191 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -96.82 127.92 37.54 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD11 ' HE2' ' A' ' 29' ' ' LYS . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HE2' HD11 ' A' ' 15' ' ' LEU . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.401 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.628 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.678 HD23 ' HG2' ' A' ' 50' ' ' GLU . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.818 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.497 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 33.2 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.651 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 113' ' ' GLN . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 117' ' ' LEU . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 113' ' ' GLN . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.564 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 137' ' ' THR . 20.6 t-80 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.4 131.91 35.3 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 m -133.22 176.32 9.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.019 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -81.28 138.4 35.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.42 -171.88 2.22 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.711 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -78.03 -33.7 50.93 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.606 0.717 . . . . 0.0 109.611 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -84.07 135.46 42.11 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.947 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' A' ' 13' ' ' VAL . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB2' HG21 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.515 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 66' ' ' SER . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 26.2 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.711 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.587 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 113' ' ' GLN . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.572 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 124' ' ' THR . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.492 ' O ' HG22 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE2' HD13 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.399 0.619 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.1 pm0 -90.6 160.86 15.7 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.209 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -99.51 178.96 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.155 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 1.3 pm0 -75.59 137.44 40.79 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -98.33 174.42 6.49 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.358 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -80.23 -54.06 6.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.713 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -87.25 148.74 45.51 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.452 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.686 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 4' ' ' GLU . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 33' ' ' VAL . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.686 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.637 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 11' ' ' VAL . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD23 ' HG2' ' A' ' 50' ' ' GLU . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.514 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' HE22 ' A' ' 98' ' ' GLN . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.47 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.4 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.656 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.627 ' HA ' HD23 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 116' ' ' LEU . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.584 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.584 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.59 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -156.7 169.26 25.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.25 173.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -71.83 122.25 20.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -76.37 171.42 14.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.589 0.709 . . . . 0.0 109.669 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 9.4 m-85 -102.82 -34.17 9.09 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.03 112.41 62.94 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.707 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.627 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HG2' HD23 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.645 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 HD12 ' HE ' ' A' ' 123' ' ' ARG . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.5 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.423 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.481 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.439 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.1 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.573 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 113' ' ' GLN . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.707 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.725 0.298 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.67 -172.41 0.18 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.54 176.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.838 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.71 137.84 31.96 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -113.28 176.73 4.9 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.247 0.546 . . . . 0.0 110.156 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -94.12 -37.26 11.69 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.79 164.28 24.57 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.804 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.517 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HB2' HG22 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.635 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.502 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HA ' HG22 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' HG12 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' HE22 ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.453 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 59.3 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.618 ' HA ' HD13 ' A' ' 108' ' ' LEU . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.615 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 77' ' ' VAL . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.554 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 66.4 162.33 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.179 0.991 . . . . 0.0 111.601 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.15 163.36 7.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.98 110.02 22.25 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.164 0.507 . . . . 0.0 110.589 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.341 9.5 p80 -107.49 138.38 43.82 Favored 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.293 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -92.25 -17.42 24.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.392 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.51 117.34 67.58 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.411 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 9' ' ' LEU . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 39' ' ' PHE . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HB2' HG11 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.444 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.647 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.58 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 103' ' ' ILE . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.3 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HA ' HD23 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.662 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 77' ' ' VAL . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.642 ' O ' HG22 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.661 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -84.91 153.42 22.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.484 27.9 m 55.36 115.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 7.8 pt-20 -78.84 112.25 15.8 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.092 -1.867 . . . . 0.0 112.398 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 m170 68.09 -164.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.31 1.444 . . . . 0.0 111.261 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -91.7 -3.49 56.21 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.846 0.831 . . . . 0.0 109.339 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.76 130.61 86.82 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 113.89 -1.504 . . . . 0.0 107.906 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HE2' HD21 ' A' ' 15' ' ' LEU . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.745 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.745 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.809 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.428 ' O ' HG22 ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.537 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.412 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.612 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.714 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HD2' ' H ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 124' ' ' THR . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 38.7 t-80 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -76.27 139.83 41.29 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.16 172.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.24 150.13 24.59 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -129.97 -169.33 2.11 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -24.2 60.65 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.3 145.06 63.46 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.459 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.644 HD11 ' HE2' ' A' ' 29' ' ' LYS . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 97' ' ' ILE . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HE2' HD11 ' A' ' 15' ' ' LEU . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.503 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.448 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.635 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.502 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 23' ' ' ASP . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.553 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.633 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 109' ' ' GLU 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.537 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.481 ' O ' HG22 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.593 ' HA ' HG22 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -142.58 150.25 40.09 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 4' ' ' GLU . 3.8 t -88.83 178.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' H ' HG12 ' A' ' 3' ' ' VAL . 9.6 pt-20 -70.16 146.69 50.62 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.448 . . . . 0.0 110.126 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -111.32 -177.01 3.09 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -73.26 -42.76 62.14 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.569 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -97.03 137.62 21.27 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.722 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.541 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 4' ' ' GLU . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB2' HG21 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HG2' HD23 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.678 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.802 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.667 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.881 HD23 ' HG3' ' A' ' 112' ' ' MET . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.881 ' HG3' HD23 ' A' ' 108' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.796 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.447 ' HA ' HG22 ' A' ' 103' ' ' ILE . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.409 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.82 153.2 31.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 4' ' ' GLU . 12.9 t 69.71 -179.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -173.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 3' ' ' VAL . 8.6 pt-20 -88.5 103.6 16.03 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.3 0.572 . . . . 0.0 110.472 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.8 -174.95 4.96 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.764 0.792 . . . . 0.0 110.534 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -92.91 -8.69 42.57 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.799 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.23 152.12 83.86 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.619 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 29' ' ' LYS . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.515 HG23 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.683 ' HB2' HG13 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' HD3' ' C ' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.488 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.44 ' OG ' HG12 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 39.4 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.655 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.467 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.558 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 77' ' ' VAL . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.567 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.504 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.421 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.57 151.33 33.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.97 160.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.788 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.55 98.52 10.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.202 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -114.99 168.99 9.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.425 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -90.5 -11.8 39.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -70.56 158.09 88.6 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.27 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HE2' HD11 ' A' ' 15' ' ' LEU . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 53' ' ' LYS 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 125' ' ' LYS 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.471 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CD2' ' HA3' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.74 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.431 ' O ' HG22 ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.444 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 26.2 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.74 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HA ' HD13 ' A' ' 108' ' ' LEU . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 106' ' ' GLU . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.596 ' HG2' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.471 ' CB ' ' HA2' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.441 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.14 104.39 16.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.559 0.695 . . . . 0.0 110.962 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 178.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.926 178.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.52 118.8 6.96 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.862 0.726 . . . . 0.0 109.209 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.256 4.0 p-80 -90.66 -176.97 4.89 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.83 -24.04 18.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.884 -167.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -82.66 148.44 58.05 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.398 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 9' ' ' LEU . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 15' ' ' LEU . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 39' ' ' PHE . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' A' ' 33' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.62 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 103' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.461 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.778 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.508 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.508 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.595 0 CA-C-O 120.919 0.39 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -127.99 149.12 50.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.52 171.54 4.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.42 115.84 30.94 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 177.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -74.06 158.22 34.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.007 0.908 . . . . 0.0 111.968 -175.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -105.01 -42.52 5.3 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.486 -170.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.8 mm-40 -86.99 134.29 37.26 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.681 178.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD11 ' HE2' ' A' ' 29' ' ' LYS . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.671 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.671 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.642 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' ' 20' ' ' LEU . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.555 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.504 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' HG12 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 62.2 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.535 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.581 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 113' ' ' GLN . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.62 177.2 4.78 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.33 167.75 23.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.73 137.27 51.86 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m80 60.2 -167.84 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.105 0.962 . . . . 0.0 111.957 177.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.96 -10.3 39.9 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.99 156.25 88.13 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.917 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' HD11 ' A' ' 15' ' ' LEU . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HB2' HG11 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.558 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.447 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 139' ' ' SER . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 108' ' ' LEU . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD2' HD12 ' A' ' 117' ' ' LEU . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 113' ' ' GLN . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.699 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 124' ' ' THR . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -85.04 133.41 34.24 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -115.35 178.28 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-O 121.416 0.627 . . . . 0.0 112.08 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.21 113.76 26.11 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 173.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -172.05 3.67 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.571 0.701 . . . . 0.0 111.763 -172.658 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.05 -20.02 29.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -78.52 132.01 66.66 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 170.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.572 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 65' ' ' ILE . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.572 HG23 ' NE2' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 20' ' ' LEU . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.428 HD21 ' HA2' ' A' ' 88' ' ' GLY . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.48 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.834 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 113' ' ' GLN . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.57 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 131' ' ' VAL . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.39 179.87 7.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.369 15.5 m 59.9 158.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 127.609 2.364 . . . . 0.0 116.679 175.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.57 111.64 21.44 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.383 -177.363 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -100.33 -160.02 0.77 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -83.41 -12.48 56.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -85.87 150.64 53.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.369 -1.741 . . . . 0.0 107.101 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.565 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' A' ' 65' ' ' ILE . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.565 HG23 ' NE2' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.652 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 98' ' ' GLN . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.47 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.726 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.556 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 113' ' ' GLN . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.608 ' H ' HG22 ' A' ' 124' ' ' THR . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 . . . . . 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.523 HE21 HD13 ' A' ' 57' ' ' LEU . 29.8 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 65' ' ' ILE . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' HG13 ' A' ' 13' ' ' VAL . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.469 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.63 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.469 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 20' ' ' LEU . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 18.9 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.611 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.598 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CD2' HG11 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.756 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.55 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.709 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG12 HG22 ' A' ' 85' ' ' THR . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.61 ' HB3' HE21 ' A' ' 102' ' ' GLN . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 HG12 ' A' ' 75' ' ' ILE . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.4 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.61 HE21 ' HB3' ' A' ' 80' ' ' ASN . 32.0 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.429 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.595 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 110.683 -0.117 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' LEU . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' A' ' 29' ' ' LYS . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HB2' HG21 ' A' ' 33' ' ' VAL . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.663 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' HD2' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.663 HD23 ' HG2' ' A' ' 50' ' ' GLU . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.755 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.755 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.597 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 120' ' ' ILE . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG3' ' CD2' ' A' ' 28' ' ' HIS . 23.0 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 65' ' ' ILE . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 14' ' ' GLN . 33.1 m170 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.715 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.579 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.491 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.646 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' HD23 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.402 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 20' ' ' LEU . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 77' ' ' VAL . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 87' ' ' HIS . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.445 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 13.6 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 139' ' ' SER . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HA ' HD23 ' A' ' 108' ' ' LEU . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.543 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 122' ' ' PHE . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.475 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' H ' HG22 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' HG22 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 . . . . . 0 C--O 1.238 0.468 0 CA-C-O 120.713 0.292 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 65' ' ' ILE . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.547 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.69 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 20' ' ' LEU . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 85' ' ' THR . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.542 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.631 HG22 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HE1' ' HG ' ' A' ' 84' ' ' SER . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HE22 ' A' ' 98' ' ' GLN . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.609 ' HG2' HG22 ' A' ' 82' ' ' VAL . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.618 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.661 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.565 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.672 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.562 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.597 ' HB2' HG22 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 33' ' ' VAL . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.661 ' HG2' HD23 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 50' ' ' GLU . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.558 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' HH21 ' A' ' 123' ' ' ARG . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 85' ' ' THR . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 75' ' ' ILE . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.523 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 21.1 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.511 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.438 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 77' ' ' VAL . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.478 HH21 ' HA3' ' A' ' 73' ' ' GLY . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 137' ' ' THR . 2.5 t60 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.583 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 N--CA 1.429 -1.502 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' GLN . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 15' ' ' LEU . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.646 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.667 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.535 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.464 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.483 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.425 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 82' ' ' VAL . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 110' ' ' SER . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.543 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.639 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 113' ' ' GLN . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.438 ' O ' HG22 ' A' ' 137' ' ' THR . 25.5 t60 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.483 HD11 ' HE2' ' A' ' 29' ' ' LYS . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' ILE . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 15' ' ' LEU . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.559 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.544 HD21 HE21 ' A' ' 51' ' ' GLN . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.544 HE21 HD21 ' A' ' 48' ' ' LEU . 10.3 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 20' ' ' LEU . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.674 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.527 ' HA ' HD12 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' HA ' HG22 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.514 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.6 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.564 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.588 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HA ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 113' ' ' GLN . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.55 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.513 ' CD2' ' HE2' ' A' ' 138' ' ' TYR . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 mm-40 . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' GLU . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 26' ' ' ILE . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 27' ' ' GLU . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.451 HD12 HE21 ' A' ' 14' ' ' GLN . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD1' HG11 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' HG12 ' A' ' 120' ' ' ILE . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.569 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.0 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.557 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.641 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.504 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.476 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 103' ' ' ILE . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.684 HE21 HD13 ' A' ' 57' ' ' LEU . 3.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD11 ' HE2' ' A' ' 29' ' ' LYS . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HE2' HD11 ' A' ' 15' ' ' LEU . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.401 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.628 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.684 HD13 HE21 ' A' ' 14' ' ' GLN . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.818 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.497 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 10.9 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.651 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 113' ' ' GLN . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 117' ' ' LEU . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 113' ' ' GLN . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.564 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 137' ' ' THR . 2.4 t60 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 . . . . . 0 N--CA 1.422 -1.834 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' A' ' 13' ' ' VAL . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB2' HG21 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.515 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 66' ' ' SER . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 34.3 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.711 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.587 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 113' ' ' GLN . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.572 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 124' ' ' THR . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.492 ' O ' HG22 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE2' HD13 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.452 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.686 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 33' ' ' VAL . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.686 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.637 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 11' ' ' VAL . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD23 ' HG2' ' A' ' 50' ' ' GLU . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.514 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' HE21 ' A' ' 102' ' ' GLN . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' HE22 ' A' ' 98' ' ' GLN . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.47 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.2 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.656 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.627 ' HA ' HD23 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 116' ' ' LEU . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.584 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.584 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.59 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.426 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.707 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.627 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HG2' HD23 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.645 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 HD12 ' HE ' ' A' ' 123' ' ' ARG . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.5 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.423 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.481 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.439 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 82' ' ' VAL . 19.8 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.573 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 113' ' ' GLN . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.707 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 N--CA 1.431 -1.388 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.517 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HB2' HG22 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.635 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.502 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HA ' HG22 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' HG12 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' HE22 ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.453 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 22.5 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.618 ' HA ' HD13 ' A' ' 108' ' ' LEU . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.615 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 77' ' ' VAL . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.554 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 9' ' ' LEU . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 39' ' ' PHE . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HB2' HG11 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.444 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.409 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.647 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.58 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 103' ' ' ILE . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 28.6 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HA ' HD23 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.662 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 77' ' ' VAL . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.642 ' O ' HG22 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HE2' HD21 ' A' ' 15' ' ' LEU . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.745 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.745 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.809 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.537 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.412 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.411 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.612 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.714 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 124' ' ' THR . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 17.1 t60 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 N--CA 1.435 -1.188 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.644 HD11 ' HE2' ' A' ' 29' ' ' LYS . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.516 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 97' ' ' ILE . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HE2' HD11 ' A' ' 15' ' ' LEU . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.503 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.448 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.635 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.502 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 23' ' ' ASP . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.553 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.633 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.622 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 109' ' ' GLU 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.537 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.481 ' O ' HG22 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.593 ' HA ' HG22 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.541 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.678 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB2' HG21 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HG2' HD23 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.678 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.802 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.667 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.881 HD23 ' HG3' ' A' ' 112' ' ' MET . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.881 ' HG3' HD23 ' A' ' 108' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.796 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.447 ' HA ' HG22 ' A' ' 103' ' ' ILE . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.409 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 C--O 1.246 0.872 0 N-CA-C 111.619 0.229 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 29' ' ' LYS . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.515 HG23 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.683 ' HB2' HG13 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.488 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.44 ' OG ' HG12 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 14.3 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.655 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.467 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.558 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 77' ' ' VAL . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.567 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.504 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.421 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 C--O 1.243 0.737 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.401 HE21 HD13 ' A' ' 57' ' ' LEU . 29.2 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HE2' HD11 ' A' ' 15' ' ' LEU . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' LYS 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 125' ' ' LYS 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.471 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CD2' ' HA3' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.74 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.417 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.444 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.444 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.443 HE21 HG22 ' A' ' 82' ' ' VAL . 33.6 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.74 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HA ' HD13 ' A' ' 108' ' ' LEU . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 106' ' ' GLU . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.471 ' CB ' ' HA2' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.441 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 . . . . . 0 N--CA 1.436 -1.162 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 9' ' ' LEU . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 15' ' ' LEU . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 39' ' ' PHE . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' A' ' 33' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.62 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 103' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.461 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.481 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.778 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.508 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.655 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.508 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.8 mm-40 . . . . . 0 N--CA 1.436 -1.17 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.446 HD11 ' HE2' ' A' ' 29' ' ' LYS . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.541 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.671 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.671 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.468 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.642 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' ' 20' ' ' LEU . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.555 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.504 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' HG12 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.7 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.535 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.581 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 113' ' ' GLN . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' HD11 ' A' ' 15' ' ' LEU . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HB2' HG11 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.558 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.447 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.561 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 139' ' ' SER . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 108' ' ' LEU . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.588 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD2' HD12 ' A' ' 117' ' ' LEU . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 113' ' ' GLN . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.699 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 124' ' ' THR . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 . . . . . 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HE22 ' A' ' 14' ' ' GLN . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 65' ' ' ILE . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG23 ' OE1' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 20' ' ' LEU . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.428 HD21 ' HA2' ' A' ' 88' ' ' GLY . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.48 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.834 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 113' ' ' GLN . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.57 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 131' ' ' VAL . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 . . . . . 0 N--CA 1.439 -1.007 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' A' ' 65' ' ' ILE . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.652 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 98' ' ' GLN . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.47 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.726 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.556 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 113' ' ' GLN . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.608 ' H ' HG22 ' A' ' 124' ' ' THR . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.436 0.636 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.51 146.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 124.767 1.227 . . . . 0.0 109.315 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' H ' ' A' ' 4' ' ' GLU . 2.7 t -113.63 169.87 4.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 120.359 -0.537 . . . . 0.0 109.825 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' H ' HG12 ' A' ' 3' ' ' VAL . 8.2 mm-40 -93.54 122.83 36.38 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 176.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -126.17 -175.72 3.45 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.813 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -114.55 -32.87 5.74 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -82.16 131.68 55.63 Favored Pre-proline 0 N--CA 1.428 -1.526 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 171.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.569 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 37.7 Cg_endo -62.82 162.76 24.11 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 122.377 2.052 . . . . 0.0 115.448 -172.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -120.39 118.66 30.93 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.12 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -79.35 97.84 6.48 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.443 0.639 . . . . 0.0 110.569 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 12.3 t -96.34 125.55 49.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.624 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -98.23 99.68 10.92 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.6 p -101.9 117.7 47.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.567 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.523 HE21 HD13 ' A' ' 57' ' ' LEU . 29.8 tt0 -86.98 122.94 31.52 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 83.7 mt -108.79 112.48 24.78 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.424 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.0 mt-10 -92.24 145.88 24.14 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 35.7 mmtp -118.33 105.3 11.59 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 173.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.684 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.9 t -97.04 127.13 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.532 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -173.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 70.6 m-85 -106.42 166.94 10.18 Favored 'General case' 0 C--N 1.267 -3.021 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 65' ' ' ILE . 78.1 mt -61.43 -38.67 88.01 Favored 'General case' 0 CA--C 1.496 -1.101 0 O-C-N 123.489 0.493 . . . . 0.0 109.96 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 9.2 t70 -46.82 -48.16 20.9 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 125.435 1.709 . . . . 0.0 111.899 -176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.32 -22.24 6.68 Favored Glycine 0 N--CA 1.413 -2.836 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -173.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 28.2 t70 -71.25 149.98 45.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -145.01 125.78 7.75 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.123 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 m -80.99 117.97 22.06 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.9 mm -92.17 118.62 38.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.413 -178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.3 tp10 -113.32 145.77 40.52 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.6 m170 -122.38 113.61 19.61 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HB2' HG13 ' A' ' 13' ' ' VAL . 10.8 mtmt -117.02 136.01 53.27 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.976 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.482 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 30.3 p80 -121.2 111.88 17.95 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -130.14 146.48 51.79 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.324 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.1 mtmm -93.09 128.65 39.08 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.309 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.17 144.44 37.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -90.19 -47.71 7.62 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.4 m -109.27 117.0 32.95 Favored 'General case' 0 N--CA 1.385 -3.714 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -61.69 -29.59 70.19 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.766 0.317 . . . . 0.0 110.162 178.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -62.6 -33.24 74.6 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.335 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -75.94 -33.03 59.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' MET . 61.4 t80 -64.17 -44.4 92.17 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.297 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -63.35 -37.88 88.97 Favored 'General case' 0 C--O 1.199 -1.56 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.313 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.43 74.58 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.342 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.82 -41.17 92.14 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.377 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -111.57 18.12 19.37 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.05 -35.35 24.72 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.48 -35.5 63.04 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.619 -0.324 . . . . 0.0 112.584 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.508 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 27.9 m95 -65.84 153.87 40.74 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.469 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 51.9 m -85.91 118.1 25.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -76.11 112.1 12.21 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.633 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.8 t -89.9 -44.3 14.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.63 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.0 pt-20 -160.15 156.22 26.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -147.18 136.71 22.83 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.691 0.757 . . . . 0.0 111.315 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.74 159.34 39.97 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -65.84 105.61 1.33 Allowed 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.03 -39.22 2.21 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.064 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -131.6 134.4 45.99 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.278 0.561 . . . . 0.0 110.682 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 76.6 t -127.61 138.85 53.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.633 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.1 tp -115.72 117.18 29.55 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.176 0.512 . . . . 0.0 111.561 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 20.9 m-85 -120.58 151.6 39.21 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.132 176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.469 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.9 ptp180 -132.6 141.65 48.78 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.026 173.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.508 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -127.4 125.11 40.07 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 175.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.684 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.6 pt20 -122.31 151.24 41.34 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -174.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -122.78 170.19 10.33 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.057 -175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -95.4 20.55 9.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.909 0.862 . . . . 0.0 109.844 178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -106.25 159.14 16.34 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 HG22 ' HB2' ' A' ' 20' ' ' LEU . 26.3 pt -90.89 -8.44 10.56 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 CA-C-O 118.689 -0.672 . . . . 0.0 112.761 -178.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 52.0 p 102.95 153.59 0.02 OUTLIER Pre-proline 0 N--CA 1.504 2.228 0 C-N-CA 127.872 2.469 . . . . 0.0 109.644 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -64.43 -32.02 60.85 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 121.954 1.77 . . . . 0.0 111.236 177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -71.74 -34.57 69.63 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.399 -178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 51.0 m -64.85 -22.79 67.06 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.324 -0.86 . . . . 0.0 113.037 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -82.32 -1.91 51.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.737 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -105.34 -30.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -92.61 -84.38 0.28 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.867 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.86 30.33 68.24 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -105.54 107.26 18.16 Favored 'General case' 0 CA--C 1.481 -1.701 0 CA-C-O 122.391 1.091 . . . . 0.0 110.715 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.43 HD11 ' CD2' ' A' ' 128' ' ' PHE . 69.1 mt -98.91 126.73 52.04 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.405 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -131.43 134.1 7.53 Favored Glycine 0 N--CA 1.419 -2.473 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.636 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 16.2 m -106.85 145.33 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.065 0 C-N-CA 117.38 -1.728 . . . . 0.0 109.847 175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 14.2 m -90.2 165.04 14.17 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 104.548 -2.39 . . . . 0.0 104.548 173.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.01 -30.11 5.7 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.14 10.77 4.02 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.734 0.414 . . . . 0.0 111.403 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 70.8 37.7 66.18 Favored Glycine 0 CA--C 1.482 -1.992 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -80.42 117.7 26.8 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.687 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 83' ' ' ILE . 26.8 mm -80.96 37.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 C-N-CA 127.541 2.336 . . . . 0.0 113.332 -168.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.415 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 57.2 m -91.85 150.24 21.16 Favored 'General case' 0 C--N 1.283 -2.311 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.675 -167.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.8 p -90.95 149.66 21.79 Favored 'General case' 0 N--CA 1.417 -2.103 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.397 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.6 159.57 41.19 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -92.7 102.43 14.84 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.6 -160.76 38.01 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -175.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -50.72 124.02 19.1 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 123.708 0.803 . . . . 0.0 111.894 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -74.52 93.78 0.92 Allowed 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.981 2.454 . . . . 0.0 110.778 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.18 164.65 35.91 Favored Pre-proline 0 C--N 1.284 -2.253 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -64.39 -18.7 64.0 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.496 2.131 . . . . 0.0 112.351 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.25 -7.52 59.04 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.316 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -107.25 -178.57 3.68 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 174.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.8 pt-20 -123.01 141.88 36.77 Favored Pre-proline 0 C--N 1.294 -1.835 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.995 -177.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 12.0 Cg_endo -80.0 125.74 6.1 Favored 'Trans proline' 0 N--CA 1.432 -2.107 0 C-N-CA 121.847 1.698 . . . . 0.0 109.095 176.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.65 -40.04 83.31 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.608 -176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.415 ' OE1' ' HA ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -157.4 -166.96 2.16 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 38.4 t -146.59 115.01 6.71 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -83.32 -69.55 0.62 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -152.38 172.26 16.76 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 18.9 mt-30 -128.07 141.98 51.35 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 123.346 0.658 . . . . 0.0 111.036 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.536 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -143.41 162.72 16.44 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -176.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.14 117.79 23.7 Favored 'General case' 0 CA--C 1.491 -1.304 0 CA-C-O 121.628 0.728 . . . . 0.0 111.987 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 113' ' ' GLN . 9.4 mt -74.27 -27.05 60.56 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.357 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.43 -24.69 67.25 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.54 0.686 . . . . 0.0 109.898 176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -93.8 -14.31 26.33 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.56 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.8 OUTLIER -64.52 159.68 21.09 Favored 'General case' 0 CA--C 1.484 -1.568 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.593 173.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 112' ' ' MET . 31.6 mt-10 -73.16 130.59 40.6 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 105.199 -2.149 . . . . 0.0 105.199 166.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.611 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 19.2 m -45.71 -46.36 14.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 -170.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -79.54 -15.11 58.27 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.04 -175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 74.6 mmm -66.79 -54.19 25.13 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.598 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -60.69 -44.6 96.34 Favored 'General case' 0 C--O 1.201 -1.466 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.617 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 110' ' ' SER . 75.9 mmtt -55.47 -39.1 69.97 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 123.486 0.491 . . . . 0.0 111.675 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -64.23 -39.78 94.68 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-O 121.539 0.685 . . . . 0.0 110.165 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.1 mt -72.61 -26.6 61.74 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.616 -179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.6 mt -67.54 -41.35 84.45 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.893 0.477 . . . . 0.0 111.678 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -14.75 25.02 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 117.726 -1.59 . . . . 0.0 111.555 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 98.57 136.56 9.34 Favored Glycine 0 N--CA 1.421 -2.313 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.896 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -73.34 129.83 85.25 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.01 -15.96 44.27 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 122.737 2.291 . . . . 0.0 114.821 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -172.98 147.31 1.62 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -176.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -149.08 139.15 22.15 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.0 m -102.27 171.38 7.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 169.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 16.8 ptmt -58.48 -43.27 88.9 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.775 1.17 . . . . 0.0 113.559 -172.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.75 -23.6 52.99 Favored 'General case' 0 CA--C 1.495 -1.162 0 CA-C-O 121.446 0.641 . . . . 0.0 109.907 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.6 mt-10 -80.54 -31.5 36.96 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.355 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 75' ' ' ILE . 28.5 t80 -65.79 -54.26 29.29 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.41 176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.6 pt-20 -67.85 -21.7 65.17 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.308 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -68.14 -50.12 56.69 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.666 0.746 . . . . 0.0 110.112 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -67.58 -35.27 72.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.113 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 -41.11 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.49 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.0 pt-20 -67.2 -27.31 67.15 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.587 0.708 . . . . 0.0 109.965 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -73.47 -38.76 65.32 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.7 mmt -65.27 -49.0 71.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -69.33 -18.69 63.83 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.684 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -25.58 66.93 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.397 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 97.0 m-85 -85.31 -55.32 4.08 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 57.0 p 55.4 17.03 1.99 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.928 1.691 . . . . 0.0 114.936 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.391 -4.32 0 N-CA-C 103.983 -3.647 . . . . 0.0 103.983 -177.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -156.42 153.72 29.32 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -119.59 169.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 CA-C-O 121.134 0.492 . . . . 0.0 111.245 -176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -69.88 129.04 38.45 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 173.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -81.2 167.46 19.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.829 0.823 . . . . 0.0 112.428 -169.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -66.69 -34.66 78.35 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.679 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -90.13 157.29 45.64 Favored Pre-proline 0 N--CA 1.427 -1.615 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.342 177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.64 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 35.5 Cg_endo -68.92 160.09 51.24 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 121.532 1.488 . . . . 0.0 114.052 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.641 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.0 121.33 44.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 -178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.441 ' HB3' ' NE2' ' A' ' 30' ' ' HIS . 96.0 mt-30 -80.51 106.4 12.49 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 16.1 t -110.07 127.04 67.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.196 -175.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -103.11 117.92 35.64 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 170.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 21.2 m -107.54 134.23 49.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-O 121.292 0.568 . . . . 0.0 110.32 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -101.63 110.93 23.01 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 84.7 mt -100.94 111.73 24.0 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.578 -176.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.48 141.12 28.86 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 71.1 mmtt -119.05 99.89 7.01 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.661 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 3.8 t -88.76 96.37 6.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.316 -174.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.709 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 84.1 m-85 -84.49 159.45 20.73 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.085 176.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.0 mt -63.96 -41.16 97.65 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.54 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -51.03 -46.47 61.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 124.701 1.251 . . . . 0.0 111.438 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 128.82 -19.42 5.54 Favored Glycine 0 N--CA 1.423 -2.173 0 C-N-CA 120.022 -1.085 . . . . 0.0 110.986 -176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.36 103.34 4.7 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.6 t -92.15 123.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.8 t -88.28 131.49 34.77 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.7 mm -105.25 122.03 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.0 tp10 -113.17 147.11 38.07 Favored 'General case' 0 C--N 1.274 -2.676 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.038 -178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -125.5 115.47 20.27 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 32.1 mmtt -122.82 138.01 54.76 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.5 t60 -121.58 124.0 43.31 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.18 146.07 36.48 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.602 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.0 mtmm -94.53 128.31 41.05 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.783 173.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -120.79 143.72 32.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.189 -179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -95.32 -37.11 11.13 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.8 t -113.42 113.8 25.7 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 177.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -30.33 71.4 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.48 -28.69 68.06 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.638 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.51 -41.89 54.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.512 ' CD2' HG11 ' A' ' 33' ' ' VAL . 57.5 t80 -59.12 -44.47 92.01 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.671 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -64.77 -39.03 92.94 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.22 -33.98 75.4 Favored 'General case' 0 C--N 1.311 -1.102 0 O-C-N 123.436 0.46 . . . . 0.0 110.104 178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.47 -39.08 91.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.565 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -110.53 17.38 20.81 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 122.038 -0.414 . . . . 0.0 111.937 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.57 -25.77 39.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -76.78 -25.59 64.51 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.373 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.55 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 33.2 m95 -77.09 159.3 29.92 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 85.4 m -89.74 120.82 31.33 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -74.0 112.23 9.93 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.756 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 54.8 t -84.3 -56.79 5.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.06 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -160.18 157.52 28.49 Favored 'General case' 0 CA--C 1.491 -1.318 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -142.25 146.72 35.44 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.318 0.58 . . . . 0.0 110.521 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -144.47 170.28 16.34 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -66.71 101.01 0.75 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.657 0.265 . . . . 0.0 110.971 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.32 -22.86 14.72 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 115.826 -0.624 . . . . 0.0 113.161 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -137.44 136.7 38.02 Favored 'General case' 0 N--CA 1.421 -1.886 0 O-C-N 122.218 -0.577 . . . . 0.0 110.661 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 99.5 t -129.36 138.26 54.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.756 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.0 tp -109.74 115.75 30.42 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 123.284 0.634 . . . . 0.0 109.865 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.2 m-85 -122.8 151.83 41.26 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.958 0.903 . . . . 0.0 111.192 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 4.9 ptp180 -132.17 144.53 50.74 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.109 0.481 . . . . 0.0 110.223 174.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.55 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.5 tppt? -136.32 129.56 31.58 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.1 pt20 -121.4 144.38 48.7 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -105.11 163.4 12.59 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.512 -172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -89.34 -13.49 37.77 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.813 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -86.94 158.99 19.17 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.94 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.709 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 6.5 pt -66.74 -51.5 55.33 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.126 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.318 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 54.6 p 160.31 161.13 0.04 OUTLIER Pre-proline 0 C--O 1.246 0.871 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 176.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.0 -25.43 22.86 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 120.949 1.1 . . . . 0.0 110.811 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -77.94 -37.09 48.44 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.938 -173.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.509 ' HA ' ' HA3' ' A' ' 73' ' ' GLY . 15.2 m -57.35 -27.68 62.46 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.579 0.704 . . . . 0.0 111.425 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 66' ' ' SER . 82.3 mttt -81.76 -20.32 39.47 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -96.48 -40.31 10.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.772 0.32 . . . . 0.0 111.127 -177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA2' ' A' ' 88' ' ' GLY . 14.4 t-20 -157.91 37.5 0.26 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 69' ' ' SER . . . -80.45 143.48 24.79 Favored Glycine 0 CA--C 1.49 -1.513 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.109 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -156.98 110.68 2.63 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 124.282 1.033 . . . . 0.0 108.731 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG12 HG22 ' A' ' 85' ' ' THR . 77.9 mt -77.19 119.64 26.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.53 143.86 14.98 Favored Glycine 0 N--CA 1.418 -2.555 0 CA-C-O 122.26 0.922 . . . . 0.0 112.922 -175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 27.9 m -109.63 151.06 12.0 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.044 0 C-N-CA 118.078 -1.449 . . . . 0.0 111.116 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -91.23 169.16 11.06 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 171.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -49.57 -31.5 10.63 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -174.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.61 ' HB3' HE21 ' A' ' 102' ' ' GLN . 38.9 m-80 -89.71 20.93 3.75 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.642 -179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 67.9 39.66 89.41 Favored Glycine 0 CA--C 1.488 -1.619 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.1 t -79.64 118.33 26.98 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.807 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 83' ' ' ILE . 28.7 mm -80.62 36.89 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.527 0 C-N-CA 127.721 2.408 . . . . 0.0 113.481 -167.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 m -93.81 153.83 18.08 Favored 'General case' 0 C--N 1.273 -2.726 0 C-N-CA 118.605 -1.238 . . . . 0.0 111.634 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.442 HG22 HG12 ' A' ' 75' ' ' ILE . 81.6 p -90.6 147.73 23.13 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.701 -1.2 . . . . 0.0 108.091 174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.25 152.35 38.97 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -86.0 102.5 13.85 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.46 ' HA2' ' OD1' ' A' ' 72' ' ' ASN . . . 84.73 -168.92 44.17 Favored Glycine 0 N--CA 1.419 -2.493 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -58.02 123.7 65.88 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 122.539 0.336 . . . . 0.0 111.211 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 8.3 Cg_endo -64.57 107.6 0.89 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.608 2.205 . . . . 0.0 110.871 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.484 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.5 pt-20 -140.81 168.6 13.84 Favored Pre-proline 0 C--N 1.29 -1.983 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 21.6 Cg_endo -65.35 -17.03 57.02 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.136 1.89 . . . . 0.0 112.241 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.32 1.03 56.34 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.448 0.642 . . . . 0.0 110.121 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.7 t -114.82 171.79 7.43 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.2 pt-20 -139.58 152.05 67.81 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 110.54 -0.17 . . . . 0.0 110.54 -176.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 17.0 Cg_exo -67.76 133.48 29.62 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.377 2.051 . . . . 0.0 110.139 175.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.4 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 75.3 mt -73.48 -31.52 33.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 122.16 0.981 . . . . 0.0 109.755 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.437 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.62 -173.79 4.46 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 103.53 -2.767 . . . . 0.0 103.53 178.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.2 m -145.24 129.46 17.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 119.028 0.831 . . . . 0.0 110.169 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -89.81 -74.29 0.49 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.948 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -156.98 -174.01 4.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.153 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.61 HE21 ' HB3' ' A' ' 80' ' ' ASN . 32.0 mt-30 -121.78 149.97 42.54 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.406 1.082 . . . . 0.0 111.901 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 33.7 pt -145.51 160.56 12.56 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 C-N-CA 123.996 0.919 . . . . 0.0 108.644 178.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -89.61 112.51 23.76 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.799 0.809 . . . . 0.0 112.517 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -67.89 -27.7 66.89 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.869 177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.48 -16.99 63.57 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.983 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 2.3 ptm180 -97.12 -11.24 24.6 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.543 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mp -59.85 161.9 5.97 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.051 170.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -63.53 -55.67 22.08 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.429 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 37.1 t 174.31 -64.41 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.581 1.152 . . . . 0.0 109.22 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -80.48 -30.89 37.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 19.2 mtm -63.82 -38.27 90.49 Favored 'General case' 0 CA--C 1.492 -1.285 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.457 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.595 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.78 -47.47 85.56 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.402 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 110' ' ' SER . 12.6 mptt -53.32 -40.6 64.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 O-C-N 123.261 0.351 . . . . 0.0 111.821 173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -62.2 -43.93 97.73 Favored 'General case' 0 CA--C 1.504 -0.819 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 112' ' ' MET . 47.8 mt -69.56 -24.3 63.69 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.344 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 56.1 mt -68.85 -44.42 73.41 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 122.324 0.25 . . . . 0.0 111.222 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -93.02 -10.58 35.71 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.84 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 92.11 147.01 19.88 Favored Glycine 0 N--CA 1.411 -3.014 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.5 mm -82.88 116.94 66.85 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.51 6.52 5.08 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.247 2.632 . . . . 0.0 113.829 -174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -147.01 129.26 15.69 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 9.1 tpp180 -154.88 133.25 11.85 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.991 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.445 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 24.1 m -123.31 168.03 13.02 Favored 'General case' 0 CA--C 1.564 1.485 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 170.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.439 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -66.42 -34.43 77.92 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -169.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.94 -28.37 61.47 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -178.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.499 ' HB2' ' HD3' ' A' ' 123' ' ' ARG . 16.5 mt-10 -75.19 -32.71 61.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.071 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.37 -53.63 52.2 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.841 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -67.91 -22.79 65.05 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.62 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.01 -49.08 55.06 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.848 0.832 . . . . 0.0 110.324 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.8 -38.9 79.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.247 178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.08 -39.3 84.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 9.7 pt-20 -68.04 -31.43 71.08 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.252 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -72.69 -38.66 67.5 Favored 'General case' 0 C--O 1.208 -1.107 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.1 mmt -62.96 -48.08 80.42 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.149 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.5 ptpt -70.89 -18.99 62.66 Favored 'General case' 0 CA--C 1.504 -0.805 0 O-C-N 122.146 -0.346 . . . . 0.0 110.862 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -22.69 67.03 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.518 176.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.24 -61.65 1.53 Allowed 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 61.3 p 50.74 27.63 3.14 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.8 1.64 . . . . 0.0 113.353 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.389 -4.446 0 N-CA-C 103.608 -3.797 . . . . 0.0 103.608 -177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.398 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -136.27 114.0 11.1 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 123.603 0.761 . . . . 0.0 108.959 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -107.05 -175.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.131 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -61.2 98.91 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 123.957 0.786 . . . . 0.0 111.795 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -106.04 -164.03 0.98 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -62.71 -46.25 89.01 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.678 0.751 . . . . 0.0 109.49 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -108.78 149.38 39.43 Favored Pre-proline 0 N--CA 1.435 -1.2 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.683 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 11.2 Cg_endo -88.53 -171.49 0.62 Allowed 'Trans proline' 0 N--CA 1.436 -1.871 0 C-N-CA 122.464 2.11 . . . . 0.0 111.562 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.55 116.18 29.82 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -176.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 54.7 mt-30 -79.09 105.01 10.12 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 123.326 0.391 . . . . 0.0 110.133 176.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 HD12 ' A' ' 9' ' ' LEU . 5.1 t -107.42 140.93 23.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.146 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -113.98 100.41 8.39 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.671 -1.604 . . . . 0.0 106.671 170.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.71 HG13 ' HB2' ' A' ' 29' ' ' LYS . 5.1 p -100.38 122.01 51.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.737 0.779 . . . . 0.0 110.583 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -101.37 122.92 44.6 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 2.1 mm? -107.16 122.66 46.95 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.325 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -98.67 138.88 35.21 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 96.6 mttt -127.98 101.62 6.39 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.3 t -88.58 98.27 7.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -174.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.49 170.22 16.89 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.442 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -67.55 -38.28 83.9 Favored 'General case' 0 C--O 1.209 -1.071 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -51.62 -42.16 61.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 113.274 -1.784 . . . . 0.0 113.295 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 123.41 -29.93 5.1 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 119.901 -1.143 . . . . 0.0 110.747 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.56 119.72 10.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 31.1 t -104.0 114.5 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.081 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 172.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.6 m -80.81 125.44 30.09 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.694 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.47 HG23 ' OE1' ' A' ' 14' ' ' GLN . 46.0 mm -103.78 111.81 34.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -112.91 135.73 53.35 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.083 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -109.55 120.28 42.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.71 ' HB2' HG13 ' A' ' 13' ' ' VAL . 26.9 mmtt -122.52 138.03 54.69 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -121.36 126.99 50.78 Favored 'General case' 0 C--N 1.28 -2.422 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -144.59 140.7 28.92 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-O 121.18 0.514 . . . . 0.0 111.823 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.0 mtmt -96.64 117.59 31.32 Favored 'General case' 0 N--CA 1.405 -2.698 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -121.44 129.97 75.07 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.366 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.991 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -70.35 -37.41 74.64 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -120.64 115.06 22.63 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -29.75 53.87 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-O 120.892 0.377 . . . . 0.0 111.351 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -66.23 -35.9 81.63 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.78 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.94 -40.35 91.31 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HB2' HG21 ' A' ' 33' ' ' VAL . 52.4 t80 -64.44 -45.72 86.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.195 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -64.14 -39.2 93.52 Favored 'General case' 0 C--O 1.203 -1.387 0 CA-C-O 120.776 0.322 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.16 -29.45 66.35 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.656 178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.03 -39.98 72.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.867 0.365 . . . . 0.0 111.059 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.32 17.36 22.94 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.161 -0.337 . . . . 0.0 111.703 -177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.16 -21.96 25.92 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.96 -14.72 64.19 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.525 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.578 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.9 m95 -86.99 159.17 19.08 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.7 m -91.53 121.58 33.34 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.06 109.45 9.72 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 59.9 t -85.47 -46.4 17.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.663 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.5 pt-20 -161.6 157.05 24.1 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -140.78 139.59 34.61 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 170.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -135.12 91.43 2.74 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HA ' ' HD2' ' A' ' 53' ' ' LYS 0.297 17.8 tptp 39.13 -76.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 128.478 2.711 . . . . 0.0 117.248 -173.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.73 -18.25 33.08 Favored Glycine 0 C--N 1.282 -2.446 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.909 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -110.96 134.07 52.88 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -128.13 138.6 54.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.663 HD23 ' HG2' ' A' ' 50' ' ' GLU . 11.2 tp -115.87 116.31 27.77 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.238 0.542 . . . . 0.0 111.023 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 16.7 m-85 -120.07 146.49 45.87 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.251 176.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -126.29 143.65 51.08 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.313 0.578 . . . . 0.0 110.504 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.578 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 10.4 tppt? -135.0 119.09 17.53 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -114.06 95.76 5.47 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-O 122.582 1.182 . . . . 0.0 111.511 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 43.4 mtm -83.88 133.31 34.73 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 112.993 -1.912 . . . . 0.0 108.436 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -79.56 92.68 5.33 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 122.35 1.072 . . . . 0.0 111.478 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.74 -176.79 2.84 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 103.932 -2.618 . . . . 0.0 103.932 173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.3 pt -108.35 170.41 2.75 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.1 p -74.15 158.75 85.2 Favored Pre-proline 0 C--N 1.297 -1.707 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.272 -171.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -53.14 -29.27 45.04 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.742 2.295 . . . . 0.0 111.363 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -74.44 -31.73 62.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.211 -178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -65.6 -22.98 66.73 Favored 'General case' 0 CA--C 1.551 1.009 0 O-C-N 121.574 -0.704 . . . . 0.0 110.952 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 -15.61 55.93 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.53 -0.731 . . . . 0.0 110.19 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.5 m -104.03 -32.95 2.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 122.321 1.058 . . . . 0.0 108.379 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.431 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 5.1 t30 -148.14 70.94 1.16 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.118 -173.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.18 62.17 4.06 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 9.9 m-85 -96.97 106.38 18.7 Favored 'General case' 0 CA--C 1.465 -2.301 0 CA-C-O 122.743 1.258 . . . . 0.0 109.933 -174.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.79 118.06 40.0 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.048 0 CA-C-N 112.742 -2.026 . . . . 0.0 105.652 175.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.26 132.82 8.44 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-O 122.313 0.952 . . . . 0.0 113.17 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 24.2 m -106.25 145.01 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.371 0 C-N-CA 117.522 -1.671 . . . . 0.0 109.925 175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -87.07 167.74 13.93 Favored 'General case' 0 C--N 1.261 -3.256 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 173.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.78 -31.2 16.16 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.289 1.035 . . . . 0.0 113.151 -172.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.423 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.8 OUTLIER -80.13 0.93 30.06 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.755 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.26 34.92 13.06 Favored Glycine 0 C--O 1.208 -1.516 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.753 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 19.6 t -79.91 117.79 26.35 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.958 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.25 36.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 C-N-CA 127.367 2.267 . . . . 0.0 113.944 -167.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 86' ' ' PHE . 9.0 m -93.49 151.52 19.67 Favored 'General case' 0 C--N 1.271 -2.824 0 C-N-CA 118.364 -1.335 . . . . 0.0 111.811 -168.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.3 p -90.58 145.68 24.68 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 120.789 -1.194 . . . . 0.0 108.069 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 84' ' ' SER . 80.5 m-85 -135.49 160.24 39.07 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.22 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 8.7 p80 -94.91 119.3 33.22 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.59 -168.67 54.83 Favored Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -56.73 120.58 38.39 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 10.5 Cg_endo -64.15 102.8 0.39 Allowed 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.068 2.512 . . . . 0.0 112.251 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -123.0 164.53 26.76 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -68.56 -12.31 34.38 Favored 'Trans proline' 0 N--CA 1.481 0.774 0 C-N-CA 122.055 1.837 . . . . 0.0 112.212 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.28 -5.96 55.7 Favored 'General case' 0 N--CA 1.424 -1.769 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.38 177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -87.78 158.09 18.86 Favored 'General case' 0 C--O 1.253 1.255 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -92.81 123.77 60.56 Favored Pre-proline 0 C--N 1.291 -1.94 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.426 -177.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -65.77 118.11 5.21 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 C-N-CA 121.733 1.622 . . . . 0.0 108.12 172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -71.69 -30.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.439 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.426 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -168.66 -175.3 2.4 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 175.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.5 p -146.24 107.94 4.31 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 170.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -69.63 -71.91 0.21 Allowed 'General case' 0 C--O 1.238 0.449 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -157.83 179.94 8.73 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -121.02 137.21 54.76 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.755 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.2 pt -134.27 156.92 41.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 C-N-CA 122.835 0.454 . . . . 0.0 110.227 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -77.99 112.99 15.47 Favored 'General case' 0 C--O 1.255 1.378 0 CA-C-O 121.67 0.747 . . . . 0.0 112.246 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.597 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.61 -29.33 68.63 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.587 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -66.27 -21.34 66.28 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.811 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 2.3 ptm180 -91.56 -15.52 28.55 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 121.02 0.438 . . . . 0.0 110.18 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -61.57 164.41 5.94 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 164.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -65.61 -72.8 0.14 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 117.826 -1.549 . . . . 0.0 108.853 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 52.5 m -162.46 -64.09 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.042 0.537 . . . . 0.0 110.413 175.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -70.09 -31.11 68.52 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -170.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.58 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.1 mtp -61.67 -44.39 97.04 Favored 'General case' 0 CA--C 1.501 -0.915 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.727 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.57 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -67.81 -32.87 73.73 Favored 'General case' 0 C--O 1.21 -1.006 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.175 -178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 110' ' ' SER . 30.7 mmmt -63.09 -37.12 85.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.792 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 118' ' ' LYS . 95.3 m-20 -69.08 -35.96 77.07 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.549 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 112' ' ' MET . 57.8 mt -71.49 -30.07 65.55 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.184 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 72.7 mt -63.41 -48.11 79.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.901 0.381 . . . . 0.0 110.489 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 115' ' ' ASN . 41.7 pttt -81.23 -21.46 39.48 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.372 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.39 128.2 5.89 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 30.1 mm -67.74 127.6 93.39 Favored Pre-proline 0 C--O 1.197 -1.665 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.76 -25.13 74.73 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.105 1.87 . . . . 0.0 114.497 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -174.41 143.4 0.84 Allowed 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.846 0.458 . . . . 0.0 111.277 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 120' ' ' ILE . 10.8 mmt180 -153.31 131.67 12.05 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 125.323 1.449 . . . . 0.0 107.434 172.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 9.1 m -83.66 169.8 14.93 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 21.9 ptmt -52.11 -41.28 62.34 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 119.569 1.077 . . . . 0.0 112.969 -175.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.14 63.64 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.033 0.92 . . . . 0.0 109.814 -176.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 13.6 mt-10 -83.18 -24.69 32.36 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.989 -176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -70.14 -53.36 17.61 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 124.293 1.037 . . . . 0.0 109.413 177.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 3.9 pt-20 -63.95 -25.7 68.25 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 120.552 -0.459 . . . . 0.0 110.638 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 6.2 t70 -63.65 -54.69 31.72 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.655 0.782 . . . . 0.0 110.653 175.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 5.6 p -66.69 -38.24 81.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.163 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.51 -39.0 84.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.5 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -69.78 -27.34 64.83 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 121.407 0.622 . . . . 0.0 110.238 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -77.21 -36.07 55.08 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -62.74 -47.56 83.04 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.216 0.607 . . . . 0.0 109.869 176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.5 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.6 ptpt -71.52 -17.54 62.33 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.651 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -22.67 64.59 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' A' ' 108' ' ' LEU . 69.1 m-85 -87.81 -52.31 5.37 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.3 p 51.36 20.43 0.96 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.716 1.606 . . . . 0.0 114.445 176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 2 CA--C 1.439 -4.686 0 N-CA-C 105.817 -2.913 . . . . 0.0 105.817 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -118.98 151.83 37.48 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.32 -177.36 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 175.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.11 108.57 14.88 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 174.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -81.35 -179.42 7.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.086 -173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -91.38 -12.72 34.04 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 121.621 0.724 . . . . 0.0 109.306 -177.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -72.82 142.71 83.59 Favored Pre-proline 0 N--CA 1.435 -1.193 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.715 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.8 Cg_endo -60.85 158.62 32.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.886 2.39 . . . . 0.0 115.568 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.689 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -108.39 125.7 52.03 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.706 -175.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -86.52 98.64 11.17 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.356 0.598 . . . . 0.0 110.212 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.1 t -98.04 120.53 47.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.439 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -98.97 102.71 14.53 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 176.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 2.7 t -95.49 119.85 44.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.606 -173.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 ' HG3' ' CD2' ' A' ' 28' ' ' HIS . 23.0 tt0 -93.2 114.66 27.2 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.579 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 55.1 mt -98.17 120.69 39.02 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -101.5 134.42 44.64 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.51 106.49 14.61 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 17.5 t -81.84 95.69 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.768 -172.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -90.21 144.07 26.2 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.186 175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 65' ' ' ILE . 85.0 mt -74.63 -20.79 59.76 Favored 'General case' 0 C--O 1.186 -2.264 0 CA-C-O 121.87 0.843 . . . . 0.0 109.005 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.83 -29.92 63.29 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.78 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.11 34.5 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.766 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -86.78 103.83 15.58 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 t -88.01 121.22 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.7 t -81.4 111.74 18.03 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.8 mm -95.33 124.06 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.208 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -126.6 145.52 50.51 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.329 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 14' ' ' GLN . 33.1 m170 -119.68 118.02 29.81 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -107.69 126.13 52.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.68 109.45 21.06 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.85 139.02 51.28 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.341 -0.944 . . . . 0.0 112.757 -177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.715 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 34.0 mtmt -92.56 118.1 30.65 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.605 176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.97 149.09 18.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -85.92 -38.7 17.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 121.354 0.597 . . . . 0.0 109.684 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.5 t -125.84 123.83 39.58 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.3 OUTLIER -61.44 -26.92 68.19 Favored 'General case' 0 C--O 1.212 -0.917 0 O-C-N 123.105 0.253 . . . . 0.0 111.37 178.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.48 -39.83 77.25 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.035 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.61 -37.59 79.9 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' MET . 69.4 t80 -62.48 -44.39 96.5 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.949 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -64.73 -37.57 88.04 Favored 'General case' 0 C--O 1.202 -1.397 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.8 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.43 -38.24 81.0 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.342 0.591 . . . . 0.0 109.653 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.29 98.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.54 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -107.99 19.42 20.03 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.744 0.307 . . . . 0.0 111.612 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.38 -27.69 38.17 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.25 -15.66 66.26 Favored Glycine 0 C--N 1.314 -0.669 0 C-N-CA 120.496 -0.859 . . . . 0.0 114.076 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.579 ' CZ3' HD22 ' A' ' 15' ' ' LEU . 23.7 m95 -82.35 157.56 23.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.491 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 28.5 m -88.82 116.26 26.96 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.97 111.71 11.63 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.646 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.5 t -91.27 -46.94 14.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.83 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.559 ' HG2' HD23 ' A' ' 57' ' ' LEU . 16.6 pt-20 -158.29 155.22 28.46 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -144.49 147.87 33.82 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-O 121.273 0.559 . . . . 0.0 110.66 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -144.24 172.55 12.76 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -75.16 100.6 4.32 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.414 -0.914 . . . . 0.0 112.42 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 115.51 -16.63 16.77 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.999 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -139.99 131.64 27.25 Favored 'General case' 0 N--CA 1.418 -2.03 0 O-C-N 122.308 -0.525 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.0 t -130.15 137.61 56.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 tp -114.89 117.83 31.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.211 0.529 . . . . 0.0 111.389 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 23.1 m-85 -123.73 151.84 42.77 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.035 1.334 . . . . 0.0 111.411 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.6 ptp180 -128.02 145.02 51.11 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.4 tppt? -142.01 126.21 17.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.0 pt20 -120.82 95.79 4.85 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 122.634 1.207 . . . . 0.0 109.46 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.402 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -116.27 19.2 14.97 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.846 -176.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -144.32 173.93 11.35 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.86 -91.42 0.56 Allowed 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 118.368 0.531 . . . . 0.0 111.446 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.462 HG22 ' HB2' ' A' ' 20' ' ' LEU . 23.8 pt -101.58 172.63 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 172.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.3 p -107.75 169.0 7.13 Favored Pre-proline 0 C--N 1.28 -2.44 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -59.88 -25.63 79.98 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.805 1.67 . . . . 0.0 110.42 171.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.54 -34.24 72.04 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.567 ' O ' ' HD3' ' A' ' 123' ' ' ARG . 14.1 m -58.13 -34.26 70.05 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 121.499 0.666 . . . . 0.0 109.952 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -80.77 -15.37 56.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.809 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.4 m -94.52 -33.29 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.403 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 28.3 t30 -98.79 -81.51 0.45 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.521 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . 63.1 82.19 0.09 OUTLIER Glycine 0 CA--C 1.523 0.574 0 N-CA-C 115.039 0.775 . . . . 0.0 115.039 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 6.5 m-85 -160.05 107.91 1.67 Allowed 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 123.745 0.818 . . . . 0.0 110.243 177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 84.7 mt -80.81 131.08 34.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.43 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 169.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.6 121.03 3.87 Favored Glycine 0 N--CA 1.422 -2.259 0 CA-C-O 121.748 0.638 . . . . 0.0 112.565 -172.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 97.5 t -114.33 136.82 49.67 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-N 115.074 -0.563 . . . . 0.0 110.123 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 m -103.85 173.13 6.44 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -48.56 -37.77 18.74 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.732 1.613 . . . . 0.0 114.881 -174.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -86.7 19.72 2.81 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.835 0.35 . . . . 0.0 111.478 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.85 36.26 73.89 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.783 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.0 t -73.52 108.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 77' ' ' VAL . 40.9 mm -81.02 38.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 C-N-CA 128.218 2.607 . . . . 0.0 113.179 -171.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.492 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.8 m -92.65 173.07 7.96 Favored 'General case' 0 C--N 1.273 -2.757 0 O-C-N 121.076 -1.015 . . . . 0.0 110.994 -169.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 61.3 p -111.53 144.99 39.87 Favored 'General case' 0 N--CA 1.407 -2.598 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -126.96 153.53 45.74 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.557 -176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 95' ' ' GLU . 10.6 t-160 -88.65 102.26 14.79 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -166.63 28.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -175.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.432 ' NH2' ' HB2' ' A' ' 118' ' ' LYS . 17.5 mmm-85 -63.19 119.73 55.27 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.134 0.574 . . . . 0.0 110.287 177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.91 99.49 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.165 2.576 . . . . 0.0 114.33 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.9 pt-20 -141.0 175.29 3.17 Favored Pre-proline 0 C--N 1.286 -2.186 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.7 Cg_endo -73.15 -9.21 23.13 Favored 'Trans proline' 0 C--N 1.345 0.375 0 CA-C-N 121.414 1.541 . . . . 0.0 111.723 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -94.34 -1.54 53.66 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.452 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.3 p -102.17 156.06 17.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.56 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 87' ' ' HIS . 42.8 mt-10 -73.09 118.3 67.33 Favored Pre-proline 0 C--N 1.314 -0.966 0 O-C-N 123.479 0.487 . . . . 0.0 112.158 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -77.98 132.15 11.51 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 C-N-CA 122.039 1.826 . . . . 0.0 109.16 172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 55.2 mt -93.16 -49.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.653 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -168.73 2.29 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.5 m -146.59 117.68 7.78 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 118.241 0.473 . . . . 0.0 110.15 169.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -83.46 -70.85 0.53 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.834 -0.347 . . . . 0.0 111.828 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.445 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 15.9 m-85 -120.45 169.63 10.14 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 13.6 mt-30 -134.7 120.24 19.25 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 125.006 1.322 . . . . 0.0 107.724 169.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.547 HG22 ' HA ' ' A' ' 139' ' ' SER . 23.1 pt -127.35 169.11 19.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.453 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 5.5 m-20 -87.71 110.48 20.47 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.165 -0.959 . . . . 0.0 112.874 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.55 ' HA ' HD23 ' A' ' 108' ' ' LEU . 9.7 mt -69.23 -28.38 66.29 Favored 'General case' 0 CA--C 1.497 -1.063 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.303 177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -64.72 -25.89 68.13 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.8 ptm180 -87.07 -20.26 27.4 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.55 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -64.59 153.18 40.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.259 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -75.32 145.79 41.48 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 169.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.0 m -40.95 -59.67 1.39 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -169.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -79.57 -16.16 56.4 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -172.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 37.4 mmm -69.43 -51.75 33.35 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.975 177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.543 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -67.35 -38.38 84.74 Favored 'General case' 0 C--O 1.215 -0.747 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.373 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -67.99 -27.61 66.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -66.28 -40.9 90.39 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 113' ' ' GLN . 25.0 mt -70.7 -32.5 69.75 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.097 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.3 mt -60.52 -42.38 96.32 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB2' ' NH2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.05 -6.03 55.96 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 117.362 -1.735 . . . . 0.0 110.957 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 102.88 147.96 19.63 Favored Glycine 0 N--CA 1.421 -2.339 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.038 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.537 HG22 ' H ' ' A' ' 122' ' ' PHE . 23.0 mm -101.49 112.58 65.32 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.672 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 68.9 Cg_endo -79.84 -4.38 13.36 Favored 'Trans proline' 0 N--CA 1.48 0.73 0 C-N-CA 123.649 2.899 . . . . 0.0 111.493 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.537 ' H ' HG22 ' A' ' 120' ' ' ILE . 74.1 m-85 -97.87 113.87 25.8 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.991 -174.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 69' ' ' SER 0.252 0.0 OUTLIER -153.6 134.56 13.9 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 179.358 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.475 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.7 m -154.26 174.55 14.64 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' H ' HG22 ' A' ' 124' ' ' THR . 22.0 ptmt -58.3 -46.37 86.25 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 119.993 1.27 . . . . 0.0 113.337 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.48 -25.44 33.52 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-O 120.879 0.371 . . . . 0.0 110.035 -174.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 24.0 mt-10 -74.77 -30.92 61.61 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.764 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -68.83 -51.47 40.35 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.9 pt-20 -68.22 -21.61 64.84 Favored 'General case' 0 C--O 1.196 -1.746 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.064 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -67.81 -44.49 77.18 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.838 0.828 . . . . 0.0 110.014 177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -74.3 -37.81 46.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.243 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.83 -36.48 77.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.968 178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.419 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.0 pt-20 -69.44 -20.28 63.77 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 120.783 0.325 . . . . 0.0 111.01 178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.51 ' CD2' ' HE1' ' A' ' 138' ' ' TYR . 9.2 t60 -84.44 -42.53 15.54 Favored 'General case' 0 C--O 1.204 -1.332 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.8 mmt -55.78 -41.81 74.62 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.747 0.419 . . . . 0.0 111.295 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.4 ptpt -67.29 -18.79 65.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.2 p -65.74 -30.88 71.61 Favored 'General case' 0 C--N 1.349 0.55 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.549 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.7 m-85 -81.92 -68.11 0.72 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.547 ' HA ' HG22 ' A' ' 103' ' ' ILE . 16.8 t 52.91 20.94 1.81 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.77 1.228 . . . . 0.0 111.717 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.444 -4.374 1 N-CA-C 102.646 -4.182 . . . . 0.0 102.646 -175.299 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.403 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.66 161.12 42.99 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 9' ' ' LEU . 20.5 m -83.99 168.89 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 123.454 0.471 . . . . 0.0 110.744 -178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.35 124.05 44.59 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 28.1 m170 68.99 -163.39 0.19 Allowed 'General case' 0 C--N 1.332 -0.162 0 O-C-N 124.51 1.131 . . . . 0.0 109.672 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -85.54 -13.39 49.1 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.415 0.626 . . . . 0.0 109.316 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.0 157.12 43.71 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 114.086 -1.415 . . . . 0.0 111.217 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.9 Cg_endo -77.7 171.06 18.07 Favored 'Trans proline' 0 N--CA 1.43 -2.246 0 C-N-CA 121.285 1.323 . . . . 0.0 110.87 172.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -112.8 118.06 33.89 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -175.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.435 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.2 mt-30 -74.58 101.57 4.26 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.545 0.688 . . . . 0.0 110.636 175.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.7 t -104.91 134.51 46.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-N 115.005 -0.998 . . . . 0.0 108.803 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -109.38 107.81 18.12 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG2' ' HB2' ' A' ' 29' ' ' LYS . 32.7 m -96.5 134.48 33.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-O 121.364 0.602 . . . . 0.0 110.595 -176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.57 110.11 22.32 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 174.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 89.0 mt -106.54 107.91 19.15 Favored 'General case' 0 N--CA 1.417 -2.076 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.816 -174.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -90.02 137.0 32.7 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.9 mmtp -108.42 103.85 13.09 Favored 'General case' 0 C--N 1.276 -2.601 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 54.2 t -90.74 106.95 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.313 0 C-N-CA 118.331 -1.348 . . . . 0.0 110.236 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -85.2 159.72 20.05 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.407 ' HB2' HG22 ' A' ' 65' ' ' ILE . 67.1 mt -58.62 -44.05 89.87 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 5.7 t70 -52.95 -35.44 58.81 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.696 1.599 . . . . 0.0 114.963 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.55 -31.83 5.8 Favored Glycine 0 C--N 1.3 -1.459 0 C-N-CA 119.133 -1.508 . . . . 0.0 112.243 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -80.67 111.26 16.94 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 5.6 m -105.19 161.74 4.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.138 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.5 t -100.62 124.79 46.7 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.3 mm -99.88 115.08 40.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 14.8 tp10 -114.01 147.19 39.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.593 -176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -132.04 108.95 9.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.551 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 41.8 mtmt -114.93 156.23 25.41 Favored 'General case' 0 C--N 1.279 -2.476 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.745 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -122.99 114.16 20.04 Favored 'General case' 0 C--N 1.272 -2.804 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.964 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 135.7 48.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.954 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 36.5 mtmt -96.61 119.81 35.78 Favored 'General case' 0 N--CA 1.406 -2.668 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.557 175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.607 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.0 OUTLIER -123.64 133.39 69.35 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.265 -177.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 8' ' ' PRO . 11.2 m-85 -80.74 -22.6 40.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 t -135.75 118.43 16.03 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.02 -30.17 67.81 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-O 120.73 0.3 . . . . 0.0 111.205 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -69.33 -33.25 72.85 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.288 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -66.64 -40.23 88.61 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.607 ' HB2' HG21 ' A' ' 33' ' ' VAL . 56.8 t80 -61.86 -46.42 89.5 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.189 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -63.67 -38.36 90.8 Favored 'General case' 0 C--O 1.208 -1.099 0 CA-C-O 121.114 0.483 . . . . 0.0 110.316 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.61 -28.49 63.84 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.742 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.8 -36.02 67.49 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.703 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.6 18.42 17.58 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.69 -33.6 10.41 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.24 -24.44 71.15 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.068 -0.586 . . . . 0.0 113.584 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 23.6 m95 -74.74 159.1 32.43 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 123.06 0.544 . . . . 0.0 109.759 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.529 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 83.1 m -91.27 117.8 29.95 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.03 113.8 17.45 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.635 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 87.9 t -91.39 -49.34 13.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.599 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.506 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -155.73 159.51 39.56 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -146.77 139.07 24.83 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.305 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.32 177.76 7.59 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.038 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -67.01 94.98 0.36 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.019 0.437 . . . . 0.0 111.621 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.69 -3.28 53.06 Favored Glycine 0 N--CA 1.438 -1.225 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.42 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -142.5 132.23 24.07 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 87.1 t -128.84 141.81 45.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.635 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.6 tp -117.92 111.84 19.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 121.551 0.691 . . . . 0.0 110.811 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 10.4 m-85 -119.97 142.04 49.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.525 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.529 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 10.1 ptp180 -122.34 134.41 54.64 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.457 0.646 . . . . 0.0 110.453 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.547 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.1 tppt? -120.87 118.16 29.22 Favored 'General case' 0 C--N 1.275 -2.673 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.69 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.08 153.13 19.12 Favored 'General case' 0 C--N 1.262 -3.22 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.358 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 21.5 ptp -135.96 168.86 18.56 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 123.451 0.469 . . . . 0.0 110.707 -175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.32 -18.07 29.28 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -171.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -90.77 163.53 14.43 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.407 HG22 ' HB2' ' A' ' 20' ' ' LEU . 38.8 pt -97.65 171.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.581 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.568 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -63.04 137.25 97.01 Favored Pre-proline 0 C--N 1.298 -1.638 0 C-N-CA 123.935 0.894 . . . . 0.0 110.742 -175.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -58.87 -46.31 23.82 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 123.426 2.75 . . . . 0.0 113.631 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.618 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.6 OUTLIER -74.29 -29.61 61.72 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 38.3 m -66.68 -23.46 66.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.341 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.2 mttt -71.07 -34.64 71.39 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 122.913 0.133 . . . . 0.0 111.05 175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -75.01 -27.33 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 122.526 1.155 . . . . 0.0 107.951 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 87' ' ' HIS . 19.6 t30 -79.27 -72.6 0.38 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.095 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 71.79 33.08 63.37 Favored Glycine 0 C--O 1.213 -1.21 0 N-CA-C 114.517 0.567 . . . . 0.0 114.517 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -118.09 140.98 48.98 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.285 0.564 . . . . 0.0 110.007 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG12 HG22 ' A' ' 85' ' ' THR . 19.6 mt -128.52 138.02 55.75 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 175.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.97 139.19 10.17 Favored Glycine 0 N--CA 1.411 -2.972 0 C-N-CA 119.235 -1.46 . . . . 0.0 114.033 -176.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 22.4 m -107.83 146.72 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.05 0 C-N-CA 118.347 -1.341 . . . . 0.0 111.119 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.9 m -91.0 170.74 9.8 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 105.398 -2.075 . . . . 0.0 105.398 173.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -46.64 -35.34 5.85 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -86.24 16.04 4.72 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.579 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 68.47 41.25 85.45 Favored Glycine 0 CA--C 1.478 -2.219 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.761 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 40.0 t -75.02 117.98 20.14 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.64 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.461 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.0 mm -80.42 36.28 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 127.989 2.516 . . . . 0.0 112.219 -168.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.542 ' HG ' ' HE1' ' A' ' 86' ' ' PHE . 8.4 p -91.65 150.02 21.36 Favored 'General case' 0 C--N 1.272 -2.777 0 O-C-N 121.318 -0.863 . . . . 0.0 111.5 -166.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.631 HG22 HG12 ' A' ' 75' ' ' ILE . 44.2 p -90.49 144.51 25.72 Favored 'General case' 0 N--CA 1.418 -2.039 0 O-C-N 120.895 -1.128 . . . . 0.0 109.296 178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.542 ' HE1' ' HG ' ' A' ' 84' ' ' SER . 32.2 m-85 -134.23 169.91 16.48 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 72' ' ' ASN . 16.9 t60 -106.48 112.8 25.96 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.15 -166.09 43.96 Favored Glycine 0 C--N 1.307 -1.066 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.287 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 24.6 mmt180 -55.95 115.86 10.77 Favored Pre-proline 0 C--O 1.25 1.091 0 C-N-CA 122.867 0.467 . . . . 0.0 110.665 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 52.9 Cg_endo -76.02 86.2 1.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.7 0 C-N-CA 123.115 2.543 . . . . 0.0 112.592 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.446 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 12.8 pt-20 -97.4 159.48 31.08 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -69.59 -12.01 32.29 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.245 1.963 . . . . 0.0 111.519 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.35 7.52 46.27 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.215 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.446 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 33.3 t -101.72 179.96 4.19 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.71 120.93 45.73 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-O 120.463 0.173 . . . . 0.0 110.89 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.31 136.35 19.68 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 121.678 1.586 . . . . 0.0 109.077 172.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.501 ' HB ' HE22 ' A' ' 98' ' ' GLN . 63.1 mt -72.41 -36.1 53.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.501 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.52 -160.67 0.67 Allowed 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.0 t -146.59 144.54 29.61 Favored 'General case' 0 N--CA 1.416 -2.153 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.803 170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -108.74 -73.16 0.7 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.725 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -152.09 179.96 8.03 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.609 ' HG2' HG22 ' A' ' 82' ' ' VAL . 23.8 mt-30 -128.07 133.23 49.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.391 1.077 . . . . 0.0 111.09 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.618 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 39.0 pt -135.23 154.42 35.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -82.1 116.82 21.85 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.631 0.729 . . . . 0.0 112.482 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.661 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.6 mt -67.33 -29.66 69.28 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.377 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -66.68 -16.41 64.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.229 176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -95.48 -18.08 20.95 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.672 HD13 ' CZ ' ' A' ' 138' ' ' TYR . 3.9 mm? -57.39 160.95 3.69 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 173.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -64.41 -73.16 0.13 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.125 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.7 t -162.92 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.265 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -69.24 -23.88 63.93 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -174.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.561 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 61.9 mmm -49.65 -56.38 10.31 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 123.716 0.635 . . . . 0.0 112.102 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.565 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.1 -33.36 73.38 Favored 'General case' 0 C--O 1.215 -0.727 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.57 -178.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -68.18 -31.55 71.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.563 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -74.05 -29.41 61.88 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.087 0.47 . . . . 0.0 109.869 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 112' ' ' MET . 55.0 mt -73.44 -31.76 64.0 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.688 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.8 mt -60.41 -52.15 66.46 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 123.188 0.595 . . . . 0.0 111.408 176.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -88.8 -13.1 40.19 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 -179.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.578 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.02 128.57 5.7 Favored Glycine 0 N--CA 1.413 -2.892 0 C-N-CA 119.447 -1.359 . . . . 0.0 111.48 177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.8 mm -58.41 132.05 84.99 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.87 -5.26 16.75 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 122.76 2.306 . . . . 0.0 114.698 -173.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -175.07 141.38 0.57 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 29.6 ttp85 -154.49 135.4 13.75 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 6.8 m -114.19 173.05 6.64 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -61.57 -39.05 89.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -173.339 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.44 -28.56 46.71 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.493 0.663 . . . . 0.0 109.684 -174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.427 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 21.7 mt-10 -73.4 -30.42 63.25 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.049 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -64.67 -53.17 51.6 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 176.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.3 -25.01 65.82 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.305 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -67.91 -47.7 68.04 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.522 0.729 . . . . 0.0 109.796 177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.613 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -70.09 -39.55 77.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.739 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.02 -40.27 88.49 Favored 'Isoleucine or valine' 0 C--O 1.246 0.896 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -69.0 -25.5 64.55 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -81.21 -33.65 32.78 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 18.2 mmt -63.58 -40.39 96.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.499 . . . . 0.0 110.065 177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 139' ' ' SER . 17.6 ptpt -69.06 -17.77 63.92 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.0 p -65.47 -27.58 68.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.672 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 82.3 m-85 -83.99 -64.88 1.08 Allowed 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 103' ' ' ILE . 20.5 t 49.86 17.13 0.26 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.377 1.471 . . . . 0.0 114.187 172.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.562 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 CA--C 1.443 -4.456 0 N-CA-C 106.736 -2.545 . . . . 0.0 106.736 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.434 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -102.35 159.12 15.69 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.8 m -69.48 171.26 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.076 0 CA-C-O 121.75 0.786 . . . . 0.0 111.809 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -94.04 127.13 39.66 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -104.29 -178.11 3.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -74.23 -39.91 62.77 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.86 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -78.74 135.79 59.48 Favored Pre-proline 0 N--CA 1.428 -1.568 0 CA-C-N 114.457 -1.247 . . . . 0.0 107.642 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.536 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 78.8 Cg_endo -73.7 -168.97 0.49 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 122.729 2.286 . . . . 0.0 114.677 -173.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.32 120.83 21.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 -177.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -79.16 107.22 11.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.138 0.494 . . . . 0.0 110.513 176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 t -109.95 120.8 61.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -98.37 110.56 23.13 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 174.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.622 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 8.5 m -106.88 141.82 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 110.819 -176.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.49 116.52 30.4 Favored 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 1.4 mm? -100.01 121.34 41.23 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.31 127.32 50.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.612 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 96.6 mttt -116.81 99.92 7.43 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.6 t -85.17 100.02 7.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 70.1 m-85 -79.63 164.69 23.6 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.3 mt -57.67 -36.41 71.86 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 123.502 0.501 . . . . 0.0 110.986 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.34 -27.19 69.15 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.888 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 112.83 -17.66 22.6 Favored Glycine 0 C--N 1.289 -2.034 0 C-N-CA 119.394 -1.384 . . . . 0.0 109.721 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.85 120.56 12.75 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.872 -0.664 . . . . 0.0 109.679 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 19.5 t -112.65 115.19 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.9 m -82.94 120.11 25.28 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.0 mm -100.28 114.73 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.453 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 4.8 tp10 -113.19 146.99 38.34 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.772 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.5 m-70 -131.99 121.37 23.81 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.597 ' HB2' HG22 ' A' ' 13' ' ' VAL . 37.0 mmtt -124.33 144.85 49.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -121.43 116.46 24.78 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.12 154.44 44.74 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.222 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.6 mtmm -105.28 119.3 38.72 Favored 'General case' 0 N--CA 1.406 -2.652 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.4 OUTLIER -121.61 132.03 71.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.408 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -73.81 -47.26 39.97 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.143 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.0 m -115.68 105.51 12.82 Favored 'General case' 0 N--CA 1.381 -3.906 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.457 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -50.97 -31.76 18.88 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.92 0.488 . . . . 0.0 112.052 -179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -65.19 -31.35 72.47 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.422 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -71.84 -36.21 70.12 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.497 ' HB2' HG21 ' A' ' 33' ' ' VAL . 41.2 t80 -64.39 -43.32 94.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.54 177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -66.07 -36.91 84.47 Favored 'General case' 0 C--O 1.205 -1.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.954 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.6 -36.02 78.13 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.133 0.492 . . . . 0.0 110.293 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.82 -40.65 95.54 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.64 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.02 18.39 19.5 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.771 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.74 -31.77 49.64 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.68 -30.83 61.28 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.525 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 15' ' ' LEU . 54.4 m95 -69.46 151.97 45.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.3 m -87.33 118.93 27.09 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.46 112.18 11.52 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.616 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 98.0 t -90.11 -46.87 14.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.661 ' HG2' HD23 ' A' ' 57' ' ' LEU . 14.9 pt-20 -157.3 156.1 31.83 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 172.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.11 143.24 31.76 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.354 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -134.57 158.38 44.14 Favored 'General case' 0 C--N 1.257 -3.444 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 173.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -71.17 96.84 1.42 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 119.335 0.97 . . . . 0.0 111.311 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.46 -9.75 10.79 Favored Glycine 0 N--CA 1.432 -1.63 0 CA-C-N 115.067 -0.969 . . . . 0.0 112.7 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.446 ' O ' ' HG2' ' A' ' 52' ' ' LYS . 9.9 t80 -144.55 127.59 16.53 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 96.3 t -129.78 136.91 57.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-O 121.193 0.52 . . . . 0.0 109.986 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.661 HD23 ' HG2' ' A' ' 50' ' ' GLU . 9.9 tp -113.46 115.04 27.41 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-O 121.157 0.504 . . . . 0.0 110.91 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.434 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 33.4 m-85 -117.84 155.89 29.33 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.201 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.1 ptp180 -134.99 141.34 46.21 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.217 0.532 . . . . 0.0 110.535 171.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.558 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 11.0 tppt? -136.22 104.97 5.82 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.601 ' HB3' ' HB ' ' A' ' 18' ' ' VAL 0.311 5.9 pt20 -89.3 137.3 32.44 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.682 0.753 . . . . 0.0 112.437 -177.729 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 25.7 mmt -93.87 159.06 15.35 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -164.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.13 -26.84 35.83 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 113.026 -1.897 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -94.54 174.4 7.14 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.402 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 26.8 pt -81.44 -36.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.501 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 23.3 t 141.98 145.55 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.278 0 C-N-CA 127.585 2.354 . . . . 0.0 106.593 176.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 18.2 Cg_endo -64.02 -32.52 64.7 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 122.027 1.818 . . . . 0.0 111.158 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -80.98 -37.59 29.06 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.139 0.495 . . . . 0.0 109.702 -177.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.1 m -60.28 -22.55 63.26 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -95.85 -4.02 44.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.895 178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.1 m -104.72 -37.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -151.58 75.56 1.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.335 1.065 . . . . 0.0 109.882 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' HA3' HH21 ' A' ' 123' ' ' ARG . . . -130.11 154.92 20.77 Favored Glycine 0 N--CA 1.402 -3.57 0 CA-C-N 114.042 -1.435 . . . . 0.0 109.899 171.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.606 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.9 m-85 -149.09 139.16 22.14 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -178.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG12 HG22 ' A' ' 85' ' ' THR . 91.5 mt -96.52 119.47 44.61 Favored 'Isoleucine or valine' 0 C--N 1.246 -3.932 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -113.59 111.3 2.63 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.308 1.005 . . . . 0.0 112.815 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 84.6 t -107.9 132.77 54.71 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 114.87 -0.665 . . . . 0.0 109.376 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -103.37 169.93 8.25 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -41.04 -42.44 1.94 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.73 2.012 . . . . 0.0 114.801 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -81.4 16.56 1.61 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.338 0.655 . . . . 0.0 112.073 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 68.8 33.69 76.03 Favored Glycine 0 CA--C 1.478 -2.234 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 178.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.7 t -74.62 111.08 9.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 26.1 mm -81.43 37.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 127.79 2.436 . . . . 0.0 113.011 -171.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.482 ' OG ' HG12 ' A' ' 82' ' ' VAL . 14.7 m -92.09 162.89 14.17 Favored 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.597 -168.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.415 HG22 HG12 ' A' ' 75' ' ' ILE . 82.8 p -113.14 159.04 19.64 Favored 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.979 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -139.16 157.08 46.58 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.011 -177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -101.39 114.73 28.99 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.37 177.61 45.76 Favored Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -58.71 132.86 86.18 Favored Pre-proline 0 C--N 1.308 -1.22 0 C-N-CA 123.324 0.65 . . . . 0.0 111.759 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -76.1 90.02 1.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.354 0 C-N-CA 122.852 2.368 . . . . 0.0 111.364 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.456 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.4 pt-20 -121.79 169.1 9.9 Favored Pre-proline 0 C--N 1.293 -1.885 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.6 Cg_endo -66.07 -18.25 56.34 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 121.971 1.781 . . . . 0.0 112.337 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.13 49.38 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 121.581 0.705 . . . . 0.0 110.301 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -115.02 163.03 16.18 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 39.2 mt-10 -127.28 138.92 33.78 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 14.9 Cg_exo -67.24 135.92 38.63 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.076 1.85 . . . . 0.0 110.306 176.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.4 mt -66.9 -39.2 82.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.425 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.523 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.61 -167.68 2.21 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.4 p -146.69 110.35 4.9 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 118.594 0.634 . . . . 0.0 110.038 169.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -71.35 -58.24 3.71 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.03 174.85 13.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.666 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 21.1 mt-30 -130.98 148.42 52.73 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.509 0.724 . . . . 0.0 111.651 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.511 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 37.8 pt -144.91 179.85 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.221 1.008 . . . . 0.0 108.756 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.55 115.91 29.63 Favored 'General case' 0 CA--C 1.497 -1.062 0 O-C-N 121.534 -0.729 . . . . 0.0 111.665 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 113' ' ' GLN . 6.9 mt -73.0 -26.78 61.45 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -67.23 -19.96 65.61 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.685 176.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -97.89 -14.17 20.83 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 113' ' ' GLN . 0.9 OUTLIER -63.56 171.53 2.54 Favored 'General case' 0 CA--C 1.494 -1.182 0 CA-C-O 122.536 1.16 . . . . 0.0 111.639 173.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -93.45 135.43 34.71 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 170.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -42.34 -48.71 5.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -170.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -77.66 -28.93 51.33 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.479 -174.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.438 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 70.0 mmm -56.74 -55.43 34.32 Favored 'General case' 0 C--N 1.316 -0.848 0 O-C-N 123.703 0.627 . . . . 0.0 110.461 175.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -62.35 -45.61 92.39 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.269 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -60.75 -31.25 70.58 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -67.87 -39.86 83.66 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.453 0.644 . . . . 0.0 110.161 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD13 HG21 ' A' ' 77' ' ' VAL . 38.0 mt -70.56 -32.8 70.36 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.298 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 70.4 mt -59.28 -46.45 88.5 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.842 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.51 -10.91 50.42 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.708 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 91.75 143.69 12.28 Favored Glycine 0 N--CA 1.416 -2.665 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.735 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 8.0 mm -87.5 115.03 61.52 Favored Pre-proline 0 C--N 1.311 -1.091 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.28 -8.44 17.42 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.801 3.001 . . . . 0.0 113.414 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -137.61 126.59 24.23 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.711 -176.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.478 HH21 ' HA3' ' A' ' 73' ' ' GLY . 27.5 ptt180 -155.36 130.63 9.57 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-O 121.386 0.612 . . . . 0.0 112.239 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 16.9 m -109.14 174.06 6.04 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 169.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 22.1 ptmt -57.3 -39.12 75.1 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.364 0.984 . . . . 0.0 112.765 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.12 -33.61 65.65 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.181 0.515 . . . . 0.0 110.507 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.451 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.2 mt-10 -74.69 -34.69 62.69 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.074 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -64.98 -53.11 51.37 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.196 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 7.3 pt-20 -66.19 -24.54 66.65 Favored 'General case' 0 C--O 1.206 -1.195 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.969 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -66.81 -47.38 72.24 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.681 0.753 . . . . 0.0 110.491 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.7 p -72.42 -39.8 63.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.303 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.22 -39.18 84.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.423 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 15.1 pt-20 -69.44 -27.41 65.23 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.25 0.548 . . . . 0.0 110.195 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.483 ' O ' HG22 ' A' ' 137' ' ' THR . 2.5 t60 -78.28 -32.64 49.62 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.583 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.6 mmt -64.57 -48.66 74.18 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.436 0.636 . . . . 0.0 109.987 177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -68.79 -17.97 64.11 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.616 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -70.84 -20.64 62.52 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.355 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.457 ' CE1' ' HA ' ' A' ' 108' ' ' LEU . 93.6 m-85 -86.29 -53.91 4.75 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 174.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.453 ' HA ' HG22 ' A' ' 103' ' ' ILE . 5.8 p 41.06 38.92 0.77 Allowed 'General case' 0 C--N 1.352 0.715 0 O-C-N 124.883 1.365 . . . . 0.0 113.616 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 119.893 -1.146 . . . . 0.0 111.176 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.739 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.24 131.01 50.62 Favored 'General case' 0 CA--C 1.487 -1.454 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.737 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 5' ' ' HIS . 25.1 m -90.25 168.15 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -106.56 110.24 22.38 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.412 ' O ' HG23 ' A' ' 3' ' ' VAL . 81.2 m-70 76.28 -171.12 0.09 Allowed 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 125.385 1.678 . . . . 0.0 108.639 -166.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -106.61 -20.8 13.25 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -118.85 156.67 51.66 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 7.0 Cg_endo -54.93 152.18 30.35 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 121.828 1.685 . . . . 0.0 111.127 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -97.77 122.16 40.55 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 73.7 mt-30 -85.61 99.1 11.04 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 121.65 0.738 . . . . 0.0 109.402 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.7 t -98.15 124.96 51.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 CA-C-N 114.526 -1.216 . . . . 0.0 108.594 -177.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -97.98 107.56 20.07 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 3.5 t -102.8 120.14 52.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.923 -170.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -94.92 112.23 23.96 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 172.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 97.4 mt -100.54 113.02 25.47 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 44.7 mt-10 -97.64 143.95 27.79 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 4.2 mptp? -115.83 100.92 8.35 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 61' ' ' GLN . 48.9 t -92.91 117.49 36.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ASP . 65.6 m-85 -109.33 171.09 7.65 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.39 -39.81 95.51 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.63 0.581 . . . . 0.0 110.672 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.09 -45.5 64.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.786 1.304 . . . . 0.0 113.226 -174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.464 ' HA3' HE21 ' A' ' 98' ' ' GLN . . . 127.37 -40.65 1.72 Allowed Glycine 0 N--CA 1.422 -2.247 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -171.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.459 ' O ' ' HD2' ' A' ' 19' ' ' TYR . 22.1 t70 -66.09 130.57 43.68 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER -125.39 131.66 71.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 C-N-CA 123.908 0.883 . . . . 0.0 109.675 -178.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 17' ' ' LYS . 13.9 m -87.74 117.67 26.73 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 51.3 mm -97.34 126.38 50.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.0 tp10 -122.17 146.39 47.28 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -124.48 112.07 16.45 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.489 ' HE2' HD11 ' A' ' 15' ' ' LEU . 30.4 mtmt -114.14 150.33 34.3 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 120.858 0.361 . . . . 0.0 110.251 178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -124.02 115.51 21.32 Favored 'General case' 0 C--N 1.271 -2.832 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 170.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -130.08 152.41 49.56 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 118.603 -1.239 . . . . 0.0 111.814 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 32.1 mtmt -102.52 129.77 49.16 Favored 'General case' 0 N--CA 1.409 -2.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -136.64 132.94 48.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.282 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -75.64 -28.58 58.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.349 0.595 . . . . 0.0 111.472 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 t -134.5 112.88 11.26 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -52.41 -30.55 29.85 Favored 'General case' 0 C--O 1.197 -1.668 0 C-N-CA 123.256 0.623 . . . . 0.0 110.558 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -62.58 -31.63 72.48 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 124.203 1.001 . . . . 0.0 111.972 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.37 -36.59 60.92 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' MET . 51.2 t80 -64.27 -44.63 91.11 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.665 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -63.71 -39.28 93.92 Favored 'General case' 0 C--O 1.196 -1.747 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.525 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.46 -28.47 62.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.571 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.48 -36.55 65.84 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.757 178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -112.15 17.03 19.89 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.44 -31.89 47.44 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.43 -18.11 79.86 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.447 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.646 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.1 m95 -84.23 157.03 21.73 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.2 m -87.35 118.26 26.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.86 112.82 13.86 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.667 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.2 t -92.48 -41.02 12.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.041 -177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.7 pt-20 -165.19 154.83 12.94 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.379 173.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -142.5 137.41 30.22 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.732 174.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.7 ptpt -136.51 166.82 22.62 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -68.14 98.77 0.82 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.483 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.73 -19.24 10.47 Favored Glycine 0 N--CA 1.427 -1.914 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.402 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -144.18 133.44 23.09 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 117.667 0.733 . . . . 0.0 110.933 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 70.1 t -126.64 136.89 59.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.667 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.7 tp -114.85 112.06 22.17 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-O 121.291 0.567 . . . . 0.0 110.789 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.646 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.3 m-85 -120.93 142.25 49.9 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.084 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 6.0 ptp180 -126.7 140.09 52.65 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.046 0.45 . . . . 0.0 110.267 175.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.0 tppt? -120.46 135.32 55.09 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -110.74 135.35 51.46 Favored 'General case' 0 C--N 1.274 -2.717 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 -174.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -106.91 154.21 21.39 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.003 -177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.53 0.96 57.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.752 0.787 . . . . 0.0 109.048 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -112.69 165.65 12.08 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.209 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.1 pt -87.02 171.54 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.771 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 m -65.89 149.2 97.8 Favored Pre-proline 0 C--N 1.291 -1.963 0 C-N-CA 123.982 0.913 . . . . 0.0 110.958 -175.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -59.37 -37.1 92.25 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.156 1.904 . . . . 0.0 110.345 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -73.04 -32.71 65.26 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.2 t -63.3 -32.52 73.95 Favored 'General case' 0 C--O 1.207 -1.167 0 O-C-N 121.968 -0.458 . . . . 0.0 110.09 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 66' ' ' SER . 87.4 mttt -70.22 -29.95 66.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.729 0.3 . . . . 0.0 111.325 178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.0 m -81.94 -27.22 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 122.112 0.958 . . . . 0.0 108.426 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 51.5 t30 -85.79 -73.91 0.43 Allowed 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 113.645 -1.616 . . . . 0.0 110.488 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.15 24.58 76.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.086 -178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.42 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 13.0 m-85 -117.03 107.59 14.72 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 122.171 0.986 . . . . 0.0 111.787 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.65 133.38 34.95 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.006 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 173.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.66 110.58 1.5 Allowed Glycine 0 N--CA 1.418 -2.559 0 CA-C-O 122.051 0.806 . . . . 0.0 113.043 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.786 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 96.4 t -109.11 132.04 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.85 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.04 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.413 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 12.9 m -95.67 170.53 9.26 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -178.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.65 -30.01 29.43 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -83.71 12.97 5.12 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 122.005 -0.434 . . . . 0.0 111.424 179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.45 35.84 59.51 Favored Glycine 0 CA--C 1.481 -2.05 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.786 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -76.85 108.92 10.6 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.913 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.0 mm -81.68 36.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 127.279 2.231 . . . . 0.0 113.529 -169.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 m -93.83 168.31 11.07 Favored 'General case' 0 C--N 1.266 -3.025 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.013 -170.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.3 p -105.4 146.83 28.93 Favored 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 173.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -131.8 165.2 24.33 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -89.86 102.07 14.77 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 176.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.74 -156.54 46.27 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.825 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 13.9 mmm180 -43.55 110.92 1.01 Allowed Pre-proline 0 C--O 1.251 1.133 0 C-N-CA 124.402 1.081 . . . . 0.0 113.103 177.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -84.62 111.99 1.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.52 0 C-N-CA 123.269 2.646 . . . . 0.0 113.356 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.436 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.7 pt-20 -140.46 163.36 43.95 Favored Pre-proline 0 C--N 1.284 -2.279 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 36.7 Cg_endo -66.94 -17.49 51.56 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 122.544 2.163 . . . . 0.0 112.232 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 4.86 53.3 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.392 178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.409 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 31.5 t -103.22 172.66 6.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 176.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.82 120.27 57.63 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.73 139.88 20.37 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.349 2.033 . . . . 0.0 109.944 174.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.417 ' HB ' HE22 ' A' ' 98' ' ' GLN . 71.6 mt -75.96 -39.43 37.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.441 0.638 . . . . 0.0 109.576 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.464 HE21 ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -158.03 -167.3 2.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 105.41 -2.071 . . . . 0.0 105.41 177.112 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.483 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 49.0 m -146.18 125.76 13.3 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 119.101 0.864 . . . . 0.0 110.536 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -97.11 -91.71 0.24 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 41.0 m-85 -107.92 169.19 8.76 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 82' ' ' VAL . 33.0 mt-30 -130.26 119.93 23.64 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 169.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.522 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.6 pt -130.89 160.23 42.29 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.674 -172.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -75.04 108.74 7.98 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.613 0.72 . . . . 0.0 111.47 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.585 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 10.7 mt -69.69 -30.15 67.74 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.205 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -65.67 -21.42 66.55 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.692 175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.9 ptm180 -89.19 -16.93 30.15 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.411 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.6 mm? -59.3 165.88 2.5 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.072 169.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HB2' ' H ' ' A' ' 110' ' ' SER . 39.8 mt-10 -59.86 -75.26 0.06 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 36.7 t -172.81 -69.12 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.916 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -67.87 -30.62 70.03 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.543 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 46.4 mmm -50.95 -53.89 29.06 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.328 176.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.639 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -68.73 -33.42 73.89 Favored 'General case' 0 C--O 1.204 -1.304 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.627 -177.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 110' ' ' SER . 73.4 mmtt -64.17 -36.7 84.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.536 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.462 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 94.3 m-20 -61.9 -40.7 96.36 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-O 121.697 0.76 . . . . 0.0 109.596 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.568 HD12 ' HA ' ' A' ' 113' ' ' GLN . 26.8 mt -70.45 -27.19 64.05 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.455 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 55.8 mt -72.85 -44.46 61.37 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 123.09 0.556 . . . . 0.0 111.939 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HB2' ' NH1' ' A' ' 89' ' ' ARG . 0.1 OUTLIER -85.84 -18.27 33.34 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 118.368 -1.333 . . . . 0.0 110.348 -177.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.51 140.08 11.14 Favored Glycine 0 N--CA 1.401 -3.651 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.0 133.58 61.18 Favored Pre-proline 0 C--N 1.281 -2.393 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.5 -1.47 11.33 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 121.842 1.694 . . . . 0.0 113.893 -176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -178.65 139.34 0.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' HD3' ' HB2' ' A' ' 127' ' ' GLU . 11.0 tpp180 -151.39 140.55 21.24 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.496 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -113.81 172.48 6.96 Favored 'General case' 0 CA--C 1.574 1.896 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.496 ' H ' HG22 ' A' ' 124' ' ' THR . 21.9 ptmt -57.73 -46.03 84.99 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.12 -23.92 35.4 Favored 'General case' 0 CA--C 1.489 -1.368 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 27.1 mt-10 -74.22 -33.43 63.37 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.88 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -62.75 -53.66 50.99 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.051 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -63.67 -26.63 68.76 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.45 -49.08 58.37 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.6 0.714 . . . . 0.0 110.49 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -69.25 -39.1 78.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.121 178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.6 -35.66 75.77 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.37 -28.38 66.14 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.347 0.594 . . . . 0.0 110.818 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.438 ' O ' HG22 ' A' ' 137' ' ' THR . 25.5 t60 -73.98 -38.92 64.01 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 176.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.62 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.9 mmt -62.94 -46.0 89.83 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.23 0.538 . . . . 0.0 110.48 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.564 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -70.63 -18.9 62.86 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.6 -23.77 64.51 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.44 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.9 m-85 -88.6 -61.72 1.65 Allowed 'General case' 0 N--CA 1.409 -2.488 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 174.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.48 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.9 p 55.05 7.89 0.21 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.979 1.712 . . . . 0.0 114.718 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.399 -3.767 0 N-CA-C 104.241 -3.544 . . . . 0.0 104.241 -174.092 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 121.378 0.609 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.54 170.54 15.87 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.36 151.13 10.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.019 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.89 121.21 31.02 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -88.28 168.42 12.72 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -174.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -82.67 -12.72 57.41 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.371 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -80.22 110.64 17.23 Favored Pre-proline 0 C--N 1.305 -1.332 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.224 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 42.1 Cg_endo -75.3 156.98 41.73 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.403 2.069 . . . . 0.0 113.559 -175.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -104.35 120.61 41.59 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -82.26 99.36 9.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 7.0 t -95.94 120.5 45.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.123 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 47.0 t-80 -97.56 114.11 25.95 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 173.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.4 m -105.28 137.74 33.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 CA-C-O 121.615 0.721 . . . . 0.0 111.296 -175.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -106.98 105.82 16.05 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 171.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.483 HD11 ' HE2' ' A' ' 29' ' ' LYS . 88.2 mt -97.46 107.53 20.06 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.335 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.0 mt-10 -92.86 145.71 24.19 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.623 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 93.7 mttt -131.24 99.65 4.93 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 40.6 t -93.13 98.6 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.473 -172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.32 163.39 22.94 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.253 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 65' ' ' ILE . 7.1 mp -66.26 -28.42 68.7 Favored 'General case' 0 CA--C 1.497 -1.06 0 CA-C-O 121.099 0.476 . . . . 0.0 110.028 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -51.23 -41.94 60.64 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.908 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.514 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 117.23 -26.93 7.97 Favored Glycine 0 N--CA 1.419 -2.463 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -76.83 114.21 15.36 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 110.542 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 39.8 t -93.49 120.57 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.653 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -78.29 124.27 27.91 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -103.78 111.44 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -113.47 128.04 56.31 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.587 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -114.2 123.49 49.71 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HE2' HD11 ' A' ' 15' ' ' LEU . 41.8 mtmt -132.7 153.83 50.76 Favored 'General case' 0 CA--C 1.49 -1.363 0 CA-C-N 116.64 -0.255 . . . . 0.0 110.694 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 p-80 -122.86 120.46 33.55 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 170.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -131.83 134.97 46.36 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.782 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 88.4 mttt -81.02 124.21 28.98 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.429 173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.9 OUTLIER -119.79 147.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -94.97 -38.63 10.59 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.872 0.844 . . . . 0.0 108.787 177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.6 t -110.55 115.44 29.62 Favored 'General case' 0 N--CA 1.397 -3.078 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -63.83 -30.21 71.33 Favored 'General case' 0 CA--C 1.483 -1.604 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 175.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -65.55 -34.48 78.34 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.822 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -73.43 -35.07 65.75 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 36' ' ' MET . 70.4 t80 -61.53 -45.86 92.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.301 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -63.56 -36.81 85.02 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.87 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.88 -36.01 72.6 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.9 84.02 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.158 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -105.96 17.59 23.39 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.728 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.34 -32.72 11.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.37 -16.04 74.89 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.531 -178.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.559 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.8 m95 -81.09 153.7 27.18 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 97.8 m -86.51 118.61 26.04 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.544 HD21 HE21 ' A' ' 51' ' ' GLN . 10.8 tp -72.15 125.6 27.7 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.651 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.0 t -103.45 -40.2 6.4 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.454 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.579 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -163.23 155.68 18.37 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.544 HE21 HD21 ' A' ' 48' ' ' LEU . 10.3 pt20 -142.71 144.75 32.83 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 121.372 0.606 . . . . 0.0 110.265 172.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 15.6 ptmt -143.14 166.99 23.16 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -68.84 97.8 0.87 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 118.289 0.495 . . . . 0.0 111.359 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.72 -19.65 11.24 Favored Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.956 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 7.8 t80 -139.04 138.27 37.02 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 117.59 0.695 . . . . 0.0 110.934 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 90.7 t -131.13 133.61 62.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 13.1 tp -106.53 117.04 33.02 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.395 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.9 m-85 -124.44 143.44 50.63 Favored 'General case' 0 C--O 1.217 -0.606 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.903 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.442 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 5.4 ptp180 -127.8 135.18 49.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-O 121.37 0.605 . . . . 0.0 110.261 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.8 tppt? -122.16 112.22 17.93 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.603 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -97.23 96.36 8.36 Favored 'General case' 0 C--N 1.263 -3.177 0 CA-C-O 121.827 0.822 . . . . 0.0 110.084 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.406 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 59.6 mtm -79.19 129.47 34.49 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 113.926 -1.488 . . . . 0.0 107.858 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -75.89 72.33 2.76 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.455 1.122 . . . . 0.0 110.979 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -153.37 174.99 13.63 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 20' ' ' LEU . 30.3 pt -118.21 -16.07 8.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.4 m 79.78 156.07 0.13 Allowed Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 124.655 1.182 . . . . 0.0 110.726 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 34.0 Cg_endo -68.1 -15.74 43.55 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.403 2.069 . . . . 0.0 112.676 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.569 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -62.41 -33.7 75.31 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.609 0.764 . . . . 0.0 110.038 -176.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.539 ' HB3' ' CD2' ' A' ' 122' ' ' PHE . 4.7 m -60.15 -29.37 68.61 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.551 0.691 . . . . 0.0 111.158 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -84.73 -16.24 42.34 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 -177.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -89.82 -44.69 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -152.93 26.26 0.55 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 119.357 -0.937 . . . . 0.0 111.705 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.52 151.47 26.68 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.268 -0.968 . . . . 0.0 110.838 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.674 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 25.6 m-85 -159.55 119.0 2.93 Favored 'General case' 0 CA--C 1.474 -1.95 0 C-N-CA 125.08 1.352 . . . . 0.0 107.701 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.526 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 96.1 mt -76.24 110.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 173.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -108.93 111.08 3.16 Favored Glycine 0 C--N 1.276 -2.783 0 CA-C-N 114.508 -1.224 . . . . 0.0 112.374 -171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.793 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 59.3 t -110.36 126.87 67.64 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.711 0 CA-C-N 114.766 -0.717 . . . . 0.0 109.66 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 m -93.97 170.18 9.73 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.527 ' HA ' HD12 ' A' ' 105' ' ' LEU . 31.3 t70 -51.98 -31.75 30.67 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.9 OUTLIER -81.55 14.81 2.35 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 122.181 -0.324 . . . . 0.0 110.766 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 67.79 36.28 86.83 Favored Glycine 0 CA--C 1.466 -2.991 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.793 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.4 t -75.67 107.36 6.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.897 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' HA ' HG22 ' A' ' 77' ' ' VAL . 32.2 mm -81.3 36.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 127.478 2.311 . . . . 0.0 112.462 -169.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 11.2 m -94.32 149.39 21.29 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.422 -168.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.0 p -93.26 148.38 22.08 Favored 'General case' 0 C--N 1.293 -1.883 0 C-N-CA 118.238 -1.385 . . . . 0.0 108.529 175.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -124.55 156.31 37.59 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -94.52 102.54 14.49 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.23 178.21 43.08 Favored Glycine 0 C--N 1.299 -1.516 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -174.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.2 mmm180 -49.47 117.96 7.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 C-N-CA 123.707 0.803 . . . . 0.0 112.585 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.55 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 24.6 Cg_endo -67.56 110.69 2.14 Favored 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 122.95 2.433 . . . . 0.0 112.198 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 15.9 pt-20 -136.02 165.47 35.53 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 34.3 Cg_endo -69.7 -15.06 37.12 Favored 'Trans proline' 0 C--N 1.331 -0.349 0 C-N-CA 121.79 1.66 . . . . 0.0 111.772 178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.21 -4.57 58.7 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.37 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.1 p -106.76 172.36 6.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -114.18 133.18 22.43 Favored Pre-proline 0 C--N 1.297 -1.676 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.079 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.89 147.85 85.52 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 121.93 1.753 . . . . 0.0 109.111 170.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 44.8 mt -80.02 -27.73 12.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.049 0.928 . . . . 0.0 108.793 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.514 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -167.45 -175.98 3.06 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 103.879 -2.637 . . . . 0.0 103.879 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.2 t -136.17 136.76 40.27 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -94.01 -73.3 0.58 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -152.07 176.7 11.25 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -171.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.672 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.6 mt-30 -130.98 138.04 49.51 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.492 0.717 . . . . 0.0 111.788 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.564 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 32.5 pt -141.31 169.35 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.819 0.848 . . . . 0.0 109.329 -175.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.2 m-20 -83.99 114.51 21.76 Favored 'General case' 0 C--O 1.256 1.424 0 CA-C-O 121.463 0.649 . . . . 0.0 112.306 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.576 ' HB3' ' NE2' ' A' ' 113' ' ' GLN . 7.6 mt -69.44 -29.81 67.59 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.081 176.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.66 -18.73 65.54 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.7 ptm180 -97.02 -14.58 21.54 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.349 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 105' ' ' LEU . 2.3 mm? -58.66 160.98 5.03 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.548 0.689 . . . . 0.0 112.326 171.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -83.19 74.62 10.0 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.882 174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 12.3 m 33.72 -79.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 128.024 2.529 . . . . 0.0 116.209 176.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -61.61 -28.25 69.23 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.588 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 51.9 mmm -58.37 -52.14 66.88 Favored 'General case' 0 C--N 1.318 -0.778 0 O-C-N 123.562 0.539 . . . . 0.0 111.087 177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.622 ' HA ' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -70.52 -31.7 68.88 Favored 'General case' 0 C--O 1.213 -0.865 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -176.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -69.82 -30.72 68.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.479 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -72.1 -32.75 67.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.622 HD12 ' HA ' ' A' ' 113' ' ' GLN . 33.8 mt -72.34 -33.09 67.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.236 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 82.3 mt -58.36 -41.89 85.73 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.063 0.545 . . . . 0.0 110.346 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.55 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 76.1 mttt -76.08 -33.76 59.54 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-O 121.533 0.683 . . . . 0.0 109.21 177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 106.78 138.58 9.03 Favored Glycine 1 N--CA 1.394 -4.157 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.674 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.1 mm -85.36 122.8 73.62 Favored Pre-proline 0 C--N 1.291 -1.95 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.09 19.35 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 123.956 3.104 . . . . 0.0 113.067 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.539 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 16.6 m-85 68.29 163.15 0.21 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.975 1.71 . . . . 0.0 115.168 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.426 ' NH1' ' HB3' ' A' ' 127' ' ' GLU . 49.4 mtm180 -151.04 178.36 9.27 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.4 m -66.79 173.54 3.47 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 118.734 0.697 . . . . 0.0 109.442 -170.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -57.17 -38.67 73.94 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -173.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.38 -27.68 52.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.582 0.706 . . . . 0.0 109.776 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 19.8 mt-10 -80.03 -30.88 39.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.221 1.01 . . . . 0.0 109.865 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -66.62 -46.05 77.1 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.991 175.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 125' ' ' LYS 0.273 6.6 pt-20 -71.2 -20.34 62.28 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.986 176.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 28.8 t70 -64.22 -42.97 96.35 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.794 0.807 . . . . 0.0 110.221 174.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 135' ' ' MET . 4.5 p -75.8 -33.85 26.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.556 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 129' ' ' GLU . 1.4 mp -67.89 -35.38 71.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.3 pt-20 -66.37 -26.93 67.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.171 0.51 . . . . 0.0 110.833 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.513 ' CD2' ' HE2' ' A' ' 138' ' ' TYR . 12.6 t60 -70.67 -42.09 71.19 Favored 'General case' 0 C--O 1.206 -1.203 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 176.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 16.0 mmt -61.9 -50.05 73.76 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.237 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.54 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -69.63 -17.77 63.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.51 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.466 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -68.79 -23.89 64.34 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 176.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.515 ' CE2' HD13 ' A' ' 108' ' ' LEU . 66.1 m-85 -86.05 -57.5 3.0 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 59.8 p 50.51 16.84 0.32 Allowed 'General case' 0 C--O 1.245 0.849 0 C-N-CA 125.49 1.516 . . . . 0.0 114.753 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.388 -4.565 0 N-CA-C 106.097 -2.801 . . . . 0.0 106.097 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.686 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -113.63 144.87 42.18 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.647 HG12 ' H ' ' A' ' 4' ' ' GLU . 6.2 t 61.93 -175.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.502 1.121 . . . . 0.0 108.985 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.647 ' H ' HG12 ' A' ' 3' ' ' VAL . 12.1 pt-20 -101.59 126.6 48.44 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -126.21 159.62 32.49 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.237 -175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -89.55 -19.19 25.3 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.771 -176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 mm-40 -68.21 124.28 89.37 Favored Pre-proline 0 N--CA 1.434 -1.264 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.203 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 7' ' ' GLU . 2.5 Cg_endo -79.96 168.05 19.46 Favored 'Trans proline' 0 N--CA 1.428 -2.328 0 C-N-CA 121.668 1.578 . . . . 0.0 110.831 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -119.31 117.31 28.22 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.519 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 79.0 mt-30 -79.32 100.63 7.66 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.366 0.603 . . . . 0.0 109.782 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 6.4 t -99.62 123.89 52.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.617 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -98.1 104.71 16.77 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 171.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.6 m -95.94 132.73 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.332 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.451 HE21 HD12 ' A' ' 26' ' ' ILE . 48.0 tt0 -103.72 108.37 19.64 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 173.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD23 ' HG2' ' A' ' 27' ' ' GLU . 1.1 mm? -91.88 115.48 28.1 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 120.603 -0.439 . . . . 0.0 109.93 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -97.17 128.6 44.22 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.3 mttt -113.7 102.22 10.04 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 9.2 t -85.18 127.65 39.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -174.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -108.68 156.31 19.71 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.67 -29.49 69.32 Favored 'General case' 0 C--O 1.187 -2.195 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 25.3 t70 -53.7 -28.34 33.17 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 126.088 1.755 . . . . 0.0 112.718 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.22 -13.55 55.26 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.36 152.16 25.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.5 p -146.82 122.26 2.75 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 28.4 t -83.29 122.73 28.82 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.451 HD12 HE21 ' A' ' 14' ' ' GLN . 51.1 mm -97.63 116.31 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.517 ' HG2' HD23 ' A' ' 15' ' ' LEU . 11.6 tt0 -113.53 125.07 53.79 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.411 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -103.35 126.41 50.49 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 42.7 mtmt -135.3 144.4 46.74 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 121.042 0.448 . . . . 0.0 111.01 175.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 9.4 p80 -123.67 109.72 14.07 Favored 'General case' 0 C--N 1.271 -2.811 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.785 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.53 142.57 50.47 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.179 -177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 34.6 mtmm -89.28 130.85 35.6 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 HG11 ' CD1' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.97 146.72 21.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -96.65 -24.39 16.02 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 121.389 0.614 . . . . 0.0 110.032 -177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 t -134.11 122.19 22.55 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -30.96 71.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.49 -32.97 74.83 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.06 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.46 -38.97 59.28 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.568 ' CD1' HG11 ' A' ' 33' ' ' VAL . 59.1 t80 -59.47 -45.05 92.75 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.317 177.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.194 -1.828 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.35 -32.77 68.93 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 120.924 0.392 . . . . 0.0 110.702 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.87 -35.29 72.32 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.847 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -115.25 18.83 15.97 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.62 -31.97 27.19 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -70.94 -36.22 65.03 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.721 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.555 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 49.7 m95 -64.46 148.93 49.53 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.425 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 58.5 m -81.13 115.41 20.54 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -72.24 107.14 4.72 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.746 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 66.1 t -81.95 -50.93 15.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.334 -177.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.466 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -161.54 159.7 28.14 Favored 'General case' 0 CA--C 1.505 -0.752 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -145.58 142.53 29.21 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.504 0.669 . . . . 0.0 111.788 175.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.95 171.7 13.71 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.508 -1.224 . . . . 0.0 108.73 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -46.01 -28.88 1.27 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 -169.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.06 5.17 4.28 Favored Glycine 0 C--N 1.268 -3.237 0 C-N-CA 119.619 -1.277 . . . . 0.0 114.195 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -145.19 134.07 22.44 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 117.368 0.584 . . . . 0.0 110.337 -175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.0 t -127.44 134.25 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.746 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 10.9 tp -107.01 117.0 32.91 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 30.6 m-85 -123.5 151.88 42.31 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.815 0.846 . . . . 0.0 111.217 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 12.7 ptp180 -133.02 142.78 48.99 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.307 0.575 . . . . 0.0 110.941 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.4 tppt? -139.1 120.57 15.03 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.4 pt20 -116.8 130.96 57.04 Favored 'General case' 0 C--N 1.272 -2.765 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.462 -175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -107.51 146.08 32.27 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.788 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 84.88 5.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.325 0.583 . . . . 0.0 111.663 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -168.54 175.03 6.43 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 45.7 pt -118.65 -11.66 11.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.429 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 33.7 m 88.01 158.43 0.09 OUTLIER Pre-proline 0 N--CA 1.506 2.36 0 C-N-CA 125.31 1.444 . . . . 0.0 111.609 -173.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 31.1 Cg_endo -67.63 -54.02 0.39 Allowed 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.896 2.397 . . . . 0.0 115.086 -178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 71' ' ' VAL . 1.2 tm? -58.36 -24.45 59.89 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.964 0.906 . . . . 0.0 110.176 -175.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.538 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . 49.5 m -63.69 -23.3 67.32 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 -30.02 43.98 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 118.698 -1.201 . . . . 0.0 110.564 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.563 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.4 m -73.23 -32.26 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.517 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -106.24 -2.78 22.02 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.121 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -46.36 107.18 0.17 Allowed Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 113.953 -1.476 . . . . 0.0 115.97 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.628 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 53.1 m-85 -157.69 133.34 9.13 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 127.395 2.278 . . . . 0.0 107.091 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.428 ' HB ' HG12 ' A' ' 120' ' ' ILE . 88.8 mt -107.56 126.78 63.86 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.307 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -132.27 139.16 10.7 Favored Glycine 0 N--CA 1.419 -2.471 0 C-N-CA 119.453 -1.356 . . . . 0.0 113.85 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 28.3 m -109.81 149.84 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.865 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.533 175.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 15.4 m -91.59 169.79 10.46 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 173.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.79 -27.02 6.42 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -92.17 17.62 9.31 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.421 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 69.55 38.31 78.78 Favored Glycine 0 CA--C 1.488 -1.625 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 14.2 t -77.6 119.18 25.79 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.865 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 83' ' ' ILE . 36.9 mm -80.17 38.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 128.355 2.662 . . . . 0.0 113.392 -167.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 5.4 m -91.86 146.23 23.92 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.178 0.99 . . . . 0.0 111.421 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.6 p -90.73 147.23 23.38 Favored 'General case' 0 N--CA 1.412 -2.356 0 O-C-N 120.846 -1.158 . . . . 0.0 108.143 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.29 162.45 23.72 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 -177.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -91.38 101.57 14.25 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.69 -165.84 48.36 Favored Glycine 0 N--CA 1.425 -2.095 0 C-N-CA 120.296 -0.954 . . . . 0.0 110.807 -177.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -51.21 123.51 20.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 C-N-CA 123.61 0.764 . . . . 0.0 111.603 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 39.1 Cg_endo -74.91 100.37 1.35 Allowed 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.839 2.359 . . . . 0.0 112.089 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.498 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.3 pt-20 -141.19 169.95 10.36 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 27.6 Cg_endo -69.2 -19.94 38.13 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 CA-C-N 120.697 1.284 . . . . 0.0 111.725 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -4.7 56.75 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.892 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.5 p -113.61 169.89 8.64 Favored 'General case' 0 N--CA 1.421 -1.922 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -113.0 144.97 32.12 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.429 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.15 142.9 31.38 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.599 2.2 . . . . 0.0 109.601 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 65.4 mt -79.97 -34.04 15.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -166.56 -175.65 3.26 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.5 p -146.41 115.54 7.0 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -78.66 -71.61 0.42 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -155.94 -178.43 7.3 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 121.195 -0.202 . . . . 0.0 110.775 -176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.569 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.0 mt-30 -114.21 151.17 33.19 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 124.011 0.82 . . . . 0.0 111.663 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.557 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.0 pt -140.51 155.6 23.07 Favored 'Isoleucine or valine' 0 C--O 1.248 0.977 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.8 m-20 -80.96 111.62 17.6 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.472 0.653 . . . . 0.0 111.704 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.641 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.5 mt -69.78 -27.22 64.73 Favored 'General case' 0 CA--C 1.488 -1.41 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.829 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.79 -17.52 64.04 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.916 176.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -91.23 -21.14 21.25 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.641 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -61.31 148.14 42.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 170.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . 0.299 0.0 OUTLIER -53.42 -72.62 0.05 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.5 m -160.22 -74.41 0.07 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 123.71 0.804 . . . . 0.0 110.472 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -79.19 -17.96 53.93 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.41 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 60.3 mmm -55.4 -55.92 26.14 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.252 0.548 . . . . 0.0 110.836 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.584 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -67.19 -31.96 72.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.414 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.434 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 51.7 mtpt -65.68 -35.34 80.5 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -63.55 -37.59 87.9 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD12 ' HA ' ' A' ' 113' ' ' GLN . 55.8 mt -73.57 -27.45 61.33 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.19 -1.368 . . . . 0.0 110.641 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 83.2 mt -64.27 -52.06 60.48 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.692 0.397 . . . . 0.0 111.661 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -90.94 -15.42 29.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 119.231 -0.988 . . . . 0.0 111.834 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.67 131.85 6.69 Favored Glycine 0 N--CA 1.403 -3.505 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.435 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.628 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 23.7 mm -66.23 119.51 62.54 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 175.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.01 10.2 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.953 3.102 . . . . 0.0 115.702 -170.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -171.45 147.84 2.46 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.504 ' NH1' ' H ' ' A' ' 74' ' ' TYR . 42.5 ttp180 -137.73 129.22 28.1 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 m -134.94 170.18 16.28 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -66.02 -43.46 87.58 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 119.594 1.088 . . . . 0.0 113.168 -170.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.476 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.43 -28.15 31.52 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.652 0.739 . . . . 0.0 109.178 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.501 ' O ' HG12 ' A' ' 131' ' ' VAL . 23.4 mt-10 -73.28 -33.07 65.03 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.796 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' CZ ' HG12 ' A' ' 132' ' ' ILE . 35.5 t80 -66.41 -54.99 17.93 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.389 176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -63.25 -26.77 68.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.609 -175.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -71.81 -48.73 44.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.283 0.563 . . . . 0.0 110.727 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 127' ' ' GLU . 6.9 p -70.97 -38.31 71.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.211 0.529 . . . . 0.0 110.358 178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.487 HG12 ' CZ ' ' A' ' 128' ' ' PHE . 1.4 mp -68.42 -32.86 57.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.1 pt-20 -69.39 -27.6 65.44 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 119.213 -0.995 . . . . 0.0 109.664 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -76.59 -37.35 56.63 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 23.4 mmt -58.82 -46.31 87.94 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 110.746 174.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 16.5 ptpt -71.76 -17.79 62.17 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.421 0.629 . . . . 0.0 110.626 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -18.07 63.31 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.479 175.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -95.31 -61.41 1.48 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.409 ' HA ' HG22 ' A' ' 103' ' ' ILE . 81.1 p 51.01 19.49 0.67 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.682 1.593 . . . . 0.0 113.457 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.382 -4.958 1 N-CA-C 102.76 -4.136 . . . . 0.0 102.76 -174.599 . . . . . . . . 2 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -102.02 -175.79 2.94 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.3 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.0 t -127.05 169.77 17.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -77.17 110.23 11.68 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -95.42 168.06 10.94 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.882 0.849 . . . . 0.0 111.455 -171.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -110.99 -30.8 7.36 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.613 -1.63 . . . . 0.0 107.191 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -96.82 127.92 37.54 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 176.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 72.6 Cg_endo -78.35 178.29 7.75 Favored 'Trans proline' 0 N--CA 1.429 -2.293 0 C-N-CA 120.722 0.948 . . . . 0.0 110.874 176.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -112.88 115.94 29.24 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -173.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -73.91 95.97 2.54 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.336 0.589 . . . . 0.0 110.155 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 23.3 t -95.06 124.76 47.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.89 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.65 107.47 19.97 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 29.6 m -100.68 136.18 33.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.638 -177.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.684 HE21 HD13 ' A' ' 57' ' ' LEU . 3.2 tt0 -106.28 111.59 24.25 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 173.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD11 ' HE2' ' A' ' 29' ' ' LYS . 82.3 mt -100.19 113.37 25.99 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -98.17 126.51 43.66 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -100.2 99.25 9.91 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 60.0 t -89.81 110.12 21.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.099 -174.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -96.01 165.95 12.0 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -68.97 -34.76 75.84 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 175.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -42.11 -45.59 4.04 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 129.82 3.248 . . . . 0.0 114.108 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.95 -30.2 6.71 Favored Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 -177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -86.96 135.01 33.44 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.88 129.59 69.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 122.764 0.426 . . . . 0.0 110.014 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -81.21 123.46 28.48 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.5 mm -103.28 114.88 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.8 tp10 -113.28 148.55 35.37 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.21 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -130.23 117.93 20.6 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.59 ' HE2' HD11 ' A' ' 15' ' ' LEU . 45.3 mtmt -123.59 157.19 34.29 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.71 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 20.5 p-80 -122.5 119.56 31.26 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 171.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.5 137.09 49.59 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.991 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 42.9 mtmt -94.68 114.5 26.44 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.77 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -116.8 141.73 33.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.874 -176.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 8' ' ' PRO . 33.8 m-85 -90.08 -39.76 12.7 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.211 0.529 . . . . 0.0 109.8 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.6 t -113.37 116.83 30.29 Favored 'General case' 0 N--CA 1.402 -2.828 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -28.24 69.55 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.25 -36.56 82.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.824 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -70.85 -41.48 71.39 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.486 ' CD2' HG11 ' A' ' 33' ' ' VAL . 63.2 t80 -59.24 -43.47 92.39 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.33 -36.23 83.43 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.062 0.458 . . . . 0.0 110.541 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.14 -32.38 68.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.21 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.01 -36.38 75.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.359 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.75 20.1 17.39 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -46.8 -39.78 12.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.796 0.838 . . . . 0.0 113.224 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -73.99 -25.94 70.16 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 121.231 -0.509 . . . . 0.0 113.731 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 27.7 m95 -74.05 156.45 37.46 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.401 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 86.6 m -88.31 121.77 31.07 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -79.18 109.28 13.36 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.628 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 44.1 t -86.86 -46.13 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.678 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.3 pt-20 -160.57 161.64 32.68 Favored 'General case' 0 CA--C 1.473 -1.985 0 CA-C-O 121.072 0.463 . . . . 0.0 110.172 173.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -145.0 148.37 33.67 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 ptmt -145.79 170.17 17.07 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -63.97 98.36 0.2 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.046 0.45 . . . . 0.0 111.648 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.54 -17.75 28.01 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.272 176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -135.04 135.93 41.7 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 117.975 0.888 . . . . 0.0 110.14 -176.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.1 t -127.76 136.86 59.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.203 0.525 . . . . 0.0 109.607 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.684 HD13 HE21 ' A' ' 14' ' ' GLN . 15.3 tp -112.02 112.41 24.03 Favored 'General case' 0 C--O 1.264 1.823 0 C-N-CA 123.438 0.695 . . . . 0.0 110.395 179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.0 m-85 -122.42 140.53 52.6 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.791 1.307 . . . . 0.0 111.379 178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 7.6 ptp180 -123.9 140.84 52.58 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.202 0.525 . . . . 0.0 110.836 176.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 13.6 tppt? -125.51 128.84 48.63 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.07 111.14 19.12 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.956 -175.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 53.5 mtm -100.06 177.75 4.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.159 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -102.3 2.28 36.74 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -92.05 167.86 11.78 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.497 HG13 ' HE2' ' A' ' 70' ' ' LYS . 18.8 pt -105.66 174.22 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.553 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 13.3 m -75.81 140.85 71.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 118.368 0.531 . . . . 0.0 111.43 -172.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.66 -40.44 37.33 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.868 2.378 . . . . 0.0 112.804 -175.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -76.34 -30.91 57.83 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.8 m -66.36 -30.23 70.58 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.151 0.5 . . . . 0.0 109.945 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 66' ' ' SER . 86.4 mttt -66.88 -22.56 65.97 Favored 'General case' 0 C--N 1.321 -0.653 0 O-C-N 121.784 -0.573 . . . . 0.0 111.13 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.502 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.0 m -97.9 -38.51 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 0.0 111.275 -176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -116.34 -15.48 10.97 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -173.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.33 156.68 25.53 Favored Glycine 0 C--O 1.25 1.115 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.818 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 30.6 m-85 -158.17 121.8 4.0 Favored 'General case' 0 N--CA 1.404 -2.73 0 C-N-CA 127.447 2.299 . . . . 0.0 105.391 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.1 mt -76.84 114.41 17.16 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 173.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.49 106.77 2.04 Favored Glycine 0 N--CA 1.404 -3.454 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.487 -172.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 89.0 t -106.68 129.05 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.404 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -98.05 167.16 11.06 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.84 -35.34 10.09 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 124.864 1.266 . . . . 0.0 113.994 -174.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -81.83 12.49 3.96 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.18 32.82 51.26 Favored Glycine 0 CA--C 1.477 -2.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.443 177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 25.3 t -74.39 111.88 10.66 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.984 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.482 ' HA ' HG22 ' A' ' 77' ' ' VAL . 33.8 mm -82.18 36.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 127.206 2.202 . . . . 0.0 112.747 -173.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 29.3 t -92.68 150.06 20.92 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.715 -169.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.2 p -90.92 146.97 23.45 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 170.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -129.26 156.14 44.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 120.753 0.311 . . . . 0.0 110.676 -177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -91.4 105.16 17.57 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 170.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.04 178.68 38.91 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -56.7 150.89 34.11 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 123.725 0.81 . . . . 0.0 110.95 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -72.54 86.77 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.908 2.405 . . . . 0.0 112.819 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.0 pt-20 -141.33 163.3 42.57 Favored Pre-proline 0 C--N 1.298 -1.649 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.5 Cg_endo -67.69 -12.67 36.32 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.024 2.482 . . . . 0.0 113.18 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.81 -12.99 58.28 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 121.912 0.863 . . . . 0.0 109.05 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.4 m -101.63 153.1 20.06 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.46 135.95 24.78 Favored Pre-proline 0 C--N 1.293 -1.874 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.262 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -82.47 106.93 1.56 Allowed 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 122.165 1.91 . . . . 0.0 107.189 171.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.497 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -60.29 -39.6 81.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.375 -1.284 . . . . 0.0 111.721 -171.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.497 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.71 -165.84 1.97 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -147.02 134.71 21.08 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -102.09 -73.29 0.66 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.998 0.428 . . . . 0.0 110.345 177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -126.54 160.76 29.68 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.999 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 10.9 mt-30 -120.37 119.99 34.68 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 164.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.651 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.7 pt -120.85 161.42 20.7 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.707 -175.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 18.7 t70 -79.89 107.44 12.68 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.669 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.7 mt -64.89 -33.87 77.04 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.929 -178.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.79 -10.24 59.26 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.096 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.2 ptm180 -88.06 -18.44 28.92 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.718 HD22 ' HB3' ' A' ' 113' ' ' GLN . 4.4 mp -60.72 174.76 0.55 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.673 169.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.85 -87.27 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.703 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 66.8 m -157.6 -78.47 0.08 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -75.2 -15.71 60.53 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 15.7 ptm -65.31 -45.34 84.75 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.852 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.718 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -69.08 -35.72 76.83 Favored 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.862 177.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.4 ' HA ' HD12 ' A' ' 117' ' ' LEU . 88.7 mttt -61.99 -28.87 69.87 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.692 175.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 65.6 t30 -69.2 -40.51 77.99 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 113' ' ' GLN . 23.1 mt -66.82 -32.67 74.1 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.839 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.9 mt -69.17 -33.73 73.84 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.35 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.535 ' HD2' ' HA ' ' A' ' 115' ' ' ASN . 9.0 ptmt -87.14 -24.64 24.44 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.632 -176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 115.64 120.72 3.33 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 121.167 -0.54 . . . . 0.0 112.511 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 26.3 mm -87.73 124.68 66.98 Favored Pre-proline 0 C--O 1.204 -1.293 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 176.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.21 27.75 0.19 Allowed 'Trans proline' 0 N--CA 1.503 2.083 0 C-N-CA 123.656 2.904 . . . . 0.0 112.996 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.2 OUTLIER 64.37 169.92 0.18 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 126.11 1.764 . . . . 0.0 112.724 -176.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.57 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 98.5 mtt180 -147.6 175.74 10.63 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 -178.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 125' ' ' LYS . 30.0 m -79.94 174.79 11.24 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 15.1 ptmt -52.25 -48.75 65.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.347 0.976 . . . . 0.0 113.629 -170.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.09 -25.03 55.1 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 121.597 0.713 . . . . 0.0 109.827 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.57 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.4 mt-10 -81.65 -27.53 34.03 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.222 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -73.88 -50.51 19.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.05 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.1 pt-20 -66.63 -20.82 66.08 Favored 'General case' 0 C--O 1.198 -1.622 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.725 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 16.7 t70 -67.09 -45.47 77.16 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.752 0.821 . . . . 0.0 110.066 175.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.564 ' HB ' ' NH1' ' A' ' 123' ' ' ARG . 4.2 p -73.77 -38.7 51.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 C-N-CA 120.384 -0.527 . . . . 0.0 109.991 176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -63.83 -38.13 81.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.454 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 6.9 pt-20 -67.27 -31.11 71.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.347 0.594 . . . . 0.0 110.062 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.528 ' O ' HG22 ' A' ' 137' ' ' THR . 2.4 t60 -75.21 -35.51 61.49 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 25.7 mmt -64.15 -46.24 84.94 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.375 0.607 . . . . 0.0 110.369 176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -70.08 -18.57 63.27 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.8 OUTLIER -63.95 -26.14 68.45 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.101 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.477 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 88.9 m-85 -82.87 -57.61 3.23 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 67.5 p 55.65 14.7 1.32 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.483 1.661 . . . . 0.0 115.483 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.45 -4.027 0 N-CA-C 105.609 -2.996 . . . . 0.0 105.609 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.9 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -81.4 131.91 35.3 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.3 m -133.22 176.32 9.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.019 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -81.28 138.4 35.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -98.42 -171.88 2.22 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.711 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -78.03 -33.7 50.93 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.606 0.717 . . . . 0.0 109.611 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -84.07 135.46 42.11 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.947 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HG2' ' HD3' ' A' ' 32' ' ' LYS . 7.5 Cg_endo -53.0 173.45 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.344 2.696 . . . . 0.0 111.829 173.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -98.55 120.21 38.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -170.737 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -80.84 101.74 9.59 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-O 121.523 0.678 . . . . 0.0 109.496 175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.0 t -99.91 123.89 52.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.089 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 78.4 m80 -98.62 98.29 9.46 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.612 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.1 p -102.18 119.53 50.61 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 CA-C-O 121.918 0.866 . . . . 0.0 110.647 -177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -84.97 115.5 22.85 Favored 'General case' 0 N--CA 1.418 -2.028 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -102.28 108.0 19.22 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.178 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -91.71 138.43 31.56 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.8 mmtp -107.47 106.94 17.57 Favored 'General case' 0 C--N 1.267 -3.003 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.672 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 48.1 t -91.48 102.96 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 C-N-CA 118.887 -1.125 . . . . 0.0 111.213 -171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.81 144.76 25.16 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.154 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.9 mt -57.41 -42.77 82.93 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 124.631 1.207 . . . . 0.0 111.926 -175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 5.4 p-10 -65.61 -20.32 66.26 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.211 -0.904 . . . . 0.0 113.229 -175.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.53 -19.28 16.79 Favored Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.464 -1.35 . . . . 0.0 113.572 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -90.7 102.93 15.68 Favored 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 119.018 -1.073 . . . . 0.0 108.997 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 3.2 m -93.04 162.85 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.075 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -115.96 132.78 56.55 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.89 121.21 59.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.9 tp10 -113.86 148.53 36.53 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -122.39 108.24 12.99 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' HG13 ' A' ' 13' ' ' VAL . 20.0 mmmt -107.92 120.83 43.4 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.574 -177.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -106.83 108.48 20.02 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 173.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -131.42 136.67 48.18 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.791 -1.163 . . . . 0.0 113.412 -176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 86.3 mttt -82.61 132.46 35.19 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.209 -1.36 . . . . 0.0 111.319 172.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.2 OUTLIER -140.35 136.97 37.08 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.659 177.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -83.49 -37.43 23.11 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.241 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.0 t -122.88 118.46 27.96 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -29.1 42.21 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -62.92 -39.56 94.93 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.416 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.64 -41.78 97.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.153 -0.931 . . . . 0.0 108.543 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.511 ' HB2' HG21 ' A' ' 33' ' ' VAL . 59.7 t80 -68.3 -45.04 74.09 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 114.113 -1.403 . . . . 0.0 110.378 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -63.74 -36.61 84.44 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 120.68 0.276 . . . . 0.0 110.598 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.17 71.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.07 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.91 -39.0 87.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.081 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -109.64 18.31 20.4 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.27 33.03 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.44 -14.23 78.85 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.359 -0.924 . . . . 0.0 113.347 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 28.4 m95 -84.94 153.7 22.65 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.515 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 19.0 m -85.12 117.76 24.27 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 177.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.96 111.21 11.1 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.613 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 55.8 t -85.6 -46.86 16.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.662 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.1 pt-20 -161.56 163.76 29.92 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -145.8 150.09 35.55 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.667 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.15 173.59 12.37 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 124.491 1.116 . . . . 0.0 108.092 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -72.44 97.24 2.03 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.371 0.605 . . . . 0.0 112.113 -174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 114.9 -15.29 19.09 Favored Glycine 0 N--CA 1.433 -1.518 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.186 176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 9.2 t80 -140.14 133.53 29.95 Favored 'General case' 0 N--CA 1.415 -2.187 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 69.8 t -128.23 142.19 44.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.662 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.5 tp -116.8 115.54 25.76 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.028 0.442 . . . . 0.0 111.16 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 12.7 m-85 -123.38 148.22 46.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.025 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.9 ptp180 -128.84 140.54 51.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.413 0.625 . . . . 0.0 111.031 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -131.48 115.16 15.8 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.672 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -99.15 150.99 21.48 Favored 'General case' 0 C--N 1.248 -3.816 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.252 -178.596 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 24.1 mmt -111.54 169.39 8.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.236 -175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -88.47 -21.5 24.16 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 122.028 0.918 . . . . 0.0 108.893 177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.36 154.56 17.14 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.161 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.9 pt -77.1 171.06 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 123.244 0.618 . . . . 0.0 112.041 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 80.3 p -58.13 157.47 16.51 Favored Pre-proline 0 C--N 1.318 -0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 114.229 -172.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' O ' HG13 ' A' ' 71' ' ' VAL . 36.4 Cg_endo -68.54 -22.03 39.02 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.053 1.835 . . . . 0.0 111.142 175.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -82.84 -34.64 26.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 p -65.81 -23.92 66.8 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.581 -0.699 . . . . 0.0 110.637 177.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 66' ' ' SER . 69.9 mmtt -65.94 -44.22 85.71 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.671 173.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.0 m -82.01 -26.6 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.712 0.768 . . . . 0.0 110.644 -169.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -132.61 -78.42 0.5 Allowed 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.413 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 64.4 109.31 0.01 OUTLIER Glycine 0 CA--C 1.537 1.429 0 O-C-N 123.904 0.752 . . . . 0.0 114.832 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -157.29 141.5 16.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.3 mt -102.19 124.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 174.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.486 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.35 96.09 0.86 Allowed Glycine 0 N--CA 1.413 -2.867 0 CA-C-O 121.958 0.754 . . . . 0.0 112.395 -171.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 58.7 t -106.42 118.55 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.422 0 C-N-CA 119.236 -0.986 . . . . 0.0 108.724 178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.9 m -85.71 162.82 18.58 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.287 -1.324 . . . . 0.0 107.571 -176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -46.18 -34.74 4.52 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 124.696 1.199 . . . . 0.0 113.877 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -81.75 9.21 8.29 Favored 'General case' 0 C--O 1.208 -1.102 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 81.69 32.1 31.16 Favored Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 177.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.821 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 21.7 t -78.32 110.51 14.12 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.268 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 77' ' ' VAL . 28.7 mm -82.42 35.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 126.308 1.843 . . . . 0.0 113.214 -171.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.8 m -94.81 151.65 19.06 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 118.221 -1.391 . . . . 0.0 110.374 -170.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.7 p -91.1 147.89 22.75 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.468 -1.293 . . . . 0.0 109.664 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.486 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 9.4 m-85 -131.07 151.84 51.0 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -100.68 102.31 13.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.475 1.131 . . . . 0.0 108.554 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 112.12 170.11 18.35 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.912 -1.675 . . . . 0.0 108.912 -173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -50.24 123.45 16.5 Favored Pre-proline 0 C--N 1.31 -1.126 0 C-N-CA 123.46 0.704 . . . . 0.0 110.384 176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -72.31 104.79 1.74 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.752 2.301 . . . . 0.0 113.04 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.479 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.3 pt-20 -140.49 170.45 9.56 Favored Pre-proline 0 C--N 1.28 -2.423 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 20.4 Cg_endo -69.98 -10.33 28.13 Favored 'Trans proline' 0 C--O 1.233 0.264 0 CA-C-N 120.987 1.388 . . . . 0.0 111.624 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.58 -7.75 52.01 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.715 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 p -94.58 161.51 14.17 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.971 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -93.31 118.65 67.71 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -69.77 132.58 23.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 121.92 1.746 . . . . 0.0 109.373 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 81.2 mt -77.6 -47.89 25.12 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.368 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' N ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -152.86 -166.75 2.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -179.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.443 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 36.7 m -144.07 139.85 29.16 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 170.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -103.16 -65.05 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 177.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -155.65 170.36 22.19 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 -176.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 34.3 tt0 -129.9 128.92 43.18 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.711 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -128.92 170.21 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.868 0.467 . . . . 0.0 111.248 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.526 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 3.0 m-20 -83.79 107.13 16.01 Favored 'General case' 0 C--O 1.252 1.185 0 O-C-N 121.84 -0.538 . . . . 0.0 110.752 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.8 mt -66.04 -31.97 73.17 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.675 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -63.4 -18.08 63.32 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.364 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.0 ptm180 -96.36 -14.02 22.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.253 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.569 HD13 ' CE2' ' A' ' 138' ' ' TYR . 2.8 mm? -54.71 160.03 2.0 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.071 171.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -54.66 -75.47 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.15 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.3 t -159.29 -86.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.259 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -77.91 -12.33 59.97 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 121.699 -0.626 . . . . 0.0 111.309 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 67.9 mmm -48.5 -55.27 11.46 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.117 0.567 . . . . 0.0 111.968 177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.587 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.5 OUTLIER -64.52 -42.73 95.6 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.54 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -53.84 -36.22 62.33 Favored 'General case' 0 C--N 1.355 0.844 0 C-N-CA 123.284 0.633 . . . . 0.0 112.678 175.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 118' ' ' LYS . 87.5 m-20 -60.55 -48.61 81.0 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 113' ' ' GLN . 16.5 mt -65.76 -30.03 70.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.402 -178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.7 mt -64.47 -39.83 94.56 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.425 178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.572 ' HB2' ' NH1' ' A' ' 89' ' ' ARG 0.274 0.0 OUTLIER -91.8 -16.63 26.53 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 117.493 -1.683 . . . . 0.0 113.465 -176.238 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 120' ' ' ILE . . . 128.76 -51.12 0.87 Allowed Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 117.786 -2.15 . . . . 0.0 114.914 171.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.528 ' C ' ' H ' ' A' ' 122' ' ' PHE . 62.2 mt 78.3 150.08 0.12 Allowed Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 120' ' ' ILE . 37.8 Cg_endo -76.45 27.0 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.4 2.067 . . . . 0.0 111.428 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.528 ' H ' ' C ' ' A' ' 120' ' ' ILE . 4.7 t80 68.88 -168.32 0.18 Allowed 'General case' 0 N--CA 1.419 -2.003 0 C-N-CA 127.741 2.416 . . . . 0.0 111.223 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.523 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 3.7 mmp_? -143.02 144.62 32.36 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -174.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.9 m -73.25 177.02 5.4 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 124' ' ' THR . 10.5 ptmt -48.83 -49.8 37.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.165 0.893 . . . . 0.0 112.915 -173.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.459 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -83.12 -22.48 33.36 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-O 121.227 0.537 . . . . 0.0 110.589 -173.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 22.7 mt-10 -80.18 -29.7 38.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.641 0.734 . . . . 0.0 109.055 -177.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 45.9 t80 -66.41 -52.28 48.17 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.94 177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.4 pt-20 -67.03 -21.39 65.93 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.153 178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.8 t70 -70.18 -47.06 63.2 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.722 0.809 . . . . 0.0 110.245 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.49 -37.49 64.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.306 177.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.33 -36.43 76.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.527 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.1 pt-20 -68.08 -30.65 69.88 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.629 178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.492 ' O ' HG22 ' A' ' 137' ' ' THR . 5.7 t60 -72.91 -37.45 67.23 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.2 mmt -60.84 -49.6 76.84 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.43 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.527 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.7 ptpt -70.15 -18.3 63.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.6 OUTLIER -64.63 -26.1 68.25 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 177.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.569 ' CE2' HD13 ' A' ' 108' ' ' LEU . 70.1 m-85 -82.85 -54.88 4.76 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 103' ' ' ILE . 80.6 p 53.98 11.46 0.35 Allowed 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.442 1.497 . . . . 0.0 113.869 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.651 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -174.379 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.485 0 CA-C-O 121.399 0.619 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.1 pm0 -90.6 160.86 15.7 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.209 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -99.51 178.96 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.321 0.581 . . . . 0.0 111.155 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 1.3 pm0 -75.59 137.44 40.79 Favored 'General case' 0 N--CA 1.416 -2.149 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.788 177.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -98.33 174.42 6.49 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.358 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -80.23 -54.06 6.09 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.713 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -87.25 148.74 45.51 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.608 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 65.8 Cg_endo -78.9 -179.93 5.91 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 121.515 1.477 . . . . 0.0 114.372 -172.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.53 121.45 35.67 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.885 -173.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.452 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 97.3 mt-30 -77.43 109.56 11.45 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.397 178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 4.8 t -113.82 120.68 64.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.464 ' NE2' ' HB3' ' A' ' 28' ' ' HIS . 60.3 t-80 -98.11 98.21 9.55 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 174.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 t -88.61 134.74 27.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -98.64 115.83 29.53 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.686 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 7.4 mp -94.64 115.52 27.66 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.993 -178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 50.1 mt-10 -100.48 136.47 40.32 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 1.9 mptm? -117.48 99.76 7.2 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.5 t -88.01 117.85 32.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 81.7 m-85 -100.19 169.72 8.95 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.132 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.74 -41.6 98.01 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 123.349 0.406 . . . . 0.0 110.264 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 10.8 t70 -52.48 -44.52 65.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 124.96 1.412 . . . . 0.0 111.821 -177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.74 -20.81 6.77 Favored Glycine 0 C--N 1.293 -1.861 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.91 122.39 15.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.019 -1.09 . . . . 0.0 108.937 173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 38.7 t -118.54 119.65 61.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.4 t -81.22 124.53 29.37 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 178.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -105.62 120.13 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.52 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.7 tp10 -114.02 148.17 37.43 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.702 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.464 ' HB3' ' NE2' ' A' ' 12' ' ' HIS . 40.7 m170 -115.27 107.67 15.57 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -118.87 103.68 9.84 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.441 -169.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 6.8 p80 -105.14 123.33 47.63 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.828 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -133.17 148.84 52.07 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.189 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 45.1 mtmt -101.11 109.93 21.89 Favored 'General case' 0 N--CA 1.41 -2.461 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.3 p -116.04 138.04 47.8 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.51 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.462 -176.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.72 -34.38 64.78 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 4' ' ' GLU . 47.4 t -125.7 116.52 21.78 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 -177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -57.79 -32.27 67.38 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.203 175.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -66.56 -36.46 82.73 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.135 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -71.52 -35.15 70.62 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.033 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 33' ' ' VAL . 83.5 t80 -63.2 -44.12 96.22 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.284 177.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -63.7 -36.44 83.86 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-O 121.423 0.63 . . . . 0.0 109.946 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.35 68.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.352 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.81 -39.55 73.0 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.729 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -105.02 20.5 18.74 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.116 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.89 -28.52 6.73 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.52 -14.71 61.22 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.262 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.686 ' CH2' ' HG ' ' A' ' 15' ' ' LEU . 37.2 m95 -83.13 152.97 25.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 93.7 m -89.71 118.38 29.27 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.23 110.59 10.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.623 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 32.3 t -85.68 -46.82 16.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.637 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.99 167.2 20.76 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -154.06 165.97 34.51 Favored 'General case' 0 C--N 1.272 -2.794 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -149.01 164.83 33.45 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -75.38 98.49 3.88 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.019 -1.073 . . . . 0.0 110.516 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.95 -23.15 5.02 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.708 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 2.6 t80 -141.09 133.63 28.5 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 11' ' ' VAL . 4.0 t -123.47 161.06 26.06 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.081 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD23 ' HG2' ' A' ' 50' ' ' GLU . 16.1 tp -128.63 110.31 12.12 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 123.481 0.713 . . . . 0.0 110.279 172.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 7.3 m-85 -120.2 140.31 51.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.549 1.14 . . . . 0.0 111.188 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.9 ptp180 -120.43 131.88 54.98 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.863 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 12.7 tppt? -121.13 119.5 32.58 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 9.8 pt20 -113.76 154.15 27.85 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.876 -175.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 12.7 ptp -141.93 143.87 33.48 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.773 -171.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -82.37 48.51 1.29 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -172.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -118.89 158.19 26.18 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 173.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' TYR . 8.1 pt -67.58 -44.67 86.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.06 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.469 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 47.0 t 145.71 149.2 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.751 2.02 . . . . 0.0 106.899 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.17 -19.43 50.77 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 121.957 1.771 . . . . 0.0 110.308 174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -82.81 -35.98 25.95 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 19.3 m -64.51 -23.1 67.16 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.368 -0.832 . . . . 0.0 111.506 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -63.5 -31.48 72.65 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 68' ' ' LEU . 1.2 m -95.35 -23.87 4.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.177 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.18 -79.54 0.52 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.778 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.82 32.29 77.41 Favored Glycine 0 CA--C 1.521 0.428 0 O-C-N 123.271 0.357 . . . . 0.0 113.225 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -113.33 111.37 21.89 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 122.197 0.998 . . . . 0.0 109.827 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.514 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 65.8 mt -97.38 132.55 41.78 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.25 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -123.77 112.29 1.82 Allowed Glycine 0 N--CA 1.411 -2.991 0 O-C-N 124.125 0.89 . . . . 0.0 111.725 -175.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 98.4 t -105.97 126.72 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.864 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB2' HG22 ' A' ' 82' ' ' VAL . 20.1 m -100.51 173.86 6.37 Favored 'General case' 0 N--CA 1.411 -2.376 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.906 -176.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -44.05 -37.03 2.79 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 126.927 2.091 . . . . 0.0 116.044 -172.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HB3' HE21 ' A' ' 102' ' ' GLN . 40.4 m-80 -85.89 11.3 11.62 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.71 31.7 48.64 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.992 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 m -76.35 123.48 32.7 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.525 0 C-N-CA 119.165 -1.014 . . . . 0.0 111.196 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.434 ' HA ' HG22 ' A' ' 77' ' ' VAL . 27.3 mm -82.04 36.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 127.105 2.162 . . . . 0.0 112.102 -173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -91.49 169.12 11.03 Favored 'General case' 0 C--N 1.276 -2.625 0 O-C-N 121.465 -0.772 . . . . 0.0 110.653 -167.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -111.22 150.24 29.84 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -133.15 153.64 51.34 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -85.92 109.28 18.63 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.48 -165.31 46.3 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 15.0 mmt180 -59.05 123.89 71.51 Favored Pre-proline 0 C--N 1.321 -0.649 0 C-N-CA 122.849 0.46 . . . . 0.0 110.59 178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 9.0 Cg_endo -67.38 99.22 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.996 2.464 . . . . 0.0 111.374 175.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.57 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 11.8 pt-20 -140.79 173.64 4.72 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -178.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.5 Cg_endo -62.61 -21.05 72.47 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.061 1.841 . . . . 0.0 112.442 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.43 -1.72 54.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.426 0.631 . . . . 0.0 110.369 176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 t -114.95 168.58 9.79 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.2 pt-20 -138.65 148.81 60.08 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 8.3 Cg_exo -70.48 129.35 16.68 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 121.912 1.741 . . . . 0.0 110.147 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.47 ' HB ' HE22 ' A' ' 98' ' ' GLN . 78.4 mt -69.26 -33.71 59.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.092 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.47 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -163.67 -168.15 1.58 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 176.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 23.8 p -147.19 125.82 12.54 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 168.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -83.11 -68.67 0.69 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.461 -0.496 . . . . 0.0 110.642 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -155.93 178.9 9.75 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.666 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 32.2 mt-30 -116.28 145.11 43.41 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 124.347 1.03 . . . . 0.0 110.954 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.656 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.1 pt -136.11 161.13 38.17 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.582 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.1 m-20 -82.49 109.22 16.51 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 111.098 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.627 ' HA ' HD23 ' A' ' 108' ' ' LEU . 11.3 mt -68.97 -31.09 69.7 Favored 'General case' 0 CA--C 1.487 -1.443 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.844 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.6 -23.78 67.22 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.07 175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.582 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -85.29 -24.95 27.49 Favored 'General case' 0 N--CA 1.433 -1.297 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.202 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.627 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.5 mm? -58.3 140.82 52.65 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 170.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -49.52 -41.75 41.9 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.151 0.907 . . . . 0.0 112.623 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 49.4 m 155.94 -61.54 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 128.198 2.599 . . . . 0.0 112.019 170.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -69.85 -30.11 67.52 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 119.68 -0.808 . . . . 0.0 112.033 -173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.42 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 40.7 mmm -53.2 -54.81 30.54 Favored 'General case' 0 C--N 1.319 -0.738 0 O-C-N 123.957 0.785 . . . . 0.0 111.043 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.596 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -67.65 -35.28 78.59 Favored 'General case' 0 C--O 1.203 -1.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.679 -177.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 110' ' ' SER . 95.7 mttt -68.66 -32.62 72.59 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -68.79 -37.39 79.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 113' ' ' GLN . 34.6 mt -72.32 -31.2 65.47 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.595 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.8 mt -59.15 -46.41 88.44 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 123.492 0.717 . . . . 0.0 111.911 177.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -94.29 -5.88 45.73 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 96.33 150.46 26.94 Favored Glycine 0 N--CA 1.412 -2.93 0 C-N-CA 119.974 -1.108 . . . . 0.0 112.41 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.467 HD11 HD23 ' A' ' 116' ' ' LEU . 21.8 mm -88.62 129.84 47.47 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -65.06 -14.64 46.35 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.182 1.921 . . . . 0.0 114.993 -176.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -174.61 143.66 0.81 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.919 0.39 . . . . 0.0 110.567 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -142.47 132.91 25.02 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.584 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.6 m -93.94 171.86 8.59 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 172.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -63.49 -37.08 85.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 120.112 1.324 . . . . 0.0 113.059 -172.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -80.64 -22.43 40.54 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.134 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.584 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 14.7 mt-10 -78.55 -30.42 46.9 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 39.7 t80 -64.84 -54.25 33.92 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.277 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.3 pt-20 -66.54 -22.65 66.16 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.105 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -47.2 57.6 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.603 0.715 . . . . 0.0 110.076 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.59 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -72.53 -37.03 55.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.884 177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.33 -39.63 85.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.6 pt-20 -67.62 -26.03 66.04 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 121.329 0.585 . . . . 0.0 109.833 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.554 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.2 t-160 -78.45 -37.17 44.25 Favored 'General case' 0 C--O 1.205 -1.249 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.59 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -64.14 -45.83 86.77 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 123.589 0.756 . . . . 0.0 110.812 176.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.45 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.9 ptpt -72.44 -17.39 61.79 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.748 0.785 . . . . 0.0 110.91 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.554 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -67.7 -21.15 65.33 Favored 'General case' 0 N--CA 1.397 -3.111 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.407 174.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -94.56 -59.64 1.89 Allowed 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 171.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 65.0 p 50.55 19.6 0.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.969 1.708 . . . . 0.0 113.076 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 1 N--CA 1.381 -5.032 1 N-CA-C 102.899 -4.08 . . . . 0.0 102.899 -176.542 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -156.7 169.26 25.12 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.25 173.51 14.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 mp0 -71.83 122.25 20.41 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -76.37 171.42 14.6 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.589 0.709 . . . . 0.0 109.669 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 9.4 m-85 -102.82 -34.17 9.09 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.03 112.41 62.94 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 104.659 -2.348 . . . . 0.0 104.659 169.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.598 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.9 Cg_endo -68.75 171.58 13.09 Favored 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 121.587 1.525 . . . . 0.0 113.921 -173.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -102.61 111.88 24.38 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.614 -169.713 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.455 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 51.0 mt-30 -73.78 109.13 7.04 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 123.684 0.615 . . . . 0.0 110.374 176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.8 t -114.34 125.21 71.59 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.817 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.239 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -97.76 108.18 20.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.6 m -101.77 131.36 49.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-O 121.592 0.71 . . . . 0.0 111.387 -176.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -102.54 108.8 20.23 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 173.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -93.62 120.36 33.8 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 120.385 -0.526 . . . . 0.0 109.861 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -104.96 146.07 29.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 34.1 mmtp -121.1 110.71 16.55 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 10.8 t -93.06 124.36 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.6 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -171.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.78 159.06 21.04 Favored 'General case' 0 N--CA 1.403 -2.814 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.781 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.8 mp -69.78 -30.04 67.5 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.11 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.707 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 7.0 p-10 -79.98 -7.65 58.92 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 -168.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.69 -4.82 34.63 Favored Glycine 0 CA--C 1.489 -1.585 0 C-N-CA 118.347 -1.883 . . . . 0.0 112.989 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -102.18 160.52 14.44 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.58 123.83 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 C-N-CA 123.635 0.774 . . . . 0.0 109.19 -178.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.3 t -83.78 124.87 31.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mm -111.26 118.08 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.768 -176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.2 tp10 -113.29 147.12 38.22 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -128.95 108.78 10.68 Favored 'General case' 0 CA--C 1.475 -1.915 0 CA-C-O 121.476 0.655 . . . . 0.0 109.399 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.3 mtmt -118.51 159.48 23.44 Favored 'General case' 0 C--N 1.262 -3.206 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.095 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -122.89 122.34 38.37 Favored 'General case' 0 C--N 1.267 -2.998 0 N-CA-C 107.553 -1.276 . . . . 0.0 107.553 168.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -125.52 135.79 52.65 Favored 'General case' 0 N--CA 1.418 -2.064 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.601 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 41.9 mtmt -100.03 104.64 16.24 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 114.964 -1.017 . . . . 0.0 108.9 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.4 p -108.25 139.95 28.59 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.266 -175.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -76.3 -26.16 55.56 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 t -142.47 125.21 15.95 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.651 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -30.61 67.88 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 123.076 0.55 . . . . 0.0 110.001 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -56.88 -43.35 81.2 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.826 -1.079 . . . . 0.0 110.387 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -71.42 -37.94 71.44 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.736 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.469 ' HB2' HG21 ' A' ' 33' ' ' VAL . 61.5 t80 -61.04 -44.55 97.23 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.356 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -65.03 -37.07 86.4 Favored 'General case' 0 C--O 1.199 -1.577 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.395 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.25 -32.55 70.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.194 0.521 . . . . 0.0 110.525 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.65 -42.65 77.65 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.022 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -105.25 14.75 28.51 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.28 -23.16 34.71 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.57 -15.27 68.77 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.886 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.603 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 30.9 m95 -85.29 158.95 20.17 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.489 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 57.7 m -88.79 119.59 29.43 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.37 108.6 9.43 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.627 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 88.0 t -88.11 -45.71 15.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' HG2' HD23 ' A' ' 57' ' ' LEU . 9.2 pt-20 -159.56 157.44 29.86 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -142.54 150.0 39.85 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 170.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 11.4 pttm -143.32 161.73 37.57 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -61.16 98.13 0.07 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.215 0.531 . . . . 0.0 110.994 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 118.69 -21.62 9.65 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.725 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.46 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 3.8 t80 -139.83 134.2 31.4 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 117.285 0.542 . . . . 0.0 111.113 -176.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 95.3 t -126.32 136.39 60.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.627 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.1 tp -113.4 112.87 24.37 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-O 121.236 0.541 . . . . 0.0 110.985 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 13.9 m-85 -119.57 145.57 46.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.217 178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.489 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 11.7 ptp180 -126.97 135.69 51.22 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.382 0.611 . . . . 0.0 110.836 175.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.1 tppt? -120.89 123.47 42.6 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 177.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.645 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.64 154.17 37.16 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.715 -175.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 9.9 mmt -132.75 163.23 29.48 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.477 ' O ' ' HE2' ' A' ' 125' ' ' LYS . 6.6 p-10 -89.01 77.14 7.71 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 123.033 1.397 . . . . 0.0 107.371 168.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -165.29 160.86 18.74 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.682 -1.599 . . . . 0.0 107.097 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 HD12 ' HE ' ' A' ' 123' ' ' ARG . 28.4 pt -100.8 171.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 22.2 p -60.29 137.14 91.74 Favored Pre-proline 0 C--N 1.287 -2.15 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -176.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -58.46 -49.58 11.72 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.684 2.922 . . . . 0.0 113.937 -176.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.9 OUTLIER -68.32 -36.78 79.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.354 0.597 . . . . 0.0 109.471 -176.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.3 m -64.03 -22.54 66.97 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -72.55 -29.58 63.69 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 118.019 0.372 . . . . 0.0 110.678 174.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -74.17 -35.76 41.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -177.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -79.98 -49.49 11.77 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.27 68.6 1.59 Allowed Glycine 0 C--O 1.173 -3.715 0 CA-C-N 114.302 -1.317 . . . . 0.0 114.579 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.607 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 3.9 m-85 -148.61 144.56 27.3 Favored 'General case' 0 C--O 1.246 0.921 0 CA-C-N 118.175 0.987 . . . . 0.0 109.926 -176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.5 HG13 ' HD2' ' A' ' 123' ' ' ARG . 58.8 mt -117.11 141.06 37.18 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.481 ' CA ' ' HB3' ' A' ' 90' ' ' PRO . . . -123.55 98.76 0.6 Allowed Glycine 0 N--CA 1.407 -3.295 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.709 -169.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.812 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.4 t -106.89 126.63 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.625 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.5 m -97.94 168.21 10.43 Favored 'General case' 0 N--CA 1.408 -2.555 0 CA-C-N 115.111 -0.949 . . . . 0.0 108.804 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -50.13 -30.01 10.29 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 126.029 1.732 . . . . 0.0 114.355 -174.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.59 14.67 7.91 Favored 'General case' 0 C--N 1.317 -0.808 0 O-C-N 121.854 -0.529 . . . . 0.0 111.957 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 75.17 32.28 56.25 Favored Glycine 0 CA--C 1.481 -2.072 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.812 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 16.3 t -73.33 110.98 7.35 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.87 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 83' ' ' ILE . 25.1 mm -82.07 37.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 126.121 1.769 . . . . 0.0 112.866 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.515 ' HB3' ' HA ' ' A' ' 99' ' ' SER . 3.1 p -91.67 170.01 10.27 Favored 'General case' 0 C--N 1.256 -3.497 0 O-C-N 121.436 -0.79 . . . . 0.0 110.486 -170.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.8 p -110.3 142.01 42.51 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.423 ' HE1' ' OG ' ' A' ' 84' ' ' SER . 6.6 m-85 -129.26 162.02 28.85 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -97.36 100.75 12.19 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 170.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.46 -167.68 30.19 Favored Glycine 0 C--N 1.299 -1.509 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.458 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.2 mmt85 -47.58 132.06 10.69 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 124.068 0.947 . . . . 0.0 112.766 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.481 ' HB3' ' CA ' ' A' ' 76' ' ' GLY . 16.1 Cg_endo -82.34 92.94 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 123.118 2.545 . . . . 0.0 112.215 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.42 165.71 26.93 Favored Pre-proline 0 C--N 1.286 -2.175 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 31.5 Cg_endo -69.35 -15.36 38.56 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.653 2.235 . . . . 0.0 112.12 -178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -90.41 7.44 38.67 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.893 0.854 . . . . 0.0 109.608 176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -119.22 159.99 23.01 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -101.07 122.6 48.04 Favored Pre-proline 0 C--N 1.296 -1.732 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -173.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -75.44 134.41 17.07 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.403 2.068 . . . . 0.0 110.968 175.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 68.1 mt -75.19 -34.69 32.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.416 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.439 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.24 -174.17 2.21 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 103.818 -2.66 . . . . 0.0 103.818 178.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 84' ' ' SER . 11.8 p -146.69 128.82 15.63 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.837 0.744 . . . . 0.0 109.795 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -83.5 -70.18 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.657 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -135.34 177.61 7.68 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-O 120.954 0.406 . . . . 0.0 109.948 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.514 ' HG2' HG22 ' A' ' 82' ' ' VAL . 19.8 mt-30 -125.29 119.69 29.13 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 168.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.62 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 18.8 pt -121.84 157.31 25.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.593 -173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.7 OUTLIER -73.1 106.51 5.0 Favored 'General case' 0 C--O 1.251 1.166 0 CA-C-O 121.535 0.683 . . . . 0.0 111.181 178.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.603 ' HA ' HD23 ' A' ' 108' ' ' LEU . 15.5 mt -67.32 -30.99 70.96 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.684 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -68.25 -15.53 63.61 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.147 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.5 ptm180 -93.64 -14.71 26.12 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.8 mm? -64.03 152.92 38.94 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.03 133.27 56.18 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.836 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.9 t 72.84 -163.3 0.11 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.056 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 30.2 p80 -63.44 -8.53 9.37 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 125.381 1.472 . . . . 0.0 114.754 -175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 53.3 mmm -43.52 -57.13 3.27 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.721 0.809 . . . . 0.0 112.189 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.573 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.5 OUTLIER -62.43 -38.39 89.53 Favored 'General case' 0 C--O 1.217 -0.653 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.389 -179.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -66.08 -37.43 85.78 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.221 0.608 . . . . 0.0 110.889 -178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -63.46 -35.59 80.94 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-O 121.158 0.504 . . . . 0.0 109.889 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 113' ' ' GLN . 19.2 mt -74.32 -27.94 60.93 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.204 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 57.9 mt -69.24 -33.76 73.76 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.334 0.654 . . . . 0.0 111.597 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 0.7 OUTLIER -80.44 -35.21 35.33 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.114 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.52 143.47 11.8 Favored Glycine 0 N--CA 1.407 -3.251 0 CA-C-N 113.538 -1.664 . . . . 0.0 109.052 -177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.8 mm -74.3 130.5 82.21 Favored Pre-proline 0 C--O 1.183 -2.434 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.14 -7.16 17.08 Favored 'Trans proline' 0 N--CA 1.483 0.882 0 C-N-CA 123.012 2.475 . . . . 0.0 115.369 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -166.03 148.57 7.23 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.5 ' HD2' HG13 ' A' ' 75' ' ' ILE . 3.2 ptm180 -153.27 130.08 10.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.655 0.264 . . . . 0.0 111.272 -176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.567 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.0 m -110.03 173.16 6.45 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 172.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -63.19 -45.17 92.97 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 119.747 1.158 . . . . 0.0 113.387 -174.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 125' ' ' LYS . . . -68.5 -30.48 69.31 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.629 0.728 . . . . 0.0 110.039 -176.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.567 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 12.1 mt-10 -73.64 -38.36 65.04 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.035 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.707 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 46.6 t80 -62.15 -54.43 41.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.919 177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 8.1 pt-20 -67.14 -21.78 65.81 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.085 -176.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.1 t70 -74.76 -47.18 32.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.615 0.721 . . . . 0.0 110.486 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.523 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -70.67 -37.23 68.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.395 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.15 -35.63 75.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.9 pt-20 -67.26 -27.69 67.41 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.331 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.529 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.6 t60 -74.32 -36.82 63.72 Favored 'General case' 0 C--O 1.205 -1.269 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -67.68 -46.81 71.26 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 124.853 1.261 . . . . 0.0 111.284 178.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.45 -18.04 62.34 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 121.738 0.78 . . . . 0.0 110.355 -178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.529 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -65.39 -21.65 66.7 Favored 'General case' 0 N--CA 1.393 -3.294 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.974 175.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 61.7 m-85 -95.36 -62.68 1.26 Allowed 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.26 172.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.522 ' HA ' HG22 ' A' ' 103' ' ' ILE . 73.4 m 51.68 18.55 0.74 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.389 -4.498 0 N-CA-C 104.45 -3.46 . . . . 0.0 104.45 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 120.725 0.298 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 69.67 -172.41 0.18 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.54 176.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.838 -174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.71 137.84 31.96 Favored 'General case' 0 N--CA 1.416 -2.133 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -113.28 176.73 4.9 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.247 0.546 . . . . 0.0 110.156 -174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -94.12 -37.26 11.69 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.79 164.28 24.57 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.804 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 56.2 Cg_endo -75.44 -177.77 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.414 1.41 . . . . 0.0 112.474 176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.645 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -110.5 121.11 44.52 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -171.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -79.42 104.73 10.23 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.433 0.635 . . . . 0.0 111.577 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 4.8 t -105.74 118.85 54.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 178.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -98.11 109.96 22.63 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 10.8 m -104.08 134.0 46.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-O 121.225 0.536 . . . . 0.0 110.537 -177.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -101.8 117.16 34.27 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.487 ' HG ' ' CH2' ' A' ' 46' ' ' TRP . 1.3 mm? -102.12 120.85 41.12 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -102.23 125.92 49.07 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 71.4 mmtt -102.13 106.14 16.96 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 7.5 t -89.33 105.43 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 118.266 -1.374 . . . . 0.0 108.722 -175.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 71.5 m-85 -84.81 149.72 25.53 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.396 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 65' ' ' ILE . 67.4 mt -77.28 -8.23 57.27 Favored 'General case' 0 C--O 1.209 -1.068 0 CA-C-O 122.601 1.191 . . . . 0.0 109.188 177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.517 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 57.0 t0 -68.56 -39.96 80.81 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.18 -1.373 . . . . 0.0 108.406 172.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.28 -6.1 17.14 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -174.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 20.2 t70 -80.11 156.97 26.78 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.237 -0.982 . . . . 0.0 108.517 175.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.8 p -154.19 115.88 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-O 121.63 0.729 . . . . 0.0 109.606 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -88.21 127.42 35.44 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.3 mm -103.89 115.07 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.2 tp10 -113.69 149.99 33.92 Favored 'General case' 0 C--N 1.281 -2.399 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.799 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -127.22 108.46 10.9 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HB2' HG22 ' A' ' 13' ' ' VAL . 52.3 mmtt -108.47 125.65 52.02 Favored 'General case' 0 CA--C 1.475 -1.914 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 27.0 p-80 -113.04 116.98 30.77 Favored 'General case' 0 C--N 1.273 -2.753 0 C-N-CA 117.504 -1.679 . . . . 0.0 108.557 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.55 161.7 19.19 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.043 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.7 mtmt -113.43 119.2 36.79 Favored 'General case' 0 N--CA 1.402 -2.831 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.36 138.04 55.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.265 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.25 -31.43 38.47 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -133.24 115.33 14.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -54.23 -27.57 35.55 Favored 'General case' 0 C--N 1.316 -0.875 0 O-C-N 123.574 0.546 . . . . 0.0 112.183 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.41 -42.99 93.07 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.919 178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -67.88 -34.27 76.33 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 36' ' ' MET . 55.3 t80 -64.69 -46.08 83.89 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.614 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 24.7 m95 -63.68 -38.52 91.42 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.44 -27.7 63.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.653 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.71 -45.21 68.74 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.137 177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.73 17.16 22.9 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.84 -26.17 3.77 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.86 -32.7 35.78 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.925 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.635 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 55.8 m95 -63.61 154.76 31.76 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 117.091 0.445 . . . . 0.0 110.444 176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.2 m -86.18 115.64 23.87 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.34 108.23 7.98 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 80.8 t -86.85 -49.07 15.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.4 pt-20 -163.63 156.69 18.51 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -139.56 141.74 37.2 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 123.326 0.651 . . . . 0.0 109.91 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -145.31 105.72 4.08 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.64 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 0.8 OUTLIER 53.19 -80.65 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 126.156 1.782 . . . . 0.0 113.734 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . -125.88 6.87 7.81 Favored Glycine 0 C--N 1.275 -2.845 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.927 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -116.98 128.92 55.66 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 118.512 1.156 . . . . 0.0 108.142 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 65.8 t -124.53 131.37 72.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.235 0.54 . . . . 0.0 109.544 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.648 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 8.0 tp -107.1 114.23 28.17 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.473 -178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -120.43 158.0 28.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.438 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -136.26 143.27 44.18 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.029 171.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.635 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.6 tppt? -135.07 120.85 19.58 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.683 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.6 pt20 -121.97 142.28 50.46 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.455 -177.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.502 ' SD ' ' HG3' ' A' ' 60' ' ' LYS . 4.6 mpp? -119.33 156.6 29.74 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 123.582 0.551 . . . . 0.0 110.959 -174.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -86.81 70.73 10.37 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 122.175 0.988 . . . . 0.0 110.629 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -166.9 152.01 7.57 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 19' ' ' TYR 0.264 9.4 pt -71.36 -67.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.563 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 84.9 p 167.12 167.85 0.11 Allowed Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 71' ' ' VAL . 2.7 Cg_exo -72.71 -26.95 15.57 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 CA-C-N 120.799 1.321 . . . . 0.0 111.346 175.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -83.26 -31.15 27.11 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.155 -172.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.418 ' O ' ' HA3' ' A' ' 73' ' ' GLY . 11.7 p -68.9 -23.85 64.24 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.619 -0.676 . . . . 0.0 111.562 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 66' ' ' SER . 84.2 mttt -78.29 -21.63 49.43 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.271 176.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -94.16 -44.39 13.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.479 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' OD1' ' HA ' ' A' ' 87' ' ' HIS . 25.4 t-20 -106.15 -79.89 0.56 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . 52.53 89.66 0.01 OUTLIER Glycine 0 C--O 1.201 -1.921 0 O-C-N 124.735 1.272 . . . . 0.0 115.267 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 8.4 m-85 -133.04 118.15 18.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.53 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 76.5 mt -88.97 118.71 34.82 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.163 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.447 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -113.45 112.04 2.81 Favored Glycine 0 N--CA 1.411 -3.011 0 O-C-N 124.29 0.994 . . . . 0.0 112.438 -173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 92.3 t -108.12 130.97 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.037 0 CA-C-N 114.718 -0.741 . . . . 0.0 109.113 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 m -97.83 171.94 7.98 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -48.35 -38.72 19.94 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.548 1.939 . . . . 0.0 113.218 -173.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -87.63 20.56 2.9 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.232 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.49 36.88 77.93 Favored Glycine 0 CA--C 1.472 -2.608 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.909 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 11.4 t -76.7 110.88 12.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.472 ' HA ' HG22 ' A' ' 77' ' ' VAL . 29.3 mm -81.29 37.48 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 127.323 2.249 . . . . 0.0 112.752 -170.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.419 ' OG ' HG12 ' A' ' 82' ' ' VAL . 16.8 m -92.99 168.6 11.03 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.706 -169.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.4 p -112.67 150.32 31.64 Favored 'General case' 0 N--CA 1.414 -2.24 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HA ' ' OD1' ' A' ' 72' ' ' ASN . 47.9 m-70 -115.39 102.0 9.43 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 173.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.98 -174.48 23.33 Favored Glycine 0 N--CA 1.437 -1.277 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -177.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.5 mmt180 -59.64 117.17 20.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 123.019 0.528 . . . . 0.0 110.298 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 36.2 Cg_endo -72.44 110.46 2.98 Favored 'Trans proline' 0 N--CA 1.436 -1.854 0 C-N-CA 122.692 2.261 . . . . 0.0 113.121 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 94' ' ' SER . 10.9 pt-20 -118.71 164.42 20.87 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 172.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -66.66 -17.31 52.53 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 121.722 1.615 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.16 8.3 44.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.643 176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.463 ' HB2' ' HG2' ' A' ' 91' ' ' GLU . 17.8 t -83.78 -174.42 5.27 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -112.37 106.77 55.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 122.214 -0.304 . . . . 0.0 111.53 -176.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -69.96 135.08 29.1 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.254 1.969 . . . . 0.0 110.161 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.453 ' HB ' HE22 ' A' ' 98' ' ' GLN . 52.2 mt -85.06 -33.91 8.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.453 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -168.08 -167.74 0.87 Allowed 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 45.4 m -146.52 112.77 5.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -71.5 -61.01 1.93 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -160.63 174.74 13.54 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 22.5 mt-30 -130.11 139.52 50.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.4 0.68 . . . . 0.0 112.138 176.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.613 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 40.5 pt -138.33 168.4 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.756 0.822 . . . . 0.0 109.293 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.471 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 12.6 m-20 -83.74 110.86 18.66 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.651 -0.656 . . . . 0.0 111.849 178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.618 ' HA ' HD13 ' A' ' 108' ' ' LEU . 7.3 mt -68.56 -30.61 69.43 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -62.21 -24.22 67.1 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.757 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 4.0 ptm180 -90.64 -16.75 28.07 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mp -59.92 154.25 19.2 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 173.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.07 91.21 6.61 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.313 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 29.3 t 32.44 -87.28 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.271 2.229 . . . . 0.0 116.064 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -71.79 -19.82 61.95 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -171.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.457 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 74.2 mmm -53.57 -55.07 28.8 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.171 0.51 . . . . 0.0 110.375 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.615 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -63.95 -43.58 95.42 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.172 179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.9 mmmt -58.22 -35.44 71.68 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.16 0.584 . . . . 0.0 111.188 -178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 118' ' ' LYS . 12.5 m-20 -72.24 -33.58 67.65 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.173 0.511 . . . . 0.0 110.755 179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.532 HD13 HG21 ' A' ' 77' ' ' VAL . 37.0 mt -75.64 -28.23 58.7 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.064 177.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 60.5 mt -66.09 -36.04 82.12 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.249 0.619 . . . . 0.0 110.297 175.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 50.5 mttp -72.35 -34.05 67.72 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.857 0.837 . . . . 0.0 108.776 175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 89.72 130.24 4.04 Favored Glycine 0 N--CA 1.402 -3.604 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 -171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 17.6 mm -68.4 125.03 91.22 Favored Pre-proline 0 C--O 1.19 -2.037 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.74 10.36 3.52 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.868 2.379 . . . . 0.0 114.201 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -168.24 132.61 1.67 Allowed 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.517 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 1.8 ptm180 -153.75 135.7 14.64 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-O 120.849 0.357 . . . . 0.0 110.122 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.554 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 11.1 m -113.86 171.82 7.36 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.474 ' HA ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -53.23 -57.26 11.12 Favored 'General case' 0 N--CA 1.405 -2.707 0 C-N-CA 125.551 1.54 . . . . 0.0 111.46 -175.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -61.68 -28.14 69.19 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.925 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.554 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 6.9 mt-10 -79.97 -31.59 39.85 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -62.64 -52.8 61.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.255 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.44 -24.66 66.48 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.021 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.6 t70 -69.26 -49.27 57.74 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.471 0.653 . . . . 0.0 110.519 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.7 p -71.75 -38.11 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.307 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.06 -37.68 80.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.507 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -67.66 -26.27 66.12 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.089 0.471 . . . . 0.0 109.981 178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -80.2 -36.03 35.45 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 27.0 mmt -61.19 -48.29 82.24 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.543 0.687 . . . . 0.0 110.063 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.507 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -71.09 -18.01 62.56 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.312 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.86 -24.48 66.88 Favored 'General case' 0 CA--C 1.557 1.242 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.76 -56.85 3.29 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.8 p 51.1 22.14 1.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.699 1.6 . . . . 0.0 114.266 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.443 -4.467 0 N-CA-C 106.025 -2.83 . . . . 0.0 106.025 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.559 -0.163 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 66.4 162.33 0.16 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.179 0.991 . . . . 0.0 111.601 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.15 163.36 7.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -104.98 110.02 22.25 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-O 121.164 0.507 . . . . 0.0 110.589 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.341 9.5 p80 -107.49 138.38 43.82 Favored 'General case' 0 CA--C 1.484 -1.579 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.293 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -92.25 -17.42 24.82 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.392 -171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.51 117.34 67.58 Favored Pre-proline 0 N--CA 1.429 -1.479 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.411 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 3.8 Cg_exo -78.2 171.1 17.59 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 121.767 1.645 . . . . 0.0 110.195 176.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -106.57 113.96 27.79 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 92.6 mt-30 -83.37 98.87 9.7 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.442 HG22 HD12 ' A' ' 9' ' ' LEU . 2.4 t -106.49 123.38 61.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.05 -174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.7 m-70 -99.74 106.71 18.65 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 171.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 28.2 m -99.53 138.3 24.35 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-O 121.5 0.667 . . . . 0.0 110.87 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -103.35 113.55 27.14 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 173.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 80.6 mt -101.04 116.12 32.1 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -97.46 146.81 24.86 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 99.4 mttt -131.86 109.64 10.24 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 9.4 t -90.06 103.94 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.301 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -85.08 177.9 7.74 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 95.3 mt -70.4 -46.49 63.9 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -45.19 -42.52 9.28 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.584 1.954 . . . . 0.0 114.587 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.07 -30.18 4.88 Favored Glycine 0 N--CA 1.419 -2.448 0 C-N-CA 119.124 -1.512 . . . . 0.0 111.511 -175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.49 117.22 8.39 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 176.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 40.3 t -98.27 115.89 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.8 t -79.02 113.44 17.14 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 46.9 mm -95.68 110.85 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.629 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 9.7 tp10 -113.24 149.4 33.84 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.187 -177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -122.04 118.57 29.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 26.9 mmmt -125.85 120.71 31.22 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 16.9 p-80 -109.32 113.64 26.63 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.958 176.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -131.37 149.17 52.65 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.794 -0.763 . . . . 0.0 112.32 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.5 mtmm -98.82 121.13 40.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.546 175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG11 ' HB2' ' A' ' 39' ' ' PHE . 5.9 t -108.82 141.38 24.24 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -177.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -92.86 -5.99 49.73 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.873 -0.517 . . . . 0.0 111.24 -176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.551 ' H ' HG12 ' A' ' 33' ' ' VAL . 31.3 t -155.01 121.31 5.27 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 173.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -59.5 -29.91 68.19 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.008 0.367 . . . . 0.0 111.964 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -65.69 -31.55 72.61 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.419 0.628 . . . . 0.0 109.748 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -72.24 -38.58 68.9 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.646 ' HB2' HG11 ' A' ' 33' ' ' VAL . 76.0 t80 -61.36 -46.3 90.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.284 177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.1 m95 -63.58 -38.52 91.46 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.186 -177.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.42 76.63 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.839 177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.67 -41.81 98.13 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.502 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -107.05 15.28 25.44 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.23 -18.1 2.13 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 178.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.23 -19.84 40.81 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.944 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.532 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 34.2 m95 -79.01 158.66 27.87 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 176.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.444 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 39.3 m -89.23 119.22 29.53 Favored 'General case' 0 N--CA 1.411 -2.394 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 176.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.4 tm? -75.32 109.99 9.3 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.647 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 93.8 t -89.63 -48.85 14.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.0 pt-20 -156.62 156.78 34.1 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -142.31 143.45 32.79 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.428 172.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.534 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 9.4 pttm -139.62 168.06 20.67 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.4 tmtp? -75.08 99.38 3.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.057 -173.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.58 -20.22 8.33 Favored Glycine 0 N--CA 1.439 -1.164 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.798 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 7.6 t80 -143.17 130.95 21.44 Favored 'General case' 0 N--CA 1.422 -1.857 0 O-C-N 122.532 -0.393 . . . . 0.0 110.098 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.3 t -127.48 141.13 47.19 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.647 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.2 tp -113.73 116.29 29.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.305 0.574 . . . . 0.0 111.088 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.0 m-85 -121.18 149.66 42.48 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.14 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 10.2 ptp180 -129.62 144.33 51.23 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.903 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 13.8 tppt? -131.64 119.78 21.9 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.58 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -118.07 134.66 54.78 Favored 'General case' 0 C--N 1.284 -2.249 0 C-N-CA 119.736 -0.785 . . . . 0.0 111.528 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 49.4 mtm -129.77 153.89 47.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.245 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -89.44 89.59 7.93 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.943 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -179.72 169.6 1.31 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 pt -93.37 171.41 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -78.98 161.07 69.95 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 -175.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' O ' HG13 ' A' ' 71' ' ' VAL . 9.6 Cg_exo -58.42 -25.22 72.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.31 1.34 . . . . 0.0 110.206 174.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.06 -32.7 67.33 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.549 -178.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.7 m -67.14 -26.47 66.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.202 1.001 . . . . 0.0 109.283 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -82.97 -19.71 36.59 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.893 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 67' ' ' PRO . 3.5 m -95.46 -31.52 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 121.52 0.676 . . . . 0.0 109.53 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -120.65 -75.63 0.59 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.75 -177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.51 47.72 10.0 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 121.566 -0.35 . . . . 0.0 113.943 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 7.8 m-85 -113.25 107.14 15.49 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-O 122.299 1.047 . . . . 0.0 109.332 -173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.1 mt -86.66 121.3 37.46 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.544 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.92 113.27 2.61 Favored Glycine 0 N--CA 1.401 -3.637 0 CA-C-O 122.223 0.902 . . . . 0.0 113.433 -171.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.815 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 71.4 t -110.74 132.48 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.184 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.015 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -97.66 167.17 11.12 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.587 ' HA ' HD12 ' A' ' 105' ' ' LEU . 14.1 t70 -51.34 -33.26 28.69 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.482 1.113 . . . . 0.0 113.11 -174.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -81.46 17.08 1.46 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 0.0 111.636 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA3' ' H ' ' A' ' 103' ' ' ILE . . . 70.95 31.4 66.97 Favored Glycine 0 N--CA 1.428 -1.853 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.373 175.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.815 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 22.6 t -72.52 108.36 3.88 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.259 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -177.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.9 mm -82.48 35.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 C-N-CA 127.495 2.318 . . . . 0.0 112.53 -171.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 98' ' ' GLN . 15.4 m -95.05 151.72 18.94 Favored 'General case' 0 C--N 1.266 -3.059 0 C-N-CA 118.192 -1.403 . . . . 0.0 110.896 -168.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -90.34 148.55 22.78 Favored 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 118.434 -1.306 . . . . 0.0 108.434 174.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -135.74 170.16 16.42 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.501 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -97.0 104.45 16.47 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.24 -159.77 37.59 Favored Glycine 0 C--N 1.301 -1.363 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.245 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 13.9 mmm-85 -50.97 129.62 29.36 Favored Pre-proline 0 C--N 1.323 -0.552 0 C-N-CA 122.798 0.439 . . . . 0.0 112.134 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 Cg_exo -71.04 91.08 0.64 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.968 2.445 . . . . 0.0 111.09 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -140.36 161.59 54.23 Favored Pre-proline 0 C--N 1.29 -2.015 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.82 -16.22 49.43 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.756 2.304 . . . . 0.0 112.627 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.62 -10.05 59.52 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.027 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.1 m -98.93 163.87 12.42 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -94.15 124.74 55.05 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -77.35 125.5 7.78 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 122.012 1.808 . . . . 0.0 109.062 172.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 74.4 mt -75.69 -35.08 30.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.709 -174.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' SER . 0.0 OUTLIER -167.05 -170.99 1.66 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 178.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.2 p -143.19 118.54 10.25 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.65 -69.45 0.7 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -133.92 170.22 15.94 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 122.704 0.402 . . . . 0.0 111.698 -174.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 28.6 mt-30 -129.05 119.59 24.49 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 169.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' O ' ' A' ' 138' ' ' TYR . 28.2 pt -120.51 176.31 3.89 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.602 -172.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -95.77 104.08 15.99 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.679 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.633 ' HA ' HD23 ' A' ' 108' ' ' LEU . 13.8 mt -68.92 -28.57 66.78 Favored 'General case' 0 CA--C 1.488 -1.435 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -62.79 -24.01 67.52 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.796 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -92.82 -16.53 25.22 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.0 mm? -57.01 159.6 4.1 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.295 173.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.7 -74.29 0.06 Allowed 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.305 1.003 . . . . 0.0 109.13 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.4 t -170.24 -75.27 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -70.66 -20.45 62.7 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.7 mmm -58.96 -50.1 75.34 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.954 175.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.662 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.8 OUTLIER -66.24 -34.99 79.26 Favored 'General case' 0 C--O 1.211 -0.962 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.804 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -65.75 -34.62 78.6 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.29 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.478 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 9.0 p30 -68.72 -37.51 79.53 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.483 ' HB3' ' HB ' ' A' ' 77' ' ' VAL . 28.5 mt -71.37 -31.07 66.88 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.411 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.7 mt -62.6 -40.2 96.18 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 122.833 0.453 . . . . 0.0 111.45 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -97.28 -5.15 37.37 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 119.548 -0.861 . . . . 0.0 112.449 179.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.79 151.22 23.29 Favored Glycine 0 N--CA 1.42 -2.373 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.491 176.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.3 mm -93.79 134.24 26.6 Favored Pre-proline 0 C--N 1.281 -2.375 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 63.7 Cg_endo -88.62 8.42 4.0 Favored 'Trans proline' 0 C--N 1.324 -0.714 0 C-N-CA 121.945 1.763 . . . . 0.0 114.539 -176.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -165.28 133.05 3.07 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.539 ' NE ' ' HA ' ' A' ' 123' ' ' ARG . 1.9 tpm_? -153.11 136.73 15.99 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.141 177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.2 m -113.69 176.73 4.9 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.548 ' H ' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -68.84 -37.8 79.4 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -170.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.528 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -79.96 -26.55 39.97 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 121.697 0.76 . . . . 0.0 109.071 -177.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 23.6 mt-10 -73.57 -35.88 65.51 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.114 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -60.64 -55.05 37.99 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.601 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -63.58 -25.43 68.23 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.067 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 15.9 t70 -70.73 -49.49 46.32 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.555 0.693 . . . . 0.0 110.382 178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.61 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -68.1 -32.92 58.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 121.189 0.519 . . . . 0.0 110.05 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.65 -38.7 77.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -66.52 -29.44 69.53 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.751 0.786 . . . . 0.0 110.272 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.642 ' O ' HG22 ' A' ' 137' ' ' THR . 11.8 m80 -64.93 -57.25 9.27 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.201 171.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 29.1 mmt -52.81 -42.31 64.98 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.498 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 18.2 ptpt -67.95 -19.65 64.99 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 134' ' ' HIS . 3.9 t -85.96 -24.64 26.44 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 174.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.558 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 72.6 m-85 -84.55 -2.52 57.48 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.104 177.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 15.9 m -69.06 25.65 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.982 0.913 . . . . 0.0 112.276 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 138' ' ' TYR . . . . . . . . 0 C--N 1.299 -1.518 0 CA-C-O 118.958 -0.912 . . . . 0.0 111.394 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.661 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -84.91 153.42 22.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.484 27.9 m 55.36 115.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -173.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 4' ' ' GLU . 7.8 pt-20 -78.84 112.25 15.8 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.092 -1.867 . . . . 0.0 112.398 -174.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 m170 68.09 -164.87 0.2 Allowed 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.31 1.444 . . . . 0.0 111.261 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -91.7 -3.49 56.21 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.846 0.831 . . . . 0.0 109.339 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -71.76 130.61 86.82 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 113.89 -1.504 . . . . 0.0 107.906 175.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 53.1 Cg_endo -69.91 170.38 16.91 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 121.164 1.243 . . . . 0.0 111.921 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -94.92 115.09 27.02 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -168.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.467 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 88.4 mt-30 -76.41 102.45 5.97 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.27 0.557 . . . . 0.0 109.963 175.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 8.0 t -98.32 125.76 51.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -98.58 108.46 21.16 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.1 m -102.52 128.65 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.573 0 CA-C-O 121.547 0.689 . . . . 0.0 110.426 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -101.28 110.36 22.36 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.2 mm? -94.99 120.02 34.49 Favored 'General case' 0 N--CA 1.409 -2.49 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.971 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -96.97 139.62 32.72 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.2 mttt -122.52 104.12 9.16 Favored 'General case' 0 C--N 1.27 -2.89 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 175.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 m -88.11 123.71 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.689 -168.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 66.4 m-85 -123.49 147.17 47.47 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 2.6 pp -82.86 -8.76 59.55 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.609 -174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 2.6 p-10 -80.81 -3.52 51.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.118 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.63 -35.96 3.98 Favored Glycine 0 N--CA 1.428 -1.857 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.46 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 18.3 t70 -77.99 138.16 38.68 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.735 0.302 . . . . 0.0 110.445 -177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.2 115.55 33.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -82.99 109.34 17.0 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.46 120.08 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.171 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 7.1 tp10 -113.68 146.95 39.03 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -123.89 108.54 12.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' HE2' HD21 ' A' ' 15' ' ' LEU . 46.1 mtmt -118.5 152.41 36.01 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 121.283 0.563 . . . . 0.0 111.255 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.436 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 p-80 -123.86 109.83 14.1 Favored 'General case' 0 C--N 1.263 -3.154 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.19 173.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -126.02 140.69 52.4 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.213 -177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.688 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 43.0 mtmt -98.08 125.52 43.11 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.195 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.6 OUTLIER -123.93 145.51 30.89 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -88.53 -45.35 9.98 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.544 0.687 . . . . 0.0 109.529 176.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 m -110.14 112.86 25.11 Favored 'General case' 1 N--CA 1.377 -4.093 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.39 -32.12 68.31 Favored 'General case' 0 CA--C 1.492 -1.285 0 CA-C-O 121.056 0.455 . . . . 0.0 110.283 177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -60.76 -36.09 78.04 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.586 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -74.41 -35.69 63.43 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 33' ' ' VAL . 44.2 t80 -61.73 -43.12 99.47 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.444 177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -66.81 -37.27 84.21 Favored 'General case' 0 C--O 1.201 -1.472 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.275 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.07 -32.59 69.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.72 -36.43 73.21 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.575 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -110.34 18.16 20.14 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.0 -27.26 61.43 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.58 -24.97 68.86 Favored Glycine 0 N--CA 1.441 -1.022 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.824 179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.546 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 53.6 m95 -77.38 154.26 32.92 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 175.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 92.8 m -88.42 125.87 34.94 Favored 'General case' 0 N--CA 1.41 -2.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 175.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 tp -75.41 127.2 32.59 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.745 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 61.7 t -98.82 -48.96 11.86 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.373 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.1 pt-20 -167.15 143.95 4.5 Favored 'General case' 0 C--O 1.211 -0.948 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 177.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -132.43 139.28 47.96 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.217 0.532 . . . . 0.0 110.94 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -144.09 94.92 2.64 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.666 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 11.1 tmtt? 57.79 -79.21 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.566 0 C-N-CA 126.884 2.074 . . . . 0.0 113.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -114.63 -5.92 20.09 Favored Glycine 0 C--N 1.274 -2.864 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.403 -177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -113.29 128.16 56.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 118.912 1.356 . . . . 0.0 109.369 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 62.4 t -124.92 129.47 73.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.274 0.559 . . . . 0.0 109.968 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.745 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.3 tp -102.59 117.99 35.87 Favored 'General case' 0 C--N 1.289 -2.044 0 C-N-CA 123.596 0.759 . . . . 0.0 109.661 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -120.14 160.49 22.77 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.103 0.961 . . . . 0.0 111.088 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -136.75 137.98 40.45 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 170.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 10.4 tppt? -136.47 128.98 30.38 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -122.14 95.49 4.67 Favored 'General case' 0 C--N 1.271 -2.841 0 CA-C-O 121.679 0.752 . . . . 0.0 109.826 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -88.19 -18.95 27.61 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.239 -0.892 . . . . 0.0 111.161 -174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.19 -173.72 3.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.8 m-20 -102.12 -40.54 6.78 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.5 pt -119.25 157.77 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.244 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.7 p -61.88 141.31 95.43 Favored Pre-proline 0 C--N 1.292 -1.925 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -63.54 -34.72 63.39 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 123.146 2.564 . . . . 0.0 111.926 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -67.78 -32.08 72.41 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 123' ' ' ARG . 72.2 m -67.87 -22.73 65.1 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -80.34 -30.8 38.07 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.863 0.364 . . . . 0.0 110.061 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.3 m -78.14 -40.86 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 121.415 0.626 . . . . 0.0 109.688 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -89.34 -69.25 0.72 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.642 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.95 78.62 0.94 Allowed Glycine 0 C--O 1.219 -0.826 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 173.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.585 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 37.0 m-85 -154.35 133.42 12.44 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 123.911 0.884 . . . . 0.0 110.084 175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 57.9 mt -113.28 130.88 66.43 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 103.906 -2.627 . . . . 0.0 103.906 170.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.537 ' HA3' ' HG3' ' A' ' 90' ' ' PRO . . . -138.05 161.47 25.55 Favored Glycine 0 C--N 1.28 -2.532 0 C-N-CA 118.463 -1.827 . . . . 0.0 114.397 -174.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.809 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 26.8 m -123.06 147.64 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.36 -0.936 . . . . 0.0 111.228 174.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.4 m -89.97 172.22 9.02 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 173.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -47.79 -34.79 9.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -173.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 54.7 m-80 -92.52 18.92 7.85 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 120.722 0.296 . . . . 0.0 111.559 -176.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.69 39.26 40.92 Favored Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.809 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 83.4 t -75.52 116.4 18.33 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.356 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 83' ' ' ILE . 33.7 mm -80.41 38.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 C-N-CA 128.101 2.56 . . . . 0.0 112.534 -169.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.8 t -91.41 151.14 20.94 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-O 122.547 1.165 . . . . 0.0 110.676 -167.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.3 p -89.82 144.85 25.61 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.88 156.61 44.1 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 121.399 0.618 . . . . 0.0 111.427 -175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -108.81 102.17 11.23 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.49 165.85 21.01 Favored Glycine 0 N--CA 1.429 -1.802 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -69.66 119.94 74.2 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.537 ' HG3' ' HA3' ' A' ' 76' ' ' GLY . 18.8 Cg_endo -58.13 98.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 124.797 3.665 . . . . 0.0 115.099 -173.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 16.4 pt-20 -138.47 168.05 17.37 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 172.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.2 Cg_endo -63.76 -18.35 63.69 Favored 'Trans proline' 0 N--CA 1.48 0.719 0 C-N-CA 122.53 2.153 . . . . 0.0 113.335 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.19 -8.69 59.21 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.358 0.599 . . . . 0.0 109.805 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.5 m -103.97 167.27 9.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 11.9 pt-20 -118.73 142.36 31.57 Favored Pre-proline 0 C--N 1.305 -1.342 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.482 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 9.5 Cg_exo -73.1 152.68 51.27 Favored 'Trans proline' 0 C--O 1.248 1.011 0 C-N-CA 122.569 2.179 . . . . 0.0 109.654 174.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.412 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 80.3 mt -89.53 -46.48 15.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.287 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -144.91 -165.1 2.07 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.0 t -146.89 113.54 6.03 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 119.159 0.891 . . . . 0.0 109.617 170.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.46 -75.82 0.21 Allowed 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.742 176.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 50.0 m-85 -128.09 164.13 23.1 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.349 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.5 tt0 -123.24 119.18 29.4 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 170.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.612 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 21.3 pt -130.15 155.54 41.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.225 0.536 . . . . 0.0 110.887 -172.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 22.7 m-20 -72.34 112.19 8.19 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.696 0.76 . . . . 0.0 112.529 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.714 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.6 mt -72.08 -26.8 62.31 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.788 178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -70.85 -20.19 62.56 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.886 175.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.646 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.9 ptm180 -87.84 -14.66 38.9 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.9 mm? -60.23 165.61 3.4 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.646 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -69.98 -64.51 0.87 Allowed 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -174.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.609 ' H ' ' CD ' ' A' ' 109' ' ' GLU . 46.6 m -167.68 -78.84 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.802 0 C-N-CA 124.942 1.297 . . . . 0.0 108.928 -178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.31 -25.98 36.01 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 115.627 1.714 . . . . 0.0 115.627 -169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 65.0 mtp -57.84 -45.64 85.94 Favored 'General case' 0 CA--C 1.494 -1.207 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.553 -175.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -59.64 -44.18 93.6 Favored 'General case' 0 N--CA 1.436 -1.145 0 O-C-N 123.573 0.546 . . . . 0.0 112.345 -179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 117' ' ' LEU . 12.3 mptt -57.91 -35.99 71.82 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.24 -32.63 70.57 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 75.7 mt -71.28 -31.41 67.45 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.771 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 75.1 mt -63.25 -43.35 98.25 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.118 0.567 . . . . 0.0 112.244 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -94.9 -14.8 24.18 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 117.794 -1.562 . . . . 0.0 111.484 178.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 110.19 138.18 7.87 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.576 174.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 16.0 mm -78.36 114.49 43.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 175.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.32 -9.34 20.29 Favored 'Trans proline' 0 C--N 1.33 -0.405 0 C-N-CA 123.471 2.781 . . . . 0.0 113.635 -172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -121.91 118.51 29.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.755 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 69' ' ' SER . 83.7 mtp180 -133.43 138.58 46.29 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 121.563 0.697 . . . . 0.0 111.527 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.454 HG22 ' H ' ' A' ' 125' ' ' LYS . 8.6 m -154.1 174.97 14.0 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 102.2 -3.259 . . . . 0.0 102.2 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.454 ' H ' HG22 ' A' ' 124' ' ' THR . 16.4 ptmt -66.33 -44.79 82.37 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 121.142 1.792 . . . . 0.0 113.538 -171.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.469 ' HA ' ' HG2' ' A' ' 129' ' ' GLU . . . -76.08 -31.49 58.77 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-O 122.116 0.96 . . . . 0.0 108.956 -173.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' CG ' ' HB ' ' A' ' 124' ' ' THR . 10.6 mm-40 -67.94 -39.63 83.42 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.516 -1.675 . . . . 0.0 108.507 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 21.0 t80 -69.61 -50.73 41.59 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.339 177.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 126' ' ' ALA . 11.6 pt-20 -69.05 -26.1 64.8 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.606 -174.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.72 -46.81 71.1 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.27 0.557 . . . . 0.0 110.231 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.1 p -67.16 -39.07 82.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.013 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.4 -38.96 81.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 13.3 pt-20 -70.63 -20.51 62.73 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.278 0.561 . . . . 0.0 110.722 178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 17.1 t60 -81.81 -47.54 12.72 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.5 mmt -56.32 -38.18 70.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.071 0.548 . . . . 0.0 111.417 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.7 ptpt -68.28 -18.72 64.6 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 1.7 t -77.06 -16.57 59.2 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.233 -0.987 . . . . 0.0 108.875 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 108' ' ' LEU . 13.0 m-85 -82.4 -59.34 2.57 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 174.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 60.8 p 51.46 15.9 0.38 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.842 1.657 . . . . 0.0 114.982 175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 CA--C 1.447 -4.172 0 N-CA-C 105.051 -3.22 . . . . 0.0 105.051 -177.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.843 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -76.27 139.83 41.29 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.16 172.85 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.24 150.13 24.59 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -129.97 -169.33 2.11 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -24.2 60.65 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.3 145.06 63.46 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-N 114.097 -1.41 . . . . 0.0 108.459 175.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.589 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 43.6 Cg_endo -69.75 166.34 27.93 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 121.772 1.648 . . . . 0.0 113.034 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -123.27 118.7 28.16 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.51 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.4 mt-30 -80.87 107.7 13.91 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.419 0.628 . . . . 0.0 110.134 176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 5.6 t -105.5 129.51 58.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.608 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -100.33 109.87 22.07 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 23.3 m -106.1 136.7 39.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-O 121.276 0.56 . . . . 0.0 110.78 -177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.48 116.4 32.04 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.644 HD11 ' HE2' ' A' ' 29' ' ' LYS . 83.8 mt -105.65 110.39 22.69 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 36.6 mt-10 -94.35 150.06 20.64 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.58 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.597 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.9 mmtp -128.7 105.03 7.99 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.581 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 11.7 t -91.1 127.5 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -175.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -103.04 165.69 10.88 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.97 -41.06 99.43 Favored 'General case' 0 CA--C 1.493 -1.213 0 O-C-N 123.308 0.38 . . . . 0.0 110.074 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.516 ' HA ' ' CE2' ' A' ' 128' ' ' PHE . 8.5 p-10 -69.69 -6.23 30.26 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.727 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.41 -12.1 56.86 Favored Glycine 0 CA--C 1.482 -2.006 0 C-N-CA 119.714 -1.232 . . . . 0.0 113.602 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' HA ' HG21 ' A' ' 97' ' ' ILE . 35.3 t70 -72.25 136.72 46.41 Favored 'General case' 0 CA--C 1.497 -1.075 0 C-N-CA 119.876 -0.729 . . . . 0.0 109.78 177.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 17.5 t -126.6 115.83 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.92 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 17' ' ' LYS . 32.1 t -80.53 129.79 34.73 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.8 mm -108.05 119.77 58.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 6.9 tp10 -113.47 148.38 36.07 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -123.96 117.62 25.18 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.644 ' HE2' HD11 ' A' ' 15' ' ' LEU . 40.1 mtmt -128.01 148.95 50.55 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.319 177.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 32.9 p-80 -123.44 117.76 25.9 Favored 'General case' 0 C--N 1.278 -2.501 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.434 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -133.87 147.96 51.21 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.037 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 29.9 mtmm -95.15 118.98 32.88 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.599 175.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' CD2' ' A' ' 39' ' ' PHE . 0.8 OUTLIER -106.84 146.38 13.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.0 -34.86 15.83 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.69 0.757 . . . . 0.0 109.172 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.1 t -128.47 122.22 30.73 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 106.908 -1.515 . . . . 0.0 106.908 176.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 50.4 mmm -65.61 -27.85 68.7 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.027 0.441 . . . . 0.0 110.215 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -66.79 -30.61 70.85 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.505 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.52 -34.71 60.82 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.338 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.492 ' CD2' HG11 ' A' ' 33' ' ' VAL . 53.8 t80 -62.58 -45.15 94.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.899 176.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.0 m95 -63.76 -38.01 89.5 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.678 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.32 -37.76 83.83 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.088 0.47 . . . . 0.0 109.894 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.5 -36.77 84.88 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.765 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -110.58 19.35 18.79 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 122.175 -0.328 . . . . 0.0 111.131 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 86.23 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.182 0 CA-C-O 122.428 1.109 . . . . 0.0 110.218 173.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.79 -39.55 0.5 Allowed Glycine 0 C--N 1.255 -3.961 0 CA-C-N 113.606 -1.633 . . . . 0.0 109.242 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.503 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 47.9 m95 -61.54 144.27 54.6 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 173.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.448 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 36.9 m -78.16 115.13 17.66 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.15 108.87 6.28 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.656 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 60.8 t -85.42 -46.55 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.635 ' HG2' HD23 ' A' ' 57' ' ' LEU . 13.8 pt-20 -165.56 161.79 18.69 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.371 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.94 145.93 35.08 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.758 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -146.28 92.91 2.24 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.85 177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.43 -79.59 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 126.908 2.083 . . . . 0.0 115.175 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -107.94 -7.39 31.28 Favored Glycine 0 C--N 1.277 -2.713 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.19 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -115.62 131.76 56.84 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 118.103 0.951 . . . . 0.0 108.507 177.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.6 t -128.25 135.76 61.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.0 tp -112.13 114.33 27.1 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.044 0.45 . . . . 0.0 110.684 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.7 m-85 -122.08 149.19 43.91 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.952 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 12.4 ptp180 -129.66 144.14 51.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.266 172.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 15.2 tppt? -132.69 120.19 21.37 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.581 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -121.64 100.41 7.0 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.051 0.929 . . . . 0.0 111.435 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.42 79.65 1.34 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.504 -1.226 . . . . 0.0 113.129 -177.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.98 177.93 1.55 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -94.44 -101.49 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.474 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.81 152.36 8.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.4 p -63.14 153.94 79.53 Favored Pre-proline 0 C--N 1.281 -2.397 0 C-N-CA 124.964 1.306 . . . . 0.0 111.168 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -61.76 -28.94 82.49 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 121.42 1.414 . . . . 0.0 110.252 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.52 -35.1 77.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.458 -177.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.2 p -57.89 -31.92 67.22 Favored 'General case' 0 CA--C 1.549 0.914 0 O-C-N 121.911 -0.493 . . . . 0.0 111.641 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -79.19 -7.3 58.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.2 m -94.47 -37.41 7.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 C-N-CA 119.658 -0.817 . . . . 0.0 109.867 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -168.78 37.57 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.258 0.552 . . . . 0.0 111.858 -175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.63 135.81 27.2 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.169 -0.468 . . . . 0.0 112.564 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -151.6 116.7 5.25 Favored 'General case' 0 CA--C 1.48 -1.735 0 C-N-CA 125.433 1.493 . . . . 0.0 107.012 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.502 ' HB ' ' CG1' ' A' ' 120' ' ' ILE . 97.1 mt -77.22 121.63 30.09 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.096 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 172.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 116' ' ' LEU . . . -127.8 132.43 7.44 Favored Glycine 0 N--CA 1.415 -2.703 0 C-N-CA 120.244 -0.979 . . . . 0.0 113.482 -175.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 20.0 m -106.68 147.3 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.934 0 C-N-CA 118.331 -1.348 . . . . 0.0 111.146 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.6 m -91.27 170.07 10.29 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.19 -26.77 3.09 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -173.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -98.3 20.46 12.52 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.898 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.633 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 72.61 36.53 58.49 Favored Glycine 0 CA--C 1.497 -1.059 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.952 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.757 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 53.8 t -75.03 118.54 21.06 Favored 'Isoleucine or valine' 0 C--O 1.191 -2.005 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.553 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 38.9 mm -80.72 39.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 127.921 2.489 . . . . 0.0 113.06 -168.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -92.2 165.32 13.19 Favored 'General case' 0 C--N 1.283 -2.325 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.905 -170.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.5 p -112.31 144.98 40.83 Favored 'General case' 0 C--N 1.273 -2.721 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -128.44 153.4 47.15 Favored 'General case' 0 N--CA 1.408 -2.545 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.452 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -91.2 103.38 16.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.73 -176.05 33.24 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -174.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -56.46 125.52 66.56 Favored Pre-proline 0 C--N 1.317 -0.826 0 CA-C-N 116.875 0.338 . . . . 0.0 110.942 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -68.65 106.5 1.47 Allowed 'Trans proline' 0 N--CA 1.437 -1.835 0 C-N-CA 122.33 2.02 . . . . 0.0 111.701 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -130.28 160.14 67.11 Favored Pre-proline 0 C--N 1.29 -2.008 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.4 -16.33 47.52 Favored 'Trans proline' 0 N--CA 1.475 0.434 0 C-N-CA 122.658 2.238 . . . . 0.0 112.493 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.25 -6.9 59.46 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.391 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.5 t -91.7 -179.8 5.43 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 12.3 pt-20 -128.47 141.93 43.09 Favored Pre-proline 0 C--N 1.297 -1.682 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.3 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 95' ' ' GLU . 2.3 Cg_endo -76.55 132.06 13.09 Favored 'Trans proline' 0 N--CA 1.439 -1.697 0 C-N-CA 122.014 1.809 . . . . 0.0 110.407 178.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 23' ' ' ASP . 64.7 mt -82.06 -34.03 12.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.608 -176.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.85 3.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.9 m -145.38 112.2 5.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 118.75 0.704 . . . . 0.0 110.052 170.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -77.32 -62.32 1.7 Allowed 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.095 177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.553 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 58.6 m-85 -145.89 -178.76 6.28 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.103 0.478 . . . . 0.0 110.001 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -132.02 120.0 21.82 Favored 'General case' 0 N--CA 1.392 -3.334 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 171.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.633 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 13.8 pt -128.12 157.18 40.44 Favored 'Isoleucine or valine' 0 C--O 1.253 1.263 0 CA-C-O 120.799 0.333 . . . . 0.0 110.915 -173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.29 113.17 18.27 Favored 'General case' 0 C--O 1.252 1.231 0 CA-C-O 121.35 0.595 . . . . 0.0 110.258 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.4 mt -67.8 -28.97 68.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.305 0.574 . . . . 0.0 111.163 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 9.1 pt-20 -75.12 -10.49 59.52 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.806 177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 140' ' ' GLY . 1.3 ttm180 -93.43 -20.86 19.91 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.622 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.3 mm? -57.59 166.4 1.33 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.248 167.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 109' ' ' GLU 0.275 0.0 OUTLIER -66.68 -69.23 0.32 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -178.628 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 p -158.41 -83.26 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 118.081 0.401 . . . . 0.0 111.452 176.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -80.55 -13.47 59.04 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -175.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.437 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.5 mmm -53.98 -51.8 62.73 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.51 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.537 ' HB2' HD13 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -61.27 -35.4 77.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.285 -179.061 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -72.89 -27.27 61.8 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -72.35 -32.15 66.24 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.8 mt -69.74 -36.04 75.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.95 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 84.3 mt -61.05 -46.1 92.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.371 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -85.96 -19.85 29.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.219 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 109.2 131.27 6.24 Favored Glycine 0 N--CA 1.403 -3.547 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.502 ' CG1' ' HB ' ' A' ' 75' ' ' ILE . 23.8 mm -68.83 126.18 92.53 Favored Pre-proline 0 C--N 1.295 -1.771 0 O-C-N 123.616 0.245 . . . . 0.0 110.618 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.6 40.22 0.4 Allowed 'Trans proline' 0 N--CA 1.49 1.301 0 C-N-CA 124.255 3.303 . . . . 0.0 113.73 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.434 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 93.9 t80 77.32 137.75 0.06 Allowed 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 126.302 1.841 . . . . 0.0 114.242 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 75.5 mtt180 -142.45 149.3 39.07 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.219 176.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 125' ' ' LYS . 15.1 m -78.75 177.68 8.48 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -57.38 -40.52 78.33 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -170.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.586 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -82.42 -29.27 30.84 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-O 121.674 0.749 . . . . 0.0 109.411 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 21.9 mt-10 -73.96 -31.27 62.94 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.922 -178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 21' ' ' ASP . 25.2 t80 -68.33 -51.98 38.53 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.991 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 10.7 pt-20 -65.99 -20.81 66.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.359 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 9.6 t70 -66.53 -47.62 72.35 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.826 0.822 . . . . 0.0 109.356 175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.573 ' O ' ' HG2' ' A' ' 135' ' ' MET . 6.9 p -71.85 -37.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.14 178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.72 -36.17 76.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.7 pt-20 -68.36 -30.23 69.13 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.519 0.676 . . . . 0.0 109.937 177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.481 ' O ' HG22 ' A' ' 137' ' ' THR . 30.3 t60 -72.36 -39.22 68.26 Favored 'General case' 0 C--O 1.198 -1.633 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 20.3 mmt -60.83 -44.35 97.06 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.892 0.377 . . . . 0.0 110.739 176.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -71.79 -18.84 62.08 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' HIS . 0.5 OUTLIER -67.1 -20.94 65.87 Favored 'General case' 0 CA--C 1.556 1.195 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 108' ' ' LEU . 55.4 m-85 -96.32 -66.62 0.89 Allowed 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.593 ' HA ' HG22 ' A' ' 103' ' ' ILE . 67.1 m 51.14 25.91 2.61 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.972 0.909 . . . . 0.0 112.353 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.547 ' O ' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 N--CA 1.399 -3.777 0 N-CA-C 104.148 -3.581 . . . . 0.0 104.148 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -142.58 150.25 40.09 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 4' ' ' GLU . 3.8 t -88.83 178.27 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' H ' HG12 ' A' ' 3' ' ' VAL . 9.6 pt-20 -70.16 146.69 50.62 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.448 . . . . 0.0 110.126 176.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -111.32 -177.01 3.09 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -73.26 -42.76 62.14 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.569 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -97.03 137.62 21.27 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.722 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 96.3 Cg_endo -82.24 -167.99 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.712 0 C-N-CA 122.043 1.828 . . . . 0.0 113.029 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -133.19 117.53 17.55 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 -177.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.541 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 78.0 mt-30 -79.17 105.35 10.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.271 0.558 . . . . 0.0 110.584 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.4 t -109.01 128.06 65.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.406 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' LYS . 55.6 m80 -98.93 102.3 13.98 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.2 p -98.7 116.46 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-O 121.91 0.862 . . . . 0.0 110.228 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -90.86 119.38 31.02 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.084 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 1.4 mm? -98.2 130.67 44.93 Favored 'General case' 0 N--CA 1.418 -2.057 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.6 mt-10 -110.89 136.39 50.0 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 175.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.1 mttt -121.53 113.74 20.23 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 61' ' ' GLN . 22.0 t -88.76 110.29 21.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -175.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -98.51 177.84 5.21 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.751 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 pp -92.04 -16.06 26.99 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.174 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -61.83 -39.2 90.97 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.322 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.27 -16.66 6.3 Favored Glycine 0 CA--C 1.463 -3.193 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.678 ' OD2' ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -85.78 172.42 10.81 Favored 'General case' 0 N--CA 1.404 -2.745 0 CA-C-O 122.555 1.169 . . . . 0.0 110.253 178.194 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.4 p -154.52 115.57 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.394 -3.265 0 CA-C-N 112.957 -1.929 . . . . 0.0 106.65 177.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.9 t -77.47 111.3 13.04 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 49.9 mm -91.65 119.67 39.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.533 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 17.0 tt0 -113.86 138.93 49.63 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.104 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 30.1 m170 -109.34 118.56 37.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 12' ' ' HIS . 18.9 mmmt -122.96 139.16 54.36 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 122.836 0.454 . . . . 0.0 110.101 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -121.13 113.22 19.71 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -130.34 137.85 50.12 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.673 -0.811 . . . . 0.0 112.371 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 40.5 mtmt -95.02 113.25 24.93 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.764 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.1 p -119.43 136.7 55.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.093 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 48.2 m-85 -76.32 -22.97 54.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 4' ' ' GLU . 47.5 t -145.24 123.97 12.59 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.48 -31.21 63.81 Favored 'General case' 0 C--O 1.214 -0.781 0 O-C-N 123.354 0.409 . . . . 0.0 111.174 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.53 -36.68 83.35 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.603 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -71.86 -31.81 66.86 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.319 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.493 ' HB2' HG21 ' A' ' 33' ' ' VAL . 46.6 t80 -70.39 -41.57 72.86 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.586 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -63.44 -38.25 90.42 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-O 120.782 0.325 . . . . 0.0 110.275 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.75 -33.46 72.48 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.319 178.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.61 87.86 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.887 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -110.73 17.56 20.51 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.02 -29.14 8.1 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -25.11 57.3 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.18 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.617 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 36.5 m95 -73.74 157.86 35.71 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.464 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 44.2 m -88.52 119.16 28.71 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.49 111.45 10.79 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.617 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 63.7 t -87.6 -46.58 16.0 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.615 ' HG2' HD23 ' A' ' 57' ' ' LEU . 8.4 pt-20 -159.26 160.93 35.83 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 175.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -146.44 139.92 25.9 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.285 172.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -146.43 93.83 2.36 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.212 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? 43.47 -81.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 127.653 2.381 . . . . 0.0 115.326 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.01 -15.98 60.18 Favored Glycine 0 C--N 1.281 -2.476 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.259 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -125.75 136.66 53.4 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 117.891 0.846 . . . . 0.0 110.568 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 68.9 t -129.97 136.35 59.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.617 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 20.4 tp -112.64 116.21 29.82 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.838 0.455 . . . . 0.0 111.131 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 9.6 m-85 -122.26 147.08 46.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.275 1.03 . . . . 0.0 111.24 178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.464 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 13.2 ptp180 -126.86 143.78 51.17 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.19 0.519 . . . . 0.0 111.743 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -137.68 123.48 20.0 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 177.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' CB ' ' HB ' ' A' ' 18' ' ' VAL . 8.2 pt20 -119.28 138.8 52.76 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 113.356 0.872 . . . . 0.0 113.356 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -127.89 157.37 40.71 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 114.179 -1.373 . . . . 0.0 108.135 -177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -89.79 91.3 8.57 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.128 0.489 . . . . 0.0 110.692 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -168.23 -172.19 1.69 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.4 pt -115.04 172.33 4.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 174.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.678 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 23.0 p -62.5 154.79 71.36 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.527 ' O ' HG13 ' A' ' 71' ' ' VAL . 11.6 Cg_endo -58.42 -22.81 60.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.609 2.206 . . . . 0.0 110.918 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -87.17 -39.65 15.3 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 t -62.81 -24.19 67.63 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 122.14 0.972 . . . . 0.0 109.956 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -88.77 -1.73 58.23 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 121.613 -0.679 . . . . 0.0 112.702 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG13 ' O ' ' A' ' 67' ' ' PRO . 4.0 m -104.39 -42.7 7.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 171.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -153.25 73.23 0.97 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.705 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.6 102.3 1.62 Allowed Glycine 0 CA--C 1.489 -1.555 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 176.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HA ' ' A' ' 121' ' ' PRO . 16.8 m-85 -111.01 106.74 15.92 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-O 122.259 1.028 . . . . 0.0 108.749 -174.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 72.0 mt -87.46 119.94 35.89 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.733 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -111.1 107.7 2.24 Favored Glycine 0 N--CA 1.414 -2.818 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.51 -174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 85.5 t -106.79 125.54 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.078 0 CA-C-O 121.666 0.746 . . . . 0.0 109.12 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -92.53 169.44 10.53 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.466 -175.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -46.9 -39.62 12.56 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.48 ' O ' ' HG2' ' A' ' 102' ' ' GLN . 51.7 m-80 -80.38 9.45 5.84 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.667 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 77.91 36.71 31.49 Favored Glycine 0 CA--C 1.476 -2.392 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.802 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 27.4 t -75.87 112.82 14.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.2 mm -81.47 38.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 127.423 2.289 . . . . 0.0 112.699 -172.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -92.0 140.67 29.43 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.402 -0.811 . . . . 0.0 111.68 -168.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.8 p -90.54 151.26 21.41 Favored 'General case' 0 C--O 1.263 1.811 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.503 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -136.81 168.04 20.3 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -111.06 101.99 10.48 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 173.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.25 176.37 37.58 Favored Glycine 0 N--CA 1.43 -1.709 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 9.7 mmm180 -45.73 124.48 6.32 Favored Pre-proline 0 C--O 1.243 0.724 0 C-N-CA 124.38 1.072 . . . . 0.0 113.015 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.56 117.96 3.12 Favored 'Trans proline' 0 N--CA 1.436 -1.857 0 C-N-CA 122.347 2.031 . . . . 0.0 111.941 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.9 pt-20 -140.54 170.58 9.28 Favored Pre-proline 0 C--N 1.277 -2.546 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 18.4 Cg_endo -65.98 -22.69 55.08 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 CA-C-N 121.23 1.475 . . . . 0.0 112.25 179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.53 -2.55 57.51 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.235 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.2 p -94.69 156.49 16.38 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 119.154 -1.019 . . . . 0.0 109.261 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -97.76 116.41 65.75 Favored Pre-proline 0 C--N 1.302 -1.486 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -67.52 134.71 33.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.565 2.177 . . . . 0.0 110.402 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 23' ' ' ASP . 90.3 mt -76.84 -47.5 27.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.536 -178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.09 -168.2 2.8 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.6 m -146.49 126.82 13.96 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -92.56 -82.27 0.33 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.948 0.404 . . . . 0.0 110.676 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.431 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 54.9 m-85 -109.5 167.52 10.07 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.374 -178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 29.2 tt0 -129.72 120.06 24.5 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.667 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 23.4 pt -134.04 157.35 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 120.941 0.401 . . . . 0.0 110.725 -172.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 2.9 m-20 -74.99 107.33 6.99 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.417 -0.802 . . . . 0.0 112.77 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 113' ' ' GLN . 13.4 mt -70.89 -26.74 63.37 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.741 -0.383 . . . . 0.0 110.759 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.1 ptm180 -87.81 -14.72 38.83 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.881 HD23 ' HG3' ' A' ' 112' ' ' MET . 4.6 mp -63.13 163.3 10.3 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.311 170.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -63.79 -75.61 0.08 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.479 -177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 7.9 p -163.9 -76.81 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.171 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -80.27 -23.26 40.9 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -171.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.881 ' HG3' HD23 ' A' ' 108' ' ' LEU . 17.3 ptm -58.99 -43.89 91.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 119.779 -0.768 . . . . 0.0 112.285 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.796 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -63.27 -38.49 91.38 Favored 'General case' 0 C--O 1.202 -1.425 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.374 174.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -64.91 -29.38 70.32 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.002 -177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.433 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 95.4 m-20 -69.65 -38.55 77.17 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-O 121.461 0.648 . . . . 0.0 110.265 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 112' ' ' MET . 27.7 mt -70.56 -28.73 65.13 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.602 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 76.5 mt -64.52 -49.42 71.37 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.914 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -82.88 -19.15 37.98 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.179 -178.057 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.22 130.55 6.67 Favored Glycine 0 N--CA 1.407 -3.257 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.4 mm -70.88 131.33 87.57 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 74' ' ' TYR . 50.9 Cg_endo -69.02 -17.22 41.03 Favored 'Trans proline' 0 C--O 1.247 0.96 0 C-N-CA 122.292 1.995 . . . . 0.0 115.149 -174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -164.26 149.15 10.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -173.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -146.52 163.43 35.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.9 m -136.97 169.41 17.83 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 103.963 -2.606 . . . . 0.0 103.963 172.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.65 -42.84 97.8 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -170.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.47 -21.0 42.46 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.881 0.848 . . . . 0.0 109.673 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 131' ' ' VAL . 24.0 mt-10 -81.91 -28.73 32.68 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.906 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -65.21 -53.05 50.4 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -65.93 -26.57 67.66 Favored 'General case' 0 C--O 1.198 -1.628 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.346 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -66.34 -43.67 85.43 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.676 0.751 . . . . 0.0 110.901 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 127' ' ' GLU . 5.9 p -77.8 -37.33 23.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.218 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.72 -34.29 69.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.4 pt-20 -69.1 -25.12 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.202 0.525 . . . . 0.0 109.824 177.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.606 ' O ' HG22 ' A' ' 137' ' ' THR . 1.8 t60 -83.8 -22.39 31.84 Favored 'General case' 0 C--O 1.192 -1.965 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 22.2 mmt -74.35 -46.87 37.93 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.61 0.719 . . . . 0.0 109.682 175.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.3 ptpt -67.48 -19.0 65.28 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -176.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.606 HG22 ' O ' ' A' ' 134' ' ' HIS . 11.0 t -68.35 -23.37 64.68 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -86.02 -56.6 3.39 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.447 ' HA ' HG22 ' A' ' 103' ' ' ILE . 51.4 p 51.4 20.83 1.05 Allowed 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.409 ' OXT' ' HD2' ' A' ' 107' ' ' ARG . . . . . . . . 0 CA--C 1.455 -3.702 0 N-CA-C 106.528 -2.629 . . . . 0.0 106.528 178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.82 153.2 31.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.628 HG12 ' H ' ' A' ' 4' ' ' GLU . 12.9 t 69.71 -179.21 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.252 1.226 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -173.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.628 ' H ' HG12 ' A' ' 3' ' ' VAL . 8.6 pt-20 -88.5 103.6 16.03 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.3 0.572 . . . . 0.0 110.472 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -87.8 -174.95 4.96 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.764 0.792 . . . . 0.0 110.534 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -92.91 -8.69 42.57 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.799 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -76.23 152.12 83.86 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.619 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 91.4 Cg_endo -79.67 178.22 7.57 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 C-N-CA 122.061 1.84 . . . . 0.0 113.992 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -121.21 116.24 24.54 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 114.101 -1.409 . . . . 0.0 108.255 -172.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.22 112.09 10.03 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 175.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG11 ' CZ ' ' A' ' 39' ' ' PHE . 11.8 t -115.67 123.1 70.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.506 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -98.61 98.53 9.67 Favored 'General case' 0 C--N 1.288 -2.065 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 170.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.683 HG13 ' HB2' ' A' ' 29' ' ' LYS . 6.7 p -99.79 121.28 50.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.361 0 CA-C-O 121.705 0.765 . . . . 0.0 110.317 -176.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.6 OUTLIER -98.42 127.27 44.28 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 2.2 mm? -116.03 125.02 51.89 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.793 -176.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -101.48 121.35 41.79 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 120.925 0.393 . . . . 0.0 110.235 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -93.54 103.08 15.29 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 173.346 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 41.5 t -86.01 101.75 10.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.351 0.596 . . . . 0.0 110.835 -174.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.4 ' CE2' ' HB3' ' A' ' 63' ' ' ASP . 83.5 m-85 -84.23 159.0 21.08 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.734 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.6 mp -63.08 -37.76 88.5 Favored 'General case' 0 C--O 1.212 -0.896 0 O-C-N 123.439 0.462 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -56.86 -39.73 74.83 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 124.797 1.311 . . . . 0.0 113.679 -177.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.85 -31.37 4.35 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.836 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.82 130.31 35.02 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 17' ' ' LYS . 4.2 m -115.34 156.62 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.236 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.807 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.0 m -99.9 129.49 45.99 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.515 HG23 ' OE1' ' A' ' 14' ' ' GLN . 47.5 mm -102.25 127.32 55.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 2.2 tp10 -112.1 143.39 43.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -121.66 108.69 13.85 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.683 ' HB2' HG13 ' A' ' 13' ' ' VAL . 28.8 mmmt -119.68 135.98 54.6 Favored 'General case' 0 C--N 1.274 -2.694 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.875 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -121.55 117.36 26.59 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.49 140.86 39.36 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.054 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.3 mtmt -98.52 104.98 17.06 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 39' ' ' PHE . 1.2 p -103.6 132.19 50.51 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.375 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.38 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 4.0 m-85 -73.49 -20.03 60.78 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -146.93 119.08 8.26 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -28.9 28.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.05 0.452 . . . . 0.0 111.191 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -56.58 -42.67 79.04 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 124.892 1.277 . . . . 0.0 110.228 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.09 -35.74 69.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.798 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.473 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 55.8 t80 -64.34 -43.7 93.78 Favored 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.717 178.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 m95 -64.58 -39.28 93.46 Favored 'General case' 0 C--O 1.201 -1.478 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.83 -32.5 69.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.369 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 -39.45 76.94 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.467 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -108.24 15.33 24.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.15 -22.57 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -77.65 -25.28 63.19 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.347 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 41.0 m95 -77.32 159.76 29.32 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.2 m -91.7 119.71 31.8 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 HD23 ' CZ ' ' A' ' 58' ' ' PHE . 3.5 tm? -78.13 111.68 14.3 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.2 t -89.14 -47.5 15.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.3 pt-20 -158.14 154.44 27.44 Favored 'General case' 0 C--O 1.213 -0.824 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 176.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -144.07 136.36 26.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 122.972 0.509 . . . . 0.0 110.758 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HE2' ' CD1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -135.29 167.66 20.61 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 53' ' ' LYS . 1.2 tmtp? -70.06 106.02 3.1 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 118.751 0.705 . . . . 0.0 109.548 -176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.49 -23.84 10.11 Favored Glycine 0 N--CA 1.431 -1.656 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.461 176.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.488 ' CD1' ' HE2' ' A' ' 52' ' ' LYS . 6.0 t80 -141.35 134.09 28.72 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-O 121.015 0.436 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 78.3 t -129.19 139.38 51.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.636 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 4.8 tp -117.99 116.23 26.49 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.273 0.558 . . . . 0.0 111.394 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 26.8 m-85 -121.34 158.78 27.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.838 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -134.05 146.87 50.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.855 0.359 . . . . 0.0 111.324 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.512 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 6.7 tppt? -151.71 119.51 6.16 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 0.0 OUTLIER -105.3 107.69 18.81 Favored 'General case' 0 C--N 1.266 -3.038 0 CA-C-O 121.503 0.668 . . . . 0.0 111.889 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.432 ' HG3' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -152.73 82.78 1.22 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 9.8 t70 179.6 -165.57 0.06 Allowed 'General case' 0 C--O 1.244 0.782 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -107.1 -100.99 0.35 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 119.172 0.896 . . . . 0.0 112.038 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.15 161.79 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.059 -1.025 . . . . 0.0 108.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.38 146.05 80.21 Favored Pre-proline 0 C--N 1.283 -2.31 0 C-N-CA 124.648 1.179 . . . . 0.0 112.662 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.33 -44.44 42.97 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 123.856 3.037 . . . . 0.0 114.369 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.546 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -83.75 -32.93 25.18 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -177.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.3 m -62.78 -23.44 67.23 Favored 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.615 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 17.5 ptpt -90.22 -10.56 43.9 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' LEU . 3.2 m -92.52 -26.37 4.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 27.8 t-20 -93.76 -65.04 1.02 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.469 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.57 28.44 55.2 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 115.289 0.875 . . . . 0.0 115.289 173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 16.0 m-85 -106.44 106.67 17.3 Favored 'General case' 0 CA--C 1.48 -1.74 0 CA-C-O 122.639 1.209 . . . . 0.0 110.515 -172.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' O ' ' HA2' ' A' ' 119' ' ' GLY . 72.2 mt -91.86 125.72 44.51 Favored 'Isoleucine or valine' 0 C--N 1.251 -3.71 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 173.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.496 ' HA2' ' HG3' ' A' ' 90' ' ' PRO . . . -119.63 119.43 4.26 Favored Glycine 0 N--CA 1.406 -3.304 0 CA-C-O 122.59 1.105 . . . . 0.0 113.889 -171.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 74.5 t -112.23 125.44 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.311 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.469 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.6 m -95.07 172.35 8.19 Favored 'General case' 0 N--CA 1.413 -2.306 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.334 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.99 -33.41 17.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.704 1.602 . . . . 0.0 113.914 -171.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -88.0 16.38 6.08 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.944 0.402 . . . . 0.0 111.523 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 74.26 32.9 57.62 Favored Glycine 0 CA--C 1.485 -1.834 0 N-CA-C 111.381 -0.687 . . . . 0.0 111.381 177.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.6 t -76.28 110.7 11.92 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.216 0 CA-C-N 115.255 -0.472 . . . . 0.0 109.767 -176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.56 ' HA ' HG22 ' A' ' 77' ' ' VAL . 30.5 mm -82.23 35.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 C-N-CA 127.052 2.141 . . . . 0.0 112.389 -172.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.44 ' OG ' HG12 ' A' ' 82' ' ' VAL . 15.0 m -95.37 154.83 17.0 Favored 'General case' 0 C--N 1.27 -2.889 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.252 -168.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.8 p -90.92 146.7 23.67 Favored 'General case' 0 C--N 1.278 -2.518 0 C-N-CA 118.591 -1.244 . . . . 0.0 109.009 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -134.99 177.42 7.82 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -98.81 101.64 13.11 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.26 -148.07 41.9 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.567 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 17.8 mmt180 -52.77 119.34 15.62 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 123.141 0.577 . . . . 0.0 111.849 178.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.496 ' HG3' ' HA2' ' A' ' 76' ' ' GLY . 14.7 Cg_endo -73.1 108.66 2.65 Favored 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 123.078 2.519 . . . . 0.0 111.524 177.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 14.2 pt-20 -140.49 164.87 33.96 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 Cg_endo -66.21 -16.66 52.62 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.639 2.226 . . . . 0.0 112.297 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.4 56.64 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.6 t -101.03 162.82 12.62 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -97.91 117.81 64.66 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 116.953 -0.112 . . . . 0.0 110.87 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.78 125.89 15.65 Favored 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.071 1.847 . . . . 0.0 109.396 174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.32 -40.87 57.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.245 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.134 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -173.54 4.15 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.3 t -146.13 123.07 11.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 170.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -93.42 -71.58 0.65 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.495 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -124.44 164.99 18.53 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.116 0.484 . . . . 0.0 111.522 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 14.3 mt-30 -128.56 121.34 28.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 166.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.655 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 41.1 pt -127.05 177.74 5.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.679 ' HB2' ' HD2' ' A' ' 107' ' ' ARG . 61.9 m-20 -92.63 111.3 22.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.671 0.272 . . . . 0.0 110.603 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.659 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.8 mt -67.99 -28.38 67.38 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.568 0.699 . . . . 0.0 109.595 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.5 -12.39 61.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.411 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.679 ' HD2' ' HB2' ' A' ' 104' ' ' ASP . 5.8 ptm180 -102.4 -10.61 19.28 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.513 0.673 . . . . 0.0 109.679 176.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.659 HD23 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mm? -66.91 159.99 27.18 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 164.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.468 ' CD ' ' H ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -66.76 -65.46 0.68 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -177.497 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.608 ' O ' ' HG2' ' A' ' 114' ' ' LYS . 69.4 m -166.08 -71.21 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 124.91 1.284 . . . . 0.0 109.475 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.3 m170 -79.5 -26.51 41.56 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -170.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.467 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 43.1 mmm -53.57 -53.81 46.38 Favored 'General case' 0 C--N 1.318 -0.785 0 O-C-N 123.431 0.457 . . . . 0.0 110.614 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.558 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -67.23 -36.25 81.28 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.009 -177.599 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.608 ' HG2' ' O ' ' A' ' 110' ' ' SER . 72.3 mmtt -66.1 -30.7 71.25 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 120.998 0.428 . . . . 0.0 110.964 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -72.47 -34.92 68.07 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD13 HG21 ' A' ' 77' ' ' VAL . 39.0 mt -72.94 -28.24 62.32 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.359 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 66.3 mt -64.38 -39.14 93.28 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.928 0.491 . . . . 0.0 110.811 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.567 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 45.5 mttp -78.22 -32.77 50.02 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 121.91 0.862 . . . . 0.0 109.253 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 75' ' ' ILE . . . 95.06 138.23 9.42 Favored Glycine 0 N--CA 1.402 -3.577 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -173.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.5 mm -70.72 131.55 87.7 Favored Pre-proline 0 C--N 1.289 -2.028 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.504 ' HA ' ' CE1' ' A' ' 74' ' ' TYR . 56.4 Cg_endo -75.24 -5.0 16.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.718 1.612 . . . . 0.0 114.647 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -167.92 138.67 2.79 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.556 0.342 . . . . 0.0 110.934 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -151.99 147.82 26.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.386 0.674 . . . . 0.0 109.654 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.481 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 3.0 m -114.37 169.66 8.88 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 126' ' ' ALA . 0.0 OUTLIER -63.88 -36.18 83.08 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 119.994 1.27 . . . . 0.0 113.135 -173.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 125' ' ' LYS . . . -73.9 -26.42 60.52 Favored 'General case' 0 CA--C 1.494 -1.205 0 CA-C-O 121.506 0.669 . . . . 0.0 109.354 -177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 15.8 mt-10 -81.92 -28.99 32.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.843 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 57.5 t80 -62.27 -54.0 47.06 Favored 'General case' 0 N--CA 1.439 -1.011 0 O-C-N 123.772 0.67 . . . . 0.0 109.861 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 6.2 pt-20 -64.76 -28.29 69.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.788 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 26.4 t70 -71.34 -43.15 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.774 0.797 . . . . 0.0 110.957 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.519 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.1 p -73.87 -37.36 47.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.163 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -64.79 -37.01 79.06 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.44 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.8 pt-20 -69.72 -22.53 63.38 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.161 0.505 . . . . 0.0 110.798 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.448 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.0 t-160 -80.0 -37.26 34.59 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.519 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.0 mmt -66.14 -45.94 79.26 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 123.883 0.873 . . . . 0.0 111.062 177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.5 ptpt -70.49 -18.11 62.97 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.688 0.756 . . . . 0.0 109.833 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 0.9 OUTLIER -70.06 -19.74 63.27 Favored 'General case' 0 N--CA 1.396 -3.151 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.357 176.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 108' ' ' LEU . 71.9 m-85 -89.34 -55.3 3.72 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 172.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.1 p 47.21 27.35 0.81 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.611 1.164 . . . . 0.0 113.547 176.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.421 ' OXT' ' HA ' ' A' ' 103' ' ' ILE . . . . . . . . 0 N--CA 1.436 -1.358 0 CA-C-O 119.163 -0.798 . . . . 0.0 112.474 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.57 151.33 33.66 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.97 160.16 2.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.788 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.55 98.52 10.58 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.202 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -114.99 168.99 9.42 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.425 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -90.5 -11.8 39.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.191 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -70.56 158.09 88.6 Favored Pre-proline 0 C--N 1.308 -1.226 0 CA-C-N 114.583 -1.189 . . . . 0.0 110.27 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.544 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 57.8 Cg_endo -69.45 177.04 5.76 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.237 1.958 . . . . 0.0 112.377 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -119.12 117.11 27.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -173.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.62 105.65 5.04 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.349 0.406 . . . . 0.0 110.158 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.5 t -109.03 122.76 64.19 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -98.7 107.99 20.56 Favored 'General case' 0 C--N 1.277 -2.569 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 33.5 m -98.28 130.5 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 CA-C-O 121.602 0.715 . . . . 0.0 111.06 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.401 HE21 HD13 ' A' ' 57' ' ' LEU . 29.2 tt0 -100.26 112.69 25.03 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 47.3 mt -100.21 120.27 39.64 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 46.4 mt-10 -97.28 138.49 34.68 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 175.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 97.4 mttt -120.92 104.39 9.8 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 4.3 t -90.28 95.78 5.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.435 0.636 . . . . 0.0 110.465 -169.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -85.97 134.16 33.88 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.0 pt? -61.95 -14.74 37.66 Favored 'General case' 0 C--O 1.207 -1.169 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' OD1' ' HB ' ' A' ' 65' ' ' ILE . 4.3 p-10 -79.14 -9.19 59.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.845 0.355 . . . . 0.0 110.824 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.67 -14.29 22.36 Favored Glycine 0 N--CA 1.426 -1.972 0 C-N-CA 120.121 -1.037 . . . . 0.0 114.429 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.11 125.52 35.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.443 0.621 . . . . 0.0 110.021 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 25.1 t -114.5 115.47 49.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 34.6 t -78.66 118.97 21.26 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -100.02 117.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 5.4 tp10 -113.46 149.71 33.85 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -127.82 120.7 28.39 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.492 ' HE2' HD11 ' A' ' 15' ' ' LEU . 39.9 mtmt -124.54 153.58 41.89 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.655 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -123.24 115.73 22.2 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.777 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -129.68 139.07 51.47 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.555 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.556 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 41.1 mtmt -98.75 112.56 24.6 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.7 OUTLIER -118.05 134.72 60.74 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.333 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.24 -178.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -77.29 -42.45 36.88 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.483 0.713 . . . . 0.0 111.283 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.3 t -117.6 116.22 26.65 Favored 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -29.34 65.42 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 120.707 0.289 . . . . 0.0 110.395 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -64.99 -36.71 85.28 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.617 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -64.99 -42.04 94.86 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.53 ' HB2' HG21 ' A' ' 33' ' ' VAL . 45.9 t80 -63.74 -43.52 96.24 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.096 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -67.4 -37.47 83.15 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 120.768 0.318 . . . . 0.0 110.796 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.89 -34.33 71.47 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.6 80.73 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.846 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -105.86 21.55 17.1 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.52 -40.73 27.87 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.28 -27.94 62.91 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.757 -178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 43.8 m95 -66.78 147.05 53.76 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 89.1 m -85.69 116.82 24.2 Favored 'General case' 0 N--CA 1.404 -2.726 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -75.2 114.43 13.71 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.674 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 99.3 t -93.7 -44.59 13.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HG2' HD23 ' A' ' 57' ' ' LEU . 10.7 pt-20 -160.72 159.01 29.67 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.74 138.14 21.82 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.299 175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -147.24 92.14 2.07 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.379 173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 53' ' ' LYS 0.256 44.9 mmtm 38.85 -85.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.1 -16.2 80.71 Favored Glycine 0 C--N 1.285 -2.255 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.015 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.87 130.63 39.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 118.153 0.976 . . . . 0.0 110.886 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 97.5 t -128.17 136.22 60.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 176.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.674 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 7.0 tp -111.2 118.86 37.1 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.246 0.546 . . . . 0.0 111.034 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -121.24 159.16 26.53 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.824 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.0 ptp180 -133.84 144.1 48.75 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 170.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 14.0 tppt? -140.68 129.78 23.45 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 6.2 pt20 -121.45 106.96 11.9 Favored 'General case' 0 C--N 1.265 -3.077 0 CA-C-O 121.429 0.633 . . . . 0.0 110.365 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -133.64 -179.2 5.38 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.606 -170.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.0 t70 66.04 -82.72 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.015 1.726 . . . . 0.0 112.2 175.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 125' ' ' LYS 0.294 1.8 p30 -176.34 -101.22 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.666 1.186 . . . . 0.0 111.467 175.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.424 ' HB ' ' OD1' ' A' ' 21' ' ' ASP . 35.5 pt -109.93 168.46 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.674 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.511 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 22.3 t -64.86 142.02 98.5 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 -177.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.11 -34.08 47.72 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.599 2.199 . . . . 0.0 111.972 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.7 OUTLIER -68.15 -31.51 71.13 Favored 'General case' 0 C--O 1.204 -1.312 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.511 ' OG ' ' HB3' ' A' ' 66' ' ' SER . 20.5 m -66.2 -23.7 66.49 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.884 -0.51 . . . . 0.0 111.891 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.33 -18.17 49.91 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.013 0.435 . . . . 0.0 110.541 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.3 m -93.3 -26.33 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -85.85 -72.09 0.51 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.232 -1.349 . . . . 0.0 111.214 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.471 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 84.33 -17.57 28.14 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 114.893 0.717 . . . . 0.0 114.893 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CD2' ' HA3' ' A' ' 119' ' ' GLY . 3.4 m-85 -78.46 108.06 11.56 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 123.477 1.608 . . . . 0.0 112.374 -167.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG12 HG22 ' A' ' 85' ' ' THR . 82.3 mt -105.02 132.77 51.0 Favored 'Isoleucine or valine' 1 C--N 1.241 -4.11 0 CA-C-N 111.722 -2.49 . . . . 0.0 104.726 174.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 90' ' ' PRO . . . -137.94 171.95 23.09 Favored Glycine 0 N--CA 1.41 -3.061 0 C-N-CA 117.826 -2.131 . . . . 0.0 115.278 -177.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 35.4 m -129.23 149.31 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.946 0 CA-C-N 113.859 -1.171 . . . . 0.0 111.016 173.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.6 m -86.63 165.29 16.27 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 170.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -55.47 -19.99 11.23 Favored 'General case' 0 C--O 1.245 0.843 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -170.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -95.63 11.69 32.36 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 121.953 -0.467 . . . . 0.0 112.143 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.74 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 85.1 36.0 11.69 Favored Glycine 0 C--O 1.209 -1.434 0 O-C-N 123.3 0.375 . . . . 0.0 112.886 178.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.0 t -82.38 119.56 32.15 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.1 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 83' ' ' ILE . 31.5 mm -80.21 36.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.54 0 C-N-CA 127.641 2.376 . . . . 0.0 113.085 -167.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 23.7 m -93.8 140.18 29.97 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.982 -168.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.477 HG22 HG12 ' A' ' 75' ' ' ILE . 75.6 p -88.44 144.51 26.32 Favored 'General case' 0 N--CA 1.416 -2.172 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.008 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -126.02 162.17 25.89 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.724 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -96.47 102.59 14.4 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.89 -162.06 33.77 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -175.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' NH1' ' HA ' ' A' ' 118' ' ' LYS . 8.4 mmm180 -48.57 118.57 7.11 Favored Pre-proline 0 C--O 1.22 -0.45 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.417 ' CB ' ' HA3' ' A' ' 76' ' ' GLY . 36.5 Cg_endo -81.52 87.4 1.46 Allowed 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.849 2.366 . . . . 0.0 112.095 178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.632 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -141.03 171.72 7.17 Favored Pre-proline 0 C--N 1.287 -2.119 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.0 Cg_endo -64.27 -17.28 59.14 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.5 2.133 . . . . 0.0 112.756 -178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.39 -16.25 60.9 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.401 0.62 . . . . 0.0 109.989 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.8 m -106.71 -179.4 3.93 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.674 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -120.25 132.54 24.08 Favored Pre-proline 0 N--CA 1.444 -0.772 0 O-C-N 122.374 -0.204 . . . . 0.0 110.8 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -70.96 137.81 32.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 C-N-CA 122.031 1.821 . . . . 0.0 109.455 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.444 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.0 mt -78.51 -35.99 19.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.939 0.876 . . . . 0.0 108.882 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.444 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.98 -171.38 3.5 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 56.2 m -143.21 136.61 28.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.662 0.665 . . . . 0.0 109.235 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -101.3 -75.82 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -143.91 171.67 13.92 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.443 HE21 HG22 ' A' ' 82' ' ' VAL . 33.6 tt0 -127.04 123.75 37.74 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.74 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 27.9 pt -123.98 161.13 27.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 123.074 0.55 . . . . 0.0 109.988 -177.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 21.8 m-20 -74.72 107.3 6.74 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.285 0.564 . . . . 0.0 112.401 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.722 ' HA ' HD13 ' A' ' 108' ' ' LEU . 5.3 mt -64.25 -32.27 73.79 Favored 'General case' 0 CA--C 1.49 -1.359 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.739 176.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 106' ' ' GLU . 9.4 pt-20 -66.78 -17.16 64.73 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.407 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 6.5 ptm180 -92.93 -17.5 23.91 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.722 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.2 mp -63.29 166.6 6.11 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.864 170.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -87.74 19.99 3.21 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -176.186 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 40.0 t 87.7 -78.97 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 126.049 1.74 . . . . 0.0 112.845 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.2 -35.47 67.33 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -171.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.473 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 36.9 mmm -55.56 -49.95 71.34 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.352 0.596 . . . . 0.0 111.623 175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -79.86 -29.04 39.95 Favored 'General case' 0 CA--C 1.493 -1.248 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.139 -177.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.57 ' HG2' ' O ' ' A' ' 110' ' ' SER . 31.1 mmmt -58.54 -35.07 71.75 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 171.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -68.03 -37.97 81.98 Favored 'General case' 0 CA--C 1.489 -1.385 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.521 HD12 ' HA ' ' A' ' 113' ' ' GLN . 64.9 mt -68.27 -23.96 64.83 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.897 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 49.2 mt -76.15 -40.03 53.6 Favored 'General case' 0 C--O 1.221 -0.442 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' HA ' ' NH1' ' A' ' 89' ' ' ARG . 48.2 mttm -76.68 -41.89 43.73 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.168 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.504 ' HA3' ' CD2' ' A' ' 74' ' ' TYR . . . 112.53 119.86 3.72 Favored Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -177.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.4 mm -56.33 128.05 72.46 Favored Pre-proline 0 C--O 1.206 -1.193 0 O-C-N 123.894 0.408 . . . . 0.0 110.055 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -76.31 12.61 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.612 2.208 . . . . 0.0 115.313 -175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -161.63 143.43 11.5 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 118.181 0.446 . . . . 0.0 110.83 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.471 ' CB ' ' HA2' ' A' ' 73' ' ' GLY . 34.3 ttp180 -149.59 128.92 12.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 121.293 0.568 . . . . 0.0 109.684 172.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.441 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 4.5 m -141.72 170.43 15.74 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 177.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 22.4 ptmt -57.87 -47.09 83.74 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 119.36 0.982 . . . . 0.0 113.219 -171.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -82.23 -30.6 30.69 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-O 121.005 0.431 . . . . 0.0 110.02 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.441 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 19.9 mt-10 -73.59 -33.4 64.59 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.504 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -63.36 -53.68 48.79 Favored 'General case' 0 CA--C 1.504 -0.815 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.875 176.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -69.84 -20.83 63.41 Favored 'General case' 0 N--CA 1.423 -1.815 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.477 -177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -72.71 -46.63 52.64 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.489 0.661 . . . . 0.0 109.789 176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -71.31 -36.63 62.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.718 0.77 . . . . 0.0 109.884 177.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.66 -35.32 72.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.513 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.5 pt-20 -68.2 -26.66 65.84 Favored 'General case' 0 C--O 1.217 -0.655 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.286 178.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.5 t-160 -72.81 -36.06 67.47 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 24.0 mmt -65.65 -46.85 77.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.646 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.1 ptpt -73.12 -17.68 61.37 Favored 'General case' 0 C--O 1.212 -0.891 0 CA-C-O 121.878 0.847 . . . . 0.0 110.673 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.6 -15.44 63.53 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-N 114.649 -1.159 . . . . 0.0 110.161 175.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.472 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 95.9 m-85 -93.65 -63.81 1.16 Allowed 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 168.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.2 p 46.97 29.05 0.96 Allowed 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.228 1.411 . . . . 0.0 113.884 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 CA--C 1.441 -4.539 0 N-CA-C 106.258 -2.737 . . . . 0.0 106.258 -179.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.14 104.39 16.96 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-O 121.559 0.695 . . . . 0.0 110.962 179.093 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 178.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.926 178.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -60.52 118.8 6.96 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 123.862 0.726 . . . . 0.0 109.209 176.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . 0.256 4.0 p-80 -90.66 -176.97 4.89 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -92.83 -24.04 18.63 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.884 -167.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -82.66 148.44 58.05 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.398 175.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 10.5 Cg_endo -57.79 150.2 64.14 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.191 1.928 . . . . 0.0 111.859 177.189 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -93.42 112.86 24.87 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.507 -1.224 . . . . 0.0 108.525 -172.584 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 52.3 mt-30 -80.0 97.25 6.71 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 173.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 9' ' ' LEU . 3.6 t -97.27 122.89 49.29 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.992 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 55' ' ' TYR . 12.2 m170 -98.31 98.7 9.92 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 172.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 7.5 p -102.35 119.91 51.33 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.408 -174.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -90.52 125.02 35.47 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.14 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 79.1 mt -109.76 112.58 24.71 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 59' ' ' ARG . 48.5 mt-10 -94.86 147.29 23.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 0.8 OUTLIER -120.8 102.79 8.62 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 173.6 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 6.7 t -90.95 121.43 41.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -178.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 23' ' ' ASP . 75.1 m-85 -90.97 174.12 7.59 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.872 -178.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 64' ' ' ASP . 83.0 mt -63.43 -44.67 93.91 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.586 ' HA ' ' CE1' ' A' ' 128' ' ' PHE . 3.8 p-10 -66.25 -26.0 67.15 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.588 -175.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' HA3' ' NE2' ' A' ' 98' ' ' GLN . . . 116.18 -12.89 16.65 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.273 -1.441 . . . . 0.0 113.208 177.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.441 ' O ' ' HD1' ' A' ' 19' ' ' TYR . 25.3 t70 -74.93 155.89 36.95 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 173.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.3 p -145.36 124.22 5.58 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-O 121.51 0.672 . . . . 0.0 110.802 -176.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.6 t -83.86 129.55 34.93 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.133 179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.1 mm -103.81 120.13 53.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.1 -178.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.6 tp10 -113.79 147.75 37.77 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -125.02 116.69 22.52 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.082 0.467 . . . . 0.0 110.158 -177.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HE2' HD11 ' A' ' 15' ' ' LEU . 15.0 mtmt -123.65 141.13 52.31 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.335 178.612 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -122.53 121.36 36.33 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 172.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -141.92 144.84 33.98 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.702 -0.799 . . . . 0.0 112.302 -178.566 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 29.8 mtmm -93.72 126.07 38.69 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.242 0.544 . . . . 0.0 111.4 176.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.447 HG21 ' HB2' ' A' ' 39' ' ' PHE . 13.6 t -119.05 137.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -81.05 -19.19 44.35 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 118.879 0.763 . . . . 0.0 112.655 -176.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.2 t -146.92 127.79 14.44 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.415 ' HE2' ' HB3' ' A' ' 36' ' ' MET . 1.5 mtp -61.55 -22.27 65.02 Favored 'General case' 0 C--O 1.203 -1.36 0 CA-C-N 118.891 0.769 . . . . 0.0 112.139 -178.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.43 -37.19 74.88 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.029 176.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.21 -40.61 77.9 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' A' ' 33' ' ' VAL . 75.1 t80 -62.17 -47.24 85.4 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.344 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 15.7 m95 -63.44 -37.74 88.44 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.276 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.12 -30.05 64.67 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.19 0.519 . . . . 0.0 110.664 179.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.26 -38.02 71.91 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.334 179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -112.91 19.34 17.39 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -178.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.44 -36.64 34.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 177.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.65 -38.06 85.52 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.674 179.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 26.4 m95 -61.39 157.79 16.01 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.561 1.144 . . . . 0.0 110.227 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.414 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 51.8 m -91.49 119.82 31.77 Favored 'General case' 0 N--CA 1.419 -1.987 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -75.42 108.18 8.04 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.702 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 45.6 t -83.86 -54.37 9.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.286 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.4 pt-20 -157.87 153.86 27.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -141.53 147.04 37.11 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-O 121.189 0.518 . . . . 0.0 110.197 173.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -141.28 153.28 45.11 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 105.151 -2.166 . . . . 0.0 105.151 173.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -68.95 102.39 1.58 Allowed 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 119.321 0.964 . . . . 0.0 111.932 -173.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.55 -27.38 4.18 Favored Glycine 0 N--CA 1.421 -2.357 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.775 179.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' HIS . 6.8 t80 -140.48 129.27 23.11 Favored 'General case' 0 N--CA 1.418 -2.054 0 CA-C-O 121.513 0.673 . . . . 0.0 110.119 -177.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 88.7 t -124.62 140.9 46.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.702 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.9 tp -116.61 112.48 21.35 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.279 0.561 . . . . 0.0 110.384 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 6.2 m-85 -117.97 145.58 44.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.254 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' CB ' ' HB2' ' A' ' 16' ' ' GLU . 9.0 ptp180 -125.4 138.85 54.04 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.388 175.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.5 tppt? -123.52 105.42 9.75 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 174.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.62 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -98.32 126.61 43.9 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.799 -179.678 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 45.6 mtm -119.55 152.35 37.14 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.062 -170.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -85.54 91.7 8.32 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.459 ' O ' ' HG ' ' A' ' 20' ' ' LEU . 4.7 t70 -178.04 178.64 0.91 Allowed 'General case' 0 C--O 1.248 0.977 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 172.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -107.31 166.42 4.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 118.398 0.545 . . . . 0.0 110.082 -178.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 65.0 p -75.26 155.79 85.88 Favored Pre-proline 0 C--N 1.279 -2.475 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.251 -178.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.98 -28.33 80.55 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.718 1.612 . . . . 0.0 110.07 174.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.5 OUTLIER -72.26 -36.02 68.92 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.659 179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.0 t -58.87 -31.86 68.93 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.955 -0.465 . . . . 0.0 110.085 178.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -75.18 -18.27 60.21 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.648 179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -99.19 -24.08 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 122.191 0.996 . . . . 0.0 109.096 177.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 74' ' ' TYR . 50.9 t30 -96.9 -77.96 0.48 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.923 -175.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 70.79 21.47 78.02 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.814 -178.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HB2' ' OD1' ' A' ' 72' ' ' ASN . 12.9 m-85 -102.85 121.38 42.38 Favored 'General case' 0 CA--C 1.479 -1.767 0 CA-C-O 122.471 1.129 . . . . 0.0 111.178 -175.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.531 HG12 HG22 ' A' ' 85' ' ' THR . 64.9 mt -118.76 127.79 75.66 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.508 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 177.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -130.41 162.02 23.23 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 118.905 -1.617 . . . . 0.0 114.116 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.762 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.4 m -123.66 150.34 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.706 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.553 172.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 m -90.21 168.29 12.04 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 171.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -50.37 -29.21 9.5 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.287 1.435 . . . . 0.0 114.832 -172.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -88.55 3.7 49.4 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.778 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 87.94 35.56 8.98 Favored Glycine 0 C--O 1.209 -1.441 0 C-N-CA 123.643 0.639 . . . . 0.0 112.355 -176.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.762 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 18.6 t -80.56 123.65 37.51 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.063 0 O-C-N 122.249 -0.56 . . . . 0.0 110.374 -177.194 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.423 HD11 HG12 ' A' ' 103' ' ' ILE . 37.0 mm -80.84 36.57 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.395 0 C-N-CA 127.664 2.386 . . . . 0.0 113.142 -168.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.1 m -94.36 136.26 34.86 Favored 'General case' 0 C--N 1.282 -2.329 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.056 -169.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.531 HG22 HG12 ' A' ' 75' ' ' ILE . 81.3 p -88.34 148.29 24.35 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.552 -179.165 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -127.71 150.94 49.55 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.584 -177.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -87.04 104.82 16.68 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.762 0.792 . . . . 0.0 109.502 173.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.4 -168.27 34.8 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 -174.691 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -50.84 126.11 23.79 Favored Pre-proline 0 C--O 1.239 0.54 0 C-N-CA 123.227 0.611 . . . . 0.0 110.48 177.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.07 91.27 0.45 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.764 2.309 . . . . 0.0 110.771 178.148 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.9 pt-20 -141.36 171.53 7.36 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -178.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 19.3 Cg_endo -66.06 -15.63 49.34 Favored 'Trans proline' 0 C--N 1.362 1.237 0 C-N-CA 122.593 2.195 . . . . 0.0 112.598 179.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.83 -3.2 56.47 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.954 0.883 . . . . 0.0 109.659 177.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.3 t -119.98 173.8 6.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.96 150.4 71.31 Favored Pre-proline 0 C--N 1.29 -2.02 0 CA-C-N 118.465 0.575 . . . . 0.0 109.57 -178.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -68.98 122.16 9.04 Favored 'Trans proline' 0 N--CA 1.436 -1.903 0 C-N-CA 121.807 1.671 . . . . 0.0 108.836 175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.461 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 59.2 mt -69.08 -32.42 54.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.343 -176.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.481 ' NE2' ' HA3' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -161.94 -175.96 4.94 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 178.492 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.7 t -146.12 135.22 22.68 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 170.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -101.51 -80.25 0.5 Allowed 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.024 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -145.81 -175.87 4.91 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.509 -176.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -126.0 139.5 53.37 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 123.309 0.644 . . . . 0.0 109.44 -176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.778 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 29.1 pt -129.92 158.87 42.39 Favored 'Isoleucine or valine' 0 C--O 1.25 1.104 0 C-N-CA 123.424 0.69 . . . . 0.0 109.292 176.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.508 ' OD2' ' HG3' ' A' ' 106' ' ' GLU . 15.4 t70 -82.06 113.97 20.29 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.625 -178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' HA ' HD13 ' A' ' 108' ' ' LEU . 4.9 mt -66.85 -34.66 78.28 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 119.715 -0.794 . . . . 0.0 111.966 -178.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.508 ' HG3' ' OD2' ' A' ' 104' ' ' ASP . 7.3 pt-20 -71.81 -16.94 62.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.973 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 0.5 OUTLIER -87.26 -16.0 36.48 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.054 176.87 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.655 HD13 ' HA ' ' A' ' 105' ' ' LEU . 2.9 mp -56.87 165.09 1.31 Allowed 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.004 0.431 . . . . 0.0 112.086 171.289 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -63.74 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.726 179.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.4 m -155.17 -85.73 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -74.38 -17.69 60.78 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.502 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 47.9 mmm -50.41 -55.04 17.5 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.41 0.684 . . . . 0.0 112.385 177.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.548 ' NE2' ' HB3' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -73.67 -33.02 64.26 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.313 -178.177 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -57.39 -36.4 71.23 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.601 172.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.24 -36.67 82.14 Favored 'General case' 0 CA--C 1.499 -0.998 0 CA-C-O 121.178 0.513 . . . . 0.0 109.942 176.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 112' ' ' MET . 59.7 mt -71.4 -25.59 62.41 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.403 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 58.8 mt -68.1 -49.1 63.34 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.865 177.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.21 -19.38 31.76 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 118.475 -1.29 . . . . 0.0 110.751 -179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.44 130.49 6.69 Favored Glycine 0 N--CA 1.408 -3.169 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.4 mm -61.69 125.5 84.85 Favored Pre-proline 0 C--N 1.298 -1.64 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.36 -12.88 36.22 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.721 2.281 . . . . 0.0 115.1 -173.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -175.9 147.24 0.76 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -145.25 169.4 18.3 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 123.06 0.544 . . . . 0.0 109.856 178.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.474 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 7.4 m -137.87 169.96 16.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.543 -2.391 . . . . 0.0 104.543 175.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -59.84 -45.75 91.42 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -171.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -79.81 -20.69 45.54 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.691 0.758 . . . . 0.0 109.812 -174.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 20.3 mt-10 -83.95 -23.26 31.19 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.848 -179.46 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 21' ' ' ASP . 50.4 t80 -67.77 -51.77 45.08 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 175.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.29 -21.45 63.87 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 120.164 -0.614 . . . . 0.0 112.062 178.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -69.04 -42.66 76.02 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-O 121.848 0.832 . . . . 0.0 109.97 176.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -77.22 -36.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.217 177.324 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.64 -36.45 77.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.834 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.492 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 11.8 pt-20 -65.59 -26.37 67.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.486 0.66 . . . . 0.0 109.924 177.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -79.65 -35.13 39.76 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 17.4 mmt -63.13 -48.13 79.83 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 176.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 18.2 ptpt -70.53 -18.24 62.94 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.384 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.51 -26.21 68.61 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.471 ' CZ ' ' HG ' ' A' ' 108' ' ' LEU . 75.6 m-85 -93.23 -61.5 1.56 Allowed 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 174.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.1 t 54.32 22.56 3.79 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.993 1.717 . . . . 0.0 112.419 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.4 -3.714 0 N-CA-C 105.252 -3.139 . . . . 0.0 105.252 179.925 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.595 0 CA-C-O 120.919 0.39 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -127.99 149.12 50.49 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.52 171.54 4.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.42 115.84 30.94 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 177.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -74.06 158.22 34.67 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 122.007 0.908 . . . . 0.0 111.968 -175.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -105.01 -42.52 5.3 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.486 -170.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 22.8 mm-40 -86.99 134.29 37.26 Favored Pre-proline 0 N--CA 1.436 -1.17 0 CA-C-N 114.891 -1.05 . . . . 0.0 108.681 178.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.9 Cg_endo -84.51 -178.25 3.27 Favored 'Trans proline' 0 N--CA 1.429 -2.288 0 C-N-CA 121.24 1.293 . . . . 0.0 110.278 173.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.6 OUTLIER -132.53 114.94 14.87 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 178.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.93 98.01 3.47 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.363 0.601 . . . . 0.0 109.942 173.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' HIS . 10.9 t -92.55 123.65 44.72 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.285 -179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -97.17 100.37 11.84 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -94.31 131.3 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.45 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.797 -178.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -104.71 105.93 16.22 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.364 -2.088 . . . . 0.0 105.364 173.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.446 HD11 ' HE2' ' A' ' 29' ' ' LYS . 73.9 mt -97.21 111.9 23.94 Favored 'General case' 0 N--CA 1.412 -2.364 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.116 -176.169 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -94.7 132.54 39.34 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 179.153 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 94.2 mttt -120.24 105.63 11.14 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.642 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 5.0 t -86.27 95.85 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.003 -169.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' ASP . 57.3 m-85 -77.82 137.3 38.34 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 170.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HB2' HG22 ' A' ' 65' ' ' ILE . 36.1 mt -63.49 -24.48 67.84 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.158 0.504 . . . . 0.0 112.271 -172.107 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.606 ' HA ' ' NH2' ' A' ' 123' ' ' ARG . 7.2 p-10 -67.66 -23.67 65.35 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.4 -15.51 11.78 Favored Glycine 0 N--CA 1.42 -2.383 0 C-N-CA 119.955 -1.117 . . . . 0.0 112.35 178.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 19.9 t70 -86.72 102.84 14.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.1 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.2 t -88.55 109.38 20.02 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.2 mm -89.84 114.31 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -112.76 129.03 56.57 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.507 -175.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -110.11 116.55 31.75 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.8 mtmt -127.99 151.96 48.49 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-O 120.748 0.308 . . . . 0.0 110.715 178.146 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.563 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -123.52 113.94 19.41 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.151 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -121.7 138.63 54.27 Favored 'General case' 0 C--N 1.292 -1.919 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.444 -179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 33.5 mtmm -93.03 122.53 35.49 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.782 178.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.536 HG21 ' HB2' ' A' ' 39' ' ' PHE . 0.5 OUTLIER -131.98 136.67 56.35 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.851 178.902 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -78.45 -35.49 46.73 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 122.41 -0.181 . . . . 0.0 111.158 -177.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.4 t -122.84 116.56 23.87 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -31.42 61.17 Favored 'General case' 0 CA--C 1.501 -0.93 0 O-C-N 123.245 0.341 . . . . 0.0 110.85 178.127 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -61.75 -41.16 97.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.01 -179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -67.49 -37.91 83.57 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.536 ' HB2' HG21 ' A' ' 33' ' ' VAL . 60.7 t80 -64.82 -41.23 95.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.292 177.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 13.6 m95 -65.28 -35.79 82.09 Favored 'General case' 0 C--O 1.194 -1.86 0 CA-C-O 120.717 0.294 . . . . 0.0 110.474 179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.01 67.8 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 120.659 -0.416 . . . . 0.0 110.314 178.027 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.42 82.33 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.724 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -110.84 17.68 20.32 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -50.52 -32.57 18.71 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 179.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.98 -30.62 65.36 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 121.549 -0.358 . . . . 0.0 113.392 -179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.541 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 31.1 m95 -68.93 154.16 42.53 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 117.228 0.514 . . . . 0.0 109.913 178.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.468 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 26.2 m -83.52 119.57 24.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 176.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.92 106.54 12.02 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 29.2 t -83.74 -46.37 18.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -176.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.671 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.4 pt-20 -163.36 152.0 14.07 Favored 'General case' 0 CA--C 1.491 -1.322 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.664 173.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -138.78 152.24 47.74 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 120.911 0.386 . . . . 0.0 110.077 174.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -147.06 167.04 25.06 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -71.22 94.77 1.2 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.326 0.584 . . . . 0.0 110.328 -173.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.34 -28.07 4.61 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.072 178.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -135.57 133.03 37.9 Favored 'General case' 0 N--CA 1.436 -1.132 0 O-C-N 122.369 -0.489 . . . . 0.0 110.145 -177.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.1 t -127.36 136.28 61.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.671 HD23 ' HG2' ' A' ' 50' ' ' GLU . 17.2 tp -112.25 116.47 30.46 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 122.932 0.493 . . . . 0.0 110.567 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 27.3 m-85 -123.22 150.26 43.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.955 179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.468 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 5.9 ptp180 -129.25 142.35 50.87 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.984 0.421 . . . . 0.0 109.873 172.278 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 17' ' ' LYS . 12.0 tppt? -136.21 125.46 24.73 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.642 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 7.9 pt20 -122.42 110.76 16.03 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-O 121.687 0.756 . . . . 0.0 110.574 178.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -77.04 -10.27 59.26 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.523 -173.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 67.74 89.09 0.1 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.821 0.848 . . . . 0.0 112.19 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 50.4 t0 173.33 171.71 0.15 Allowed 'General case' 0 C--O 1.25 1.098 0 N-CA-C 104.176 -2.528 . . . . 0.0 104.176 175.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.542 HG22 ' HB2' ' A' ' 20' ' ' LEU . 20.3 pt -109.29 167.89 4.06 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.555 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 13.6 m -68.51 151.24 97.35 Favored Pre-proline 0 C--N 1.293 -1.883 0 C-N-CA 123.457 0.703 . . . . 0.0 110.208 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.44 -44.72 30.76 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.994 2.463 . . . . 0.0 113.23 -175.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -71.21 -31.38 67.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -177.829 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.555 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 8.2 m -64.86 -23.49 67.25 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.852 178.049 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 66' ' ' SER . 79.5 mttt -80.19 -25.83 39.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.693 176.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.8 m -88.41 -36.2 8.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.19 0.519 . . . . 0.0 109.691 -177.275 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -83.11 -71.36 0.5 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.719 178.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 69.06 64.87 2.82 Favored Glycine 0 C--O 1.197 -2.158 0 N-CA-C 115.249 0.86 . . . . 0.0 115.249 174.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -128.68 150.72 50.13 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -178.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.504 HG13 ' HD2' ' A' ' 123' ' ' ARG . 43.4 mt -125.72 142.1 43.5 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.937 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.451 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -124.17 100.81 0.65 Allowed Glycine 0 N--CA 1.423 -2.232 0 CA-C-O 122.153 0.863 . . . . 0.0 112.436 -173.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 87.3 t -106.16 129.71 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.856 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.218 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -98.31 170.98 8.49 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.644 -177.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -50.05 -35.8 26.5 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 125.36 1.464 . . . . 0.0 113.301 -172.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -83.73 16.04 2.92 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 178.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 71.19 34.76 64.25 Favored Glycine 0 CA--C 1.477 -2.293 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 177.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.791 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 13.8 t -73.8 110.51 7.66 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HA ' HG22 ' A' ' 77' ' ' VAL . 36.3 mm -81.94 36.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 127.037 2.135 . . . . 0.0 112.288 -172.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.453 ' OG ' HG12 ' A' ' 82' ' ' VAL . 17.7 m -93.36 162.28 14.05 Favored 'General case' 0 C--N 1.279 -2.477 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.177 -170.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.5 p -106.2 142.4 35.96 Favored 'General case' 0 N--CA 1.399 -2.982 0 C-N-CA 118.081 -1.448 . . . . 0.0 110.803 177.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.451 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 12.4 m-85 -130.3 138.47 50.49 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.184 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 29.5 m170 -97.82 102.94 14.83 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.236 -0.985 . . . . 0.0 108.777 176.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.32 177.01 18.66 Favored Glycine 0 N--CA 1.42 -2.406 0 N-CA-C 108.58 -1.808 . . . . 0.0 108.58 -172.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -55.07 120.58 30.49 Favored Pre-proline 0 C--N 1.314 -0.962 0 C-N-CA 122.847 0.459 . . . . 0.0 110.87 178.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HG2' ' O ' ' A' ' 117' ' ' LEU . 19.4 Cg_endo -68.82 102.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 122.816 2.344 . . . . 0.0 112.427 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.8 pt-20 -140.3 167.96 16.3 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.003 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 17.9 Cg_endo -63.64 -19.6 67.69 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.481 2.121 . . . . 0.0 112.268 178.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.76 -3.46 58.61 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.399 0.618 . . . . 0.0 110.335 176.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 t -100.12 168.26 9.93 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 177.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -111.11 126.86 27.85 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -172.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -73.5 105.54 2.01 Favored 'Trans proline' 0 N--CA 1.44 -1.627 0 C-N-CA 122.34 2.027 . . . . 0.0 108.262 171.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.9 mt -67.61 -41.3 85.51 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.086 -174.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.69 -176.63 6.05 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 179.459 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -146.21 125.65 13.18 Favored 'General case' 0 N--CA 1.418 -2.033 0 C-N-CA 119.399 -0.92 . . . . 0.0 108.559 172.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -83.21 -64.15 1.22 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.786 0.327 . . . . 0.0 110.588 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -167.84 -177.54 3.47 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.645 -178.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 24.7 mt-30 -126.16 148.14 49.48 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 123.478 0.711 . . . . 0.0 111.405 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.619 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 26.8 pt -137.2 165.01 28.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.64 -177.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.501 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 1.0 OUTLIER -85.88 109.46 18.73 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.265 0.555 . . . . 0.0 111.487 178.085 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 108' ' ' LEU . 14.4 mt -68.77 -29.78 68.23 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.232 0.539 . . . . 0.0 110.727 178.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -68.93 -16.04 63.64 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.236 175.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 4.3 ptm180 -92.37 -18.57 23.12 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -60.62 165.75 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.538 171.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -70.87 -84.51 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.523 177.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.9 m -154.43 -76.01 0.11 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.021 0.439 . . . . 0.0 111.221 176.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -67.09 -25.33 66.17 Favored 'General case' 0 C--O 1.204 -1.318 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.874 -173.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.535 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 66.8 mmm -53.47 -58.28 7.68 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 123.698 0.623 . . . . 0.0 110.762 175.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.581 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 1.6 pt20 -72.8 -34.74 67.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.468 -177.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -69.45 -26.67 64.7 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -69.65 -39.2 77.24 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 113' ' ' GLN . 36.7 mt -69.1 -30.09 68.3 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.25 179.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 61.2 mt -65.29 -46.96 78.32 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.552 177.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.73 -17.99 32.28 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 117.664 -1.615 . . . . 0.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.55 131.46 7.34 Favored Glycine 0 N--CA 1.408 -3.227 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 178.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 25.1 mm -67.83 138.26 92.91 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -84.92 10.02 3.91 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.114 1.876 . . . . 0.0 115.004 -177.298 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -175.07 147.03 0.9 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 117.897 0.317 . . . . 0.0 110.469 -177.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.606 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 79.9 mtp180 -147.9 143.34 27.32 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 122.851 0.461 . . . . 0.0 110.644 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 127' ' ' GLU . 8.2 m -131.85 163.55 28.03 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 167.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.406 ' HB2' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -59.01 -37.24 76.45 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -172.339 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -76.48 -31.03 57.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.526 0.679 . . . . 0.0 109.738 -174.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.522 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 17.7 mt-10 -75.84 -36.46 59.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.675 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -58.45 -52.76 64.26 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.36 174.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -71.47 -21.74 61.91 Favored 'General case' 0 N--CA 1.426 -1.647 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.533 -177.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.64 -40.9 66.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.47 0.653 . . . . 0.0 110.107 177.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.3 p -76.6 -38.13 30.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.911 176.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.03 -33.9 66.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 179.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.55 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.9 pt-20 -69.18 -24.68 64.08 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.289 0.566 . . . . 0.0 110.2 177.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.525 ' O ' ' HB ' ' A' ' 137' ' ' THR . 3.3 t-160 -80.2 -34.2 37.57 Favored 'General case' 0 C--O 1.201 -1.476 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.536 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 26.6 mmt -67.15 -44.92 78.59 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 123.49 0.716 . . . . 0.0 110.22 177.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.55 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.1 ptpt -71.21 -17.66 62.51 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.694 0.759 . . . . 0.0 109.968 -179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -68.18 -25.62 65.33 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 114.438 -1.256 . . . . 0.0 109.193 176.36 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -93.65 -62.27 1.39 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 172.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 103' ' ' ILE . 8.0 t 52.08 19.42 1.03 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.429 1.492 . . . . 0.0 111.895 177.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.392 -4.289 0 N-CA-C 103.121 -3.992 . . . . 0.0 103.121 -175.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.62 177.2 4.78 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -136.33 167.75 23.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -177.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.73 137.27 51.86 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.2 m80 60.2 -167.84 0.17 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.105 0.962 . . . . 0.0 111.957 177.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -91.96 -10.3 39.9 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -66.99 156.25 88.13 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.917 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -76.92 -172.38 1.41 Allowed 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.333 2.022 . . . . 0.0 111.256 174.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.632 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.9 122.52 41.44 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.2 mt-30 -90.16 108.69 19.9 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.448 0.642 . . . . 0.0 110.953 178.089 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.93 132.54 60.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.712 -176.698 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -97.62 100.53 11.93 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 172.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 t -97.68 116.89 41.37 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.756 -171.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -94.24 114.93 27.11 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 174.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 27' ' ' GLU . 93.9 mt -102.58 106.15 16.78 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -179.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -93.13 142.7 27.01 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 97.9 mttt -119.14 103.0 9.13 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 176.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -90.47 117.04 32.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -91.57 166.89 12.59 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.412 -176.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.3 -37.13 84.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.008 -178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 128' ' ' PHE . 6.5 p-10 -74.69 -11.51 60.19 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -174.493 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.29 -13.42 30.93 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.005 -1.569 . . . . 0.0 113.136 176.074 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -86.61 157.91 19.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 175.357 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 0.6 OUTLIER -143.85 125.72 10.9 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.958 -177.539 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 t -85.55 132.88 34.11 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 50.6 mm -104.92 115.54 47.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.015 -177.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 10.8 tp10 -113.66 147.08 38.78 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.086 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -130.88 113.19 13.73 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.263 0.625 . . . . 0.0 109.598 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' HD11 ' A' ' 15' ' ' LEU . 32.2 mtmt -114.88 151.78 33.36 Favored 'General case' 0 C--N 1.277 -2.559 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.159 179.005 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -123.24 109.94 14.6 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -127.29 146.13 50.55 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 118.164 -1.414 . . . . 0.0 112.83 -176.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 44.6 mtmt -94.1 130.05 40.42 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.363 172.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.591 HG11 ' HB2' ' A' ' 39' ' ' PHE . 11.9 t -118.58 141.1 39.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -74.3 -30.09 61.92 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 119.318 0.963 . . . . 0.0 110.778 -179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 t -143.43 129.89 20.05 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.825 175.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.4 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -56.97 -30.87 64.47 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.971 0.415 . . . . 0.0 111.198 177.674 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.07 -39.7 75.44 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.728 179.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.92 -35.47 57.31 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.694 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.591 ' HB2' HG11 ' A' ' 33' ' ' VAL . 80.6 t80 -58.4 -46.97 85.36 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 121.576 0.703 . . . . 0.0 109.297 176.499 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -63.05 -39.62 95.26 Favored 'General case' 0 C--O 1.209 -1.05 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.236 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.73 -30.02 66.43 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.73 -45.05 76.12 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.176 179.615 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.05 18.89 21.19 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.236 -177.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -47.8 -30.11 3.73 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 177.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.4 -45.75 36.52 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.316 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.554 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 30.2 m95 -55.1 150.95 9.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.92 1.288 . . . . 0.0 110.586 178.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 75.3 m -84.98 116.12 23.2 Favored 'General case' 0 N--CA 1.419 -1.994 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.58 115.73 13.32 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.64 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 58.9 t -95.17 -51.6 10.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.874 -178.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 57' ' ' LEU . 11.8 pt-20 -153.89 151.76 29.84 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -144.72 146.92 32.42 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-O 121.686 0.755 . . . . 0.0 111.613 174.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -143.74 168.09 20.74 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 173.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -60.66 -26.15 66.87 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -167.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.56 -21.66 9.08 Favored Glycine 0 C--N 1.266 -3.342 0 C-N-CA 119.919 -1.134 . . . . 0.0 113.308 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -138.36 135.3 35.22 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-N 117.106 0.453 . . . . 0.0 111.796 -171.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 71.2 t -127.85 132.46 68.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 5.3 tp -112.27 115.06 28.18 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 121.449 0.642 . . . . 0.0 111.599 -179.592 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.493 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.7 m-85 -118.67 146.75 44.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.629 176.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -127.36 140.21 52.34 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-O 121.405 0.622 . . . . 0.0 110.503 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 16.6 tppt? -120.72 134.43 55.29 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 177.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.26 131.7 47.14 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -175.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 34.3 tpp -91.0 149.66 21.75 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.545 -169.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -82.85 -8.24 59.59 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.35 -177.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -131.14 -178.0 4.64 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.499 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 19.4 pt -93.21 167.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.262 0.553 . . . . 0.0 112.239 -174.08 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.541 ' HB2' ' OG ' ' A' ' 69' ' ' SER . 8.9 m -71.71 147.69 92.11 Favored Pre-proline 0 C--N 1.3 -1.569 0 C-N-CA 123.98 0.912 . . . . 0.0 111.441 -177.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -69.29 -39.28 7.62 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.673 2.249 . . . . 0.0 112.359 -179.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.3 OUTLIER -70.18 -27.47 64.54 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -178.208 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.541 ' OG ' ' HB2' ' A' ' 66' ' ' SER . 15.7 m -68.81 -24.1 64.35 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.744 177.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -78.64 -26.8 45.27 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 121.532 -0.73 . . . . 0.0 110.02 176.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.5 m -87.75 -42.06 14.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.887 -176.021 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' HIS . 96.0 m-20 -134.86 25.56 3.64 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.573 -174.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 69' ' ' SER . . . -78.93 141.85 24.76 Favored Glycine 0 C--N 1.299 -1.483 0 C-N-CA 120.183 -1.008 . . . . 0.0 112.264 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.681 ' HA ' ' O ' ' A' ' 120' ' ' ILE . 57.4 m-85 -154.01 116.42 4.36 Favored 'General case' 0 CA--C 1.47 -2.13 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 -177.277 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 85.9 mt -77.01 116.49 20.37 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.931 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 173.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.23 133.54 8.76 Favored Glycine 0 N--CA 1.413 -2.84 0 C-N-CA 120.047 -1.073 . . . . 0.0 113.702 -174.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 19.5 m -108.96 146.92 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.298 0 C-N-CA 118.251 -1.38 . . . . 0.0 110.881 176.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.431 ' HB2' ' CG2' ' A' ' 82' ' ' VAL . 18.5 m -89.2 169.15 11.7 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 172.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -53.47 -26.5 20.67 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.107 0.963 . . . . 0.0 112.923 -172.209 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -91.12 19.21 5.98 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' O ' ' HA ' ' A' ' 102' ' ' GLN . . . 69.99 39.14 74.56 Favored Glycine 0 CA--C 1.484 -1.845 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 177.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.77 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 43.6 t -77.07 116.98 21.21 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.143 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.8 mm -80.68 38.18 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 C-N-CA 128.121 2.568 . . . . 0.0 112.693 -169.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 p -91.6 142.05 28.04 Favored 'General case' 0 C--N 1.277 -2.549 0 O-C-N 121.614 -0.679 . . . . 0.0 111.831 -168.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.4 p -90.26 149.64 22.28 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.381 -1.328 . . . . 0.0 109.565 175.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -131.9 165.62 23.47 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.452 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 72' ' ' ASN . 84.9 m-70 -108.86 116.51 32.12 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 168.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.84 170.89 41.85 Favored Glycine 0 C--N 1.286 -2.195 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -175.103 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -52.33 123.12 27.46 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.965 0.382 . . . . 0.0 110.758 179.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.81 94.27 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.589 2.859 . . . . 0.0 112.933 -176.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.558 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 13.2 pt-20 -140.79 175.55 3.04 Favored Pre-proline 0 C--N 1.284 -2.28 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 16.4 Cg_endo -66.28 -15.84 49.57 Favored 'Trans proline' 0 C--N 1.366 1.47 0 C-N-CA 121.924 1.75 . . . . 0.0 112.209 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.43 2.24 41.7 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.725 176.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 27.6 t -124.61 167.45 14.49 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 172.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -135.01 131.89 20.08 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 -175.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -62.68 140.2 79.47 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.028 2.485 . . . . 0.0 112.419 -178.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.447 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 62.3 mt -75.36 -36.57 36.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.194 -179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.447 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -162.14 -177.34 5.68 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 178.7 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.5 m -146.01 120.43 9.67 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.8 -72.79 0.36 Allowed 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.163 -178.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -150.52 -176.45 5.5 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.81 -0.177 . . . . 0.0 111.246 -176.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.561 ' HG2' HG22 ' A' ' 82' ' ' VAL . 24.2 mt-30 -125.75 146.06 49.93 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.418 0.687 . . . . 0.0 112.244 -178.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.482 HG22 ' HA ' ' A' ' 139' ' ' SER . 28.3 pt -140.34 160.58 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.593 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 27.0 m-20 -79.38 112.88 17.05 Favored 'General case' 0 CA--C 1.487 -1.455 0 C-N-CA 120.432 -0.507 . . . . 0.0 111.214 177.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HA ' HD23 ' A' ' 108' ' ' LEU . 10.6 mt -71.04 -30.7 66.97 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.678 175.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -67.24 -15.98 64.01 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.427 177.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.593 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 3.1 ptm180 -91.99 -27.36 17.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.575 175.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.1 mm? -58.25 149.05 25.22 Favored 'General case' 0 CA--C 1.492 -1.288 0 C-N-CA 123.09 0.556 . . . . 0.0 111.543 175.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -68.81 138.56 54.88 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 166.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 113' ' ' GLN . 34.0 t -39.76 -62.97 0.63 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.257 1.423 . . . . 0.0 114.824 -170.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . 0.299 32.5 m170 -70.92 -13.28 61.96 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -172.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.463 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 52.8 mtp -71.74 -53.94 11.84 Favored 'General case' 0 CA--C 1.495 -1.146 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.502 172.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.588 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -66.39 -36.72 83.57 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.865 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.431 ' HD2' HD12 ' A' ' 117' ' ' LEU . 28.0 mmmt -62.82 -33.37 75.08 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 122.574 0.349 . . . . 0.0 110.478 176.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.429 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 61.5 t30 -69.91 -34.96 74.18 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 113' ' ' GLN . 40.6 mt -74.49 -26.35 59.95 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.042 178.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 52.5 mt -73.81 -45.99 48.02 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.214 0.53 . . . . 0.0 110.139 176.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' CD ' ' HA ' ' A' ' 115' ' ' ASN . 9.9 ptmt -76.61 -27.32 55.71 Favored 'General case' 0 C--O 1.213 -0.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 107.77 127.1 5.61 Favored Glycine 0 N--CA 1.405 -3.412 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 176.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 29.0 mm -74.01 133.42 78.75 Favored Pre-proline 0 C--N 1.297 -1.684 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.72 23.96 0.12 Allowed 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.994 3.13 . . . . 0.0 112.979 177.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.552 ' H ' ' C ' ' A' ' 120' ' ' ILE . 0.9 OUTLIER 63.96 171.32 0.17 Allowed 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 128.378 2.671 . . . . 0.0 113.204 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.699 ' HB3' ' HB2' ' A' ' 127' ' ' GLU . 94.3 mtt180 -145.93 176.67 9.52 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -174.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.528 HG22 ' H ' ' A' ' 125' ' ' LYS . 11.6 m -84.85 176.83 8.25 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.528 ' H ' HG22 ' A' ' 124' ' ' THR . 16.7 ptmt -58.87 -46.46 87.75 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 119.587 1.085 . . . . 0.0 113.723 -172.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.419 ' N ' ' HG3' ' A' ' 125' ' ' LYS . . . -74.24 -27.01 60.57 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 121.973 0.892 . . . . 0.0 109.273 -174.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' ' 123' ' ' ARG . 24.1 mt-10 -78.41 -32.73 48.82 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-N 114.092 -1.413 . . . . 0.0 109.532 -178.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 21' ' ' ASP . 30.2 t80 -67.56 -51.68 47.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.676 176.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 12.8 pt-20 -65.99 -20.57 66.24 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.19 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 14.5 t70 -66.85 -53.9 27.83 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.696 0.76 . . . . 0.0 110.202 173.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.2 p -65.0 -33.92 67.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.314 179.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -65.96 -40.38 87.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.006 176.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.516 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 10.1 pt-20 -67.82 -30.46 69.88 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.106 177.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -70.14 -38.4 75.51 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.586 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 21.4 mmt -62.08 -48.25 81.05 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 123.024 0.53 . . . . 0.0 110.349 176.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.519 ' HA ' ' OG ' ' A' ' 139' ' ' SER . 17.9 ptpt -71.49 -17.17 62.36 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.63 0.729 . . . . 0.0 112.08 -179.355 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.58 -19.64 65.82 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 173.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.408 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 81.3 m-85 -90.99 -74.5 0.5 Allowed 'General case' 0 N--CA 1.413 -2.307 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 171.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 136' ' ' LYS . 74.8 m 42.52 25.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.663 1.185 . . . . 0.0 114.167 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.393 -4.18 0 N-CA-C 107.636 -2.186 . . . . 0.0 107.636 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -85.04 133.41 34.24 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -115.35 178.28 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-O 121.416 0.627 . . . . 0.0 112.08 -172.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.21 113.76 26.11 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 105.458 -2.052 . . . . 0.0 105.458 173.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -81.73 -172.05 3.67 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.571 0.701 . . . . 0.0 111.763 -172.658 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -86.05 -20.02 29.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 175.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -78.52 132.01 66.66 Favored Pre-proline 0 N--CA 1.425 -1.688 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 170.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.673 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 52.2 Cg_endo -71.91 163.38 39.02 Favored 'Trans proline' 0 N--CA 1.431 -2.205 0 C-N-CA 120.865 1.043 . . . . 0.0 111.806 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -96.07 115.12 26.95 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.492 -172.523 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 89.8 mt-30 -79.41 105.13 10.5 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.3 t -109.67 121.79 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.237 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -98.0 109.95 22.62 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 34.0 m -102.81 133.84 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.307 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.903 -176.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -105.67 111.38 24.04 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 174.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 ' HB3' ' CZ3' ' A' ' 46' ' ' TRP . 82.7 mt -106.81 101.73 11.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.037 -172.621 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.401 ' CG ' HE22 ' A' ' 14' ' ' GLN . 47.8 mt-10 -86.46 147.03 26.17 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 43.2 mmtm -117.36 102.25 9.08 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 175.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.08 104.93 15.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-O 121.031 0.443 . . . . 0.0 109.857 -172.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -89.48 143.27 26.95 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 65' ' ' ILE . 75.8 mt -57.25 -38.5 73.95 Favored 'General case' 0 C--O 1.205 -1.28 0 O-C-N 124.046 0.841 . . . . 0.0 110.681 -177.019 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.57 ' HB2' HH11 ' A' ' 123' ' ' ARG . 6.7 p-10 -73.28 -2.46 22.06 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -174.269 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 110.09 -19.48 27.39 Favored Glycine 0 N--CA 1.427 -1.922 0 C-N-CA 119.648 -1.263 . . . . 0.0 113.153 176.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.9 146.43 46.15 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 1.9 p -150.06 116.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.424 0 CA-C-O 121.781 0.801 . . . . 0.0 109.946 177.091 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.6 m -87.43 124.54 33.53 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.437 -179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG23 ' OE1' ' A' ' 14' ' ' GLN . 49.7 mm -103.1 127.52 56.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 C-N-CA 122.865 0.466 . . . . 0.0 109.849 -175.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -126.11 148.0 49.48 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -130.84 108.15 9.64 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 13' ' ' VAL . 36.6 mtmt -114.35 156.59 24.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.822 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -123.49 109.69 14.14 Favored 'General case' 0 C--N 1.271 -2.807 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.935 172.131 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -123.04 135.87 54.6 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.122 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 38.6 mtmt -96.66 116.69 29.54 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.601 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 39' ' ' PHE . 8.8 t -115.4 131.78 66.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.895 -176.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -75.13 -37.29 61.46 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.27 0.557 . . . . 0.0 110.621 -179.001 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.7 t -120.97 112.83 19.25 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' PHE . 0.1 OUTLIER -57.75 -27.76 63.32 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.728 177.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -60.37 -36.76 78.81 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.243 178.508 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.63 -38.0 77.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.216 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' HB3' ' O ' ' A' ' 36' ' ' MET . 73.2 t80 -60.89 -47.41 86.51 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.912 178.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.6 m95 -63.97 -40.29 96.07 Favored 'General case' 0 CA--C 1.493 -1.218 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.176 -178.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.54 -33.45 74.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.096 179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.87 87.5 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.592 178.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -107.46 14.65 25.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -177.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.67 -25.9 20.13 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.52 -27.16 55.37 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.646 178.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.561 ' HB2' ' CD1' ' A' ' 58' ' ' PHE . 25.3 m95 -73.24 157.42 37.13 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 178.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.427 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 88.7 m -89.13 115.83 26.94 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -73.52 110.91 8.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.632 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 36.4 t -87.04 -45.66 16.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.611 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.5 pt-20 -164.6 159.83 19.5 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.33 175.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -144.57 143.26 30.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.149 174.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -138.23 162.66 33.72 Favored 'General case' 0 C--N 1.272 -2.801 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -58.71 104.1 0.2 Allowed 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.272 0.558 . . . . 0.0 112.431 -172.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.92 -11.76 59.03 Favored Glycine 0 N--CA 1.421 -2.322 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.942 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -136.2 126.28 26.15 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 118.504 1.152 . . . . 0.0 109.557 178.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 84.3 t -126.64 135.28 64.17 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.167 0.508 . . . . 0.0 110.124 -178.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.632 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 12.9 tp -109.78 115.63 30.2 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.497 179.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 14.4 m-85 -123.66 144.03 49.88 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.113 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 5.7 ptp180 -125.69 138.62 53.9 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.512 174.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.51 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 14.3 tppt? -119.81 127.92 53.22 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.05 95.73 4.81 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.067 -173.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 54.1 mtm -81.72 138.54 35.21 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.642 -178.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.87 82.51 7.5 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.094 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 125' ' ' LYS . 49.3 t0 177.07 168.76 0.56 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 174.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 20' ' ' LEU . 42.0 pt -94.3 173.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.8 p -72.54 145.79 87.93 Favored Pre-proline 0 C--N 1.296 -1.752 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.574 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.75 -39.85 84.03 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.306 2.671 . . . . 0.0 112.816 -177.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -68.67 -32.73 72.76 Favored 'General case' 0 C--O 1.21 -1.014 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -177.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.7 m -67.32 -22.22 65.63 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -76.56 -26.36 55.02 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 175.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.4 m -90.2 -33.42 5.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.127 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.031 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.428 HD21 ' HA2' ' A' ' 88' ' ' GLY . 26.3 t-20 -89.47 -75.07 0.45 Allowed 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.673 -179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' HA2' ' CB ' ' A' ' 123' ' ' ARG . . . 83.26 2.19 90.38 Favored Glycine 0 C--O 1.236 0.277 0 N-CA-C 116.915 1.526 . . . . 0.0 116.915 173.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -85.18 106.74 16.84 Favored 'General case' 0 CA--C 1.466 -2.278 0 CA-C-O 122.917 1.342 . . . . 0.0 110.165 -168.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 77.9 mt -86.13 136.32 23.14 Favored 'Isoleucine or valine' 1 C--N 1.238 -4.258 0 CA-C-N 113.004 -1.907 . . . . 0.0 106.409 176.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -114.57 98.13 0.86 Allowed Glycine 0 CA--C 1.477 -2.297 0 CA-C-O 121.889 0.716 . . . . 0.0 112.887 -168.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.811 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 73.2 t -106.31 123.23 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.083 0 CA-C-O 121.848 0.833 . . . . 0.0 109.648 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.1 m -89.11 166.45 13.84 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.712 -176.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -28.09 40.31 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -171.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -82.02 0.88 38.27 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.834 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 89.01 34.37 8.92 Favored Glycine 0 CA--C 1.481 -2.049 0 O-C-N 123.445 0.466 . . . . 0.0 112.043 -179.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.811 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 47.5 t -78.75 116.68 22.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 CA-C-N 115.576 -0.312 . . . . 0.0 110.376 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . 0.265 27.5 mm -82.09 39.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 127.442 2.297 . . . . 0.0 113.563 -172.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 39.9 t -91.19 167.34 12.41 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -171.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.8 p -115.54 141.73 47.67 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 172.113 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.503 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.7 m-85 -118.74 171.45 8.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -103.71 101.89 11.73 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 72' ' ' ASN . . . 94.74 -178.66 36.59 Favored Glycine 0 C--N 1.306 -1.129 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -176.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.625 ' HD3' ' O ' ' A' ' 118' ' ' LYS . 26.3 mmt180 -47.39 123.01 8.59 Favored Pre-proline 0 C--O 1.243 0.756 0 O-C-N 124.14 0.553 . . . . 0.0 109.614 175.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.543 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 11.7 Cg_endo -62.76 101.41 0.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.489 2.793 . . . . 0.0 111.911 179.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.475 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 12.1 pt-20 -140.07 165.76 28.44 Favored Pre-proline 0 C--N 1.29 -1.985 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 22.9 Cg_endo -67.48 -13.16 38.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.692 2.261 . . . . 0.0 112.874 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.432 ' HB3' ' OE2' ' A' ' 91' ' ' GLU . . . -89.11 -3.23 58.71 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.456 0.646 . . . . 0.0 109.794 176.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.7 t -109.19 169.75 8.49 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 174.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.39 143.92 30.77 Favored Pre-proline 0 C--N 1.303 -1.441 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.187 -175.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.82 121.82 5.62 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.276 1.984 . . . . 0.0 106.992 168.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' HB ' ' NE2' ' A' ' 98' ' ' GLN . 65.6 mt -76.06 -39.02 36.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 CA-C-O 121.517 0.675 . . . . 0.0 110.933 -173.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.48 ' NE2' ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -156.29 -176.09 5.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 -179.232 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 75.5 m -143.18 110.56 5.77 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 119.608 1.094 . . . . 0.0 109.706 173.023 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -72.91 -68.02 0.52 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -154.28 174.45 14.79 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.039 -1.096 . . . . 0.0 108.039 -175.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 31.4 tt0 -131.02 130.52 43.43 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.834 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 43.9 pt -129.44 163.46 34.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 123.48 0.712 . . . . 0.0 109.185 -177.822 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.736 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.5 OUTLIER -76.18 113.18 13.44 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.696 -0.627 . . . . 0.0 111.314 179.975 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.633 HD13 ' HB2' ' A' ' 113' ' ' GLN . 11.1 mt -72.66 -30.71 64.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.34 178.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.05 -16.67 64.13 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.773 0.321 . . . . 0.0 110.97 177.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.736 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 8.7 ptm180 -91.74 -18.0 24.57 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD22 ' HB3' ' A' ' 113' ' ' GLN . 3.3 mp -57.79 144.32 38.92 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.909 175.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.22 85.83 1.4 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.304 -178.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 m 43.71 -88.6 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 127.129 2.172 . . . . 0.0 115.529 176.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -79.21 -17.97 53.83 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -172.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 75.7 mmm -53.51 -55.65 23.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.27 0.557 . . . . 0.0 110.851 178.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.681 ' HB3' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -67.0 -37.79 84.84 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.965 -178.806 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -62.98 -36.32 83.14 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 122.541 0.337 . . . . 0.0 111.098 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -69.58 -35.95 75.83 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.679 179.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 112' ' ' MET . 35.9 mt -73.65 -22.93 59.83 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.0 179.131 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 63.3 mt -69.08 -37.15 78.31 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.107 0.48 . . . . 0.0 109.937 175.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.625 ' O ' ' HD3' ' A' ' 89' ' ' ARG . 19.1 mtpp -85.24 -31.03 23.36 Favored 'General case' 0 CA--C 1.478 -1.807 0 CA-C-O 121.852 0.834 . . . . 0.0 109.088 177.203 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 97.06 146.56 21.21 Favored Glycine 0 N--CA 1.405 -3.411 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -178.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 24.2 mm -80.13 126.65 78.98 Favored Pre-proline 0 C--N 1.283 -2.315 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 11.56 1.22 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.838 2.359 . . . . 0.0 114.26 -175.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -162.37 138.75 7.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -177.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.57 HH11 ' HB2' ' A' ' 21' ' ' ASP . 33.8 ttm180 -145.43 150.49 36.62 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.004 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 31.2 m -148.29 167.86 24.06 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 175.489 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.523 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 0.1 OUTLIER -52.99 -60.06 3.75 Favored 'General case' 0 N--CA 1.411 -2.422 0 C-N-CA 125.445 1.498 . . . . 0.0 111.291 -174.474 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.56 -23.19 62.56 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.933 -173.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' O ' HG12 ' A' ' 131' ' ' VAL . 5.9 mm-40 -82.0 -32.67 30.48 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.885 -176.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.48 -53.07 25.73 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 5.3 pt-20 -63.93 -24.35 67.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.918 178.517 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.8 -50.81 31.63 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.06 0.457 . . . . 0.0 110.666 177.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.5 p -68.79 -37.54 77.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.179 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.71 -38.15 80.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 178.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 8.6 pt-20 -70.12 -24.14 63.14 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.943 177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' HB ' ' A' ' 137' ' ' THR . 2.4 t60 -78.52 -27.82 46.08 Favored 'General case' 0 C--O 1.207 -1.154 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.518 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.1 mmt -69.08 -47.64 64.73 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.647 0.737 . . . . 0.0 109.916 174.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.522 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.8 ptpt -72.85 -16.91 61.58 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-O 121.893 0.854 . . . . 0.0 110.503 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 134' ' ' HIS . 1.0 OUTLIER -62.08 -24.27 67.0 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.882 172.407 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.413 ' HB3' ' HD3' ' A' ' 107' ' ' ARG . 97.5 m-85 -88.45 -56.24 3.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 172.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 32.6 p 47.33 23.2 0.32 Allowed 'General case' 0 C--O 1.247 0.96 0 C-N-CA 126.157 1.783 . . . . 0.0 115.524 178.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 2 N--CA 1.39 -4.411 0 N-CA-C 106.441 -2.664 . . . . 0.0 106.441 178.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.39 179.87 7.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 -175.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . 0.369 15.5 m 59.9 158.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.524 0 C-N-CA 127.609 2.364 . . . . 0.0 116.679 175.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -87.57 111.64 21.44 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.383 -177.363 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -100.33 -160.02 0.77 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -83.41 -12.48 56.4 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 172.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -85.87 150.64 53.48 Favored Pre-proline 0 N--CA 1.439 -1.007 0 CA-C-N 113.369 -1.741 . . . . 0.0 107.101 173.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 1.5 Cg_endo -83.73 -169.85 0.76 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 121.798 1.665 . . . . 0.0 110.937 175.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' LYS . 0.5 OUTLIER -130.9 116.34 17.75 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 -179.141 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 32' ' ' LYS . 75.8 mt-30 -79.37 111.5 15.67 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.172 0.51 . . . . 0.0 110.935 177.298 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.605 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 3.4 t -112.23 129.07 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.04 -179.894 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.86 101.32 10.91 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 1.9 t -94.71 123.24 46.75 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.305 -175.638 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.415 ' OE1' HG23 ' A' ' 26' ' ' ILE . 0.5 OUTLIER -98.62 118.15 34.67 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 176.661 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD22 ' CZ3' ' A' ' 46' ' ' TRP . 82.5 mt -108.74 112.85 25.36 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 -175.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -91.46 136.58 33.01 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' VAL . 34.8 mmtp -121.19 99.57 6.56 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.652 ' HB ' ' HB3' ' A' ' 61' ' ' GLN . 12.0 t -86.89 106.79 16.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.513 -176.227 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -94.12 155.9 16.85 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.112 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG22 ' A' ' 65' ' ' ILE . 38.9 mt -78.86 -6.67 56.67 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.327 1.061 . . . . 0.0 111.272 -176.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.647 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 2.7 p30 -75.37 -27.7 59.25 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.731 172.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.27 -22.97 8.25 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.102 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -87.7 119.46 28.04 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 117.283 0.541 . . . . 0.0 110.865 178.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 17' ' ' LYS . 42.9 t -94.28 116.04 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 m -84.48 119.58 25.32 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 HG23 ' OE1' ' A' ' 14' ' ' GLN . 36.1 mm -90.72 125.69 43.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 15' ' ' LEU . 8.3 tp10 -124.34 147.08 48.43 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 -176.046 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -120.73 124.99 46.49 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.808 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -127.63 133.09 49.68 Favored 'General case' 0 C--O 1.195 -1.794 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.261 -177.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 39.5 p-80 -121.59 121.15 36.78 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 174.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.14 144.04 44.84 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.404 -0.518 . . . . 0.0 111.065 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.543 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 32.8 mtmm -102.62 109.26 20.82 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 175.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.3 p -112.65 131.67 63.55 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.993 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.324 -176.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -71.01 -34.57 71.47 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.3 t -129.3 119.64 24.28 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -178.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -28.75 64.82 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.395 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.86 -36.66 84.65 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.62 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -67.21 -39.77 86.32 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.441 ' CZ ' HG11 ' A' ' 11' ' ' VAL . 56.6 t80 -63.84 -46.69 83.91 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 114.319 -1.31 . . . . 0.0 110.283 179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.3 m95 -63.54 -37.97 89.34 Favored 'General case' 0 C--O 1.212 -0.899 0 CA-C-O 120.858 0.361 . . . . 0.0 110.24 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.59 -32.87 73.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.151 178.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.1 -39.81 86.81 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.336 178.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -107.67 19.19 20.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.038 -177.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.47 75.89 0.26 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-O 122.108 0.956 . . . . 0.0 111.176 174.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 169.9 -40.08 0.2 Allowed Glycine 0 C--N 1.273 -2.926 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.973 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.599 ' CE3' ' HB2' ' A' ' 60' ' ' LYS . 23.1 m95 -64.3 151.72 43.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 173.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.443 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 27.5 m -84.06 115.87 22.58 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -73.19 108.4 6.05 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.669 ' HB ' ' HG ' ' A' ' 57' ' ' LEU . 84.8 t -88.84 -45.49 15.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.866 -176.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 57' ' ' LEU . 12.2 pt-20 -159.48 154.91 25.59 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 175.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -144.5 139.21 28.11 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.319 0.58 . . . . 0.0 110.457 171.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -146.07 108.61 4.48 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.822 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.39 -85.06 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.822 1.649 . . . . 0.0 111.841 -175.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 11' ' ' VAL . . . -126.68 0.1 7.29 Favored Glycine 0 N--CA 1.408 -3.222 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.562 -177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -100.67 122.35 43.17 Favored 'General case' 0 N--CA 1.411 -2.395 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 92.6 t -125.32 129.84 72.99 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.231 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.644 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.669 ' HG ' ' HB ' ' A' ' 49' ' ' VAL . 6.8 tp -110.06 119.03 38.0 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-O 121.191 0.519 . . . . 0.0 111.069 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 46' ' ' TRP . 25.6 m-85 -123.52 147.08 47.58 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.049 178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB ' ' A' ' 47' ' ' THR . 9.8 ptp180 -121.69 137.2 54.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.822 172.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.599 ' HB2' ' CE3' ' A' ' 46' ' ' TRP . 15.2 tppt? -129.12 113.77 15.51 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.652 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . 8.9 pt20 -110.37 121.77 46.09 Favored 'General case' 0 C--N 1.267 -2.989 0 CA-C-O 121.807 0.813 . . . . 0.0 109.389 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 37.9 mtm -102.64 162.84 12.6 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.337 -169.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -84.14 49.52 1.67 Allowed 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.505 -174.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -134.15 136.02 43.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.365 -177.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 21' ' ' ASP . 19.3 pt -95.04 0.67 10.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.373 173.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.42 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 16.4 m 68.99 160.73 0.15 Allowed Pre-proline 0 CA--C 1.57 1.712 0 O-C-N 123.674 0.609 . . . . 0.0 109.978 -177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 66' ' ' SER . 17.9 Cg_endo -63.57 -25.62 69.72 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.412 2.075 . . . . 0.0 112.008 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 71' ' ' VAL . 0.2 OUTLIER -66.93 -31.02 71.32 Favored 'General case' 0 C--O 1.206 -1.194 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.995 -176.152 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.3 m -68.53 -22.7 64.49 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 120.886 -1.134 . . . . 0.0 111.65 177.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -80.37 -24.12 40.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.163 0.506 . . . . 0.0 109.643 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 68' ' ' LEU . 2.7 m -93.78 -33.22 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.756 0.789 . . . . 0.0 109.435 179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -100.88 -76.39 0.56 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 114.724 -1.125 . . . . 0.0 110.411 -176.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 72.21 6.63 65.39 Favored Glycine 0 C--O 1.226 -0.4 0 N-CA-C 114.137 0.415 . . . . 0.0 114.137 177.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -85.58 116.86 24.12 Favored 'General case' 0 N--CA 1.396 -3.175 0 CA-C-O 122.719 1.247 . . . . 0.0 109.497 -172.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 79.0 mt -99.23 126.07 52.6 Favored 'Isoleucine or valine' 2 C--N 1.222 -4.936 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 173.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' HA3' ' CD1' ' A' ' 86' ' ' PHE . . . -111.54 100.42 1.19 Allowed Glycine 1 N--CA 1.391 -4.301 0 O-C-N 124.229 0.955 . . . . 0.0 112.744 -169.075 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 95.9 t -107.18 127.94 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.407 0 CA-C-O 121.86 0.838 . . . . 0.0 109.775 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.6 m -96.48 166.46 11.68 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.407 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -52.53 -29.06 23.34 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.716 1.207 . . . . 0.0 113.446 -174.282 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -80.78 8.66 7.66 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 176.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.726 ' HA3' ' O ' ' A' ' 103' ' ' ILE . . . 76.46 34.43 45.01 Favored Glycine 0 CA--C 1.482 -2.009 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.84 ' O ' ' HA ' ' A' ' 77' ' ' VAL . 29.0 t -76.2 112.74 14.3 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.32 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.47 ' HB ' ' H ' ' A' ' 101' ' ' PHE . 27.3 mm -82.3 38.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 127.795 2.438 . . . . 0.0 112.742 -173.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -91.35 174.42 7.39 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -171.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 66.2 p -117.61 143.59 45.99 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 172.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.53 ' CD1' ' HA3' ' A' ' 76' ' ' GLY . 2.9 m-85 -121.56 156.81 32.09 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -93.27 102.64 14.92 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 174.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.11 -172.94 32.6 Favored Glycine 0 N--CA 1.426 -2.014 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 -175.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.451 ' NH1' ' HB2' ' A' ' 118' ' ' LYS . 8.9 mmm180 -44.0 121.24 3.74 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.12 0.968 . . . . 0.0 111.973 175.161 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 118' ' ' LYS . 57.8 Cg_endo -78.56 84.04 2.11 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.386 2.057 . . . . 0.0 113.142 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.526 ' HB2' ' HD2' ' A' ' 92' ' ' PRO . 10.5 pt-20 -138.34 168.6 15.35 Favored Pre-proline 0 C--N 1.271 -2.835 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 91' ' ' GLU . 12.7 Cg_endo -62.69 -16.19 51.38 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.913 2.408 . . . . 0.0 112.658 -177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.25 -10.2 59.23 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-O 121.856 0.836 . . . . 0.0 110.062 177.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.9 m -116.59 163.8 15.55 Favored 'General case' 0 N--CA 1.419 -2.003 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.603 177.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -110.53 141.25 23.62 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.66 141.5 41.73 Favored 'Trans proline' 0 C--O 1.248 0.975 0 C-N-CA 122.706 2.271 . . . . 0.0 110.765 174.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.401 ' HB ' HE22 ' A' ' 98' ' ' GLN . 61.3 mt -82.57 -37.18 14.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.953 0.406 . . . . 0.0 110.82 -178.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.401 HE22 ' HB ' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -157.28 -160.39 0.94 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.4 m -146.68 124.66 12.03 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 118.75 0.705 . . . . 0.0 109.725 167.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -88.34 -64.66 1.11 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.774 0.321 . . . . 0.0 110.17 175.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.47 ' H ' ' HB ' ' A' ' 83' ' ' ILE . 5.6 m-85 -141.73 172.11 13.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.702 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 81' ' ' GLY . 20.9 mt-30 -133.55 120.94 21.41 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.92 1.288 . . . . 0.0 107.563 172.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.726 ' O ' ' HA3' ' A' ' 81' ' ' GLY . 19.6 pt -129.72 166.97 25.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.272 -172.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.623 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 0.9 OUTLIER -83.16 110.29 17.91 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.907 0.861 . . . . 0.0 112.382 177.669 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.556 ' HA ' HD23 ' A' ' 108' ' ' LEU . 17.8 mt -69.16 -27.12 65.25 Favored 'General case' 0 CA--C 1.496 -1.113 0 O-C-N 121.663 -0.648 . . . . 0.0 110.507 178.727 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -68.62 -15.57 63.57 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.046 176.423 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 104' ' ' ASP . 5.7 ptm180 -96.46 -18.01 20.16 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 105' ' ' LEU . 3.4 mm? -58.06 154.39 12.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 169.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -53.36 -75.17 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 O-C-N 123.672 0.607 . . . . 0.0 111.379 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.4 p -161.24 -73.33 0.06 Allowed 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.005 0.431 . . . . 0.0 112.078 175.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -79.34 -23.0 43.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.915 -174.242 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.466 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 57.0 mmm -48.07 -56.67 7.2 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.474 0.709 . . . . 0.0 110.918 176.603 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.61 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -65.25 -35.53 81.32 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.11 -178.449 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -71.76 -27.56 63.06 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.917 -177.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -70.64 -36.22 73.31 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 113' ' ' GLN . 30.2 mt -70.51 -30.48 67.26 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.896 177.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 113' ' ' GLN . 79.6 mt -63.84 -49.63 72.05 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.164 177.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER -81.08 -23.03 38.75 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 118.245 -1.382 . . . . 0.0 109.129 -179.606 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.22 137.55 8.79 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.354 177.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 20.9 mm -77.42 119.42 77.4 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.53 -0.4 6.67 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.228 2.618 . . . . 0.0 114.767 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 86.6 t80 179.55 146.55 0.21 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -175.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' NH2' ' HA ' ' A' ' 21' ' ' ASP . 12.9 ptt180 -154.62 158.83 40.31 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 174.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 125' ' ' LYS . 6.8 m -113.94 176.76 4.9 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 172.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.608 ' H ' HG22 ' A' ' 124' ' ' THR . 0.2 OUTLIER -61.44 -56.97 14.33 Favored 'General case' 0 N--CA 1.396 -3.152 0 C-N-CA 125.067 1.347 . . . . 0.0 112.143 -170.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -69.44 -23.03 63.62 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.937 -177.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HG3' ' HB ' ' A' ' 124' ' ' THR . 10.4 mt-10 -75.08 -32.22 61.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.269 179.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -64.8 -52.62 55.83 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.102 177.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.68 -22.8 66.66 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.951 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 16.4 t70 -71.31 -51.37 24.7 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.642 0.734 . . . . 0.0 110.565 176.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.551 ' O ' ' HG2' ' A' ' 135' ' ' MET . 7.4 p -68.19 -35.16 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.208 179.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.25 -35.46 74.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.23 177.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' HA ' ' HG2' ' A' ' 136' ' ' LYS . 12.3 pt-20 -70.84 -23.75 62.4 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.72 178.173 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -77.3 -40.13 45.45 Favored 'General case' 0 C--O 1.202 -1.413 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' MET . . . . . 0.551 ' HG2' ' O ' ' A' ' 131' ' ' VAL . 28.5 mmt -60.36 -45.96 91.65 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.312 0.577 . . . . 0.0 110.718 176.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.528 ' HG2' ' HA ' ' A' ' 133' ' ' GLU . 17.0 ptpt -72.49 -18.3 61.68 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.567 -179.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.3 -23.65 67.37 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 108' ' ' LEU . 68.0 m-85 -92.0 -61.27 1.66 Allowed 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.153 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.469 ' HA ' HG22 ' A' ' 103' ' ' ILE . 96.4 p 53.49 17.8 1.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.857 1.663 . . . . 0.0 113.67 178.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.395 -4.049 0 N-CA-C 104.711 -3.356 . . . . 0.0 104.711 -175.211 . . . . . . . . 1 1 . 1 stop_ save_